epirubicin has been researched along with Liver Neoplasms in 519 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (5.01) | 18.7374 |
| 1990's | 180 (34.68) | 18.2507 |
| 2000's | 153 (29.48) | 29.6817 |
| 2010's | 138 (26.59) | 24.3611 |
| 2020's | 22 (4.24) | 2.80 |
| Authors | Studies |
|---|---|
| He, L; Hui, LP; Koike, K; Li, Q; Li, W; Zhao, CY | 1 |
| Aramaki, O; Fujii, M; Kawasaki, S; Kokudo, N; Kubota, K; Matsuyama, Y; Moriguchi, M; Otsuji, E; Sakamoto, H; Sasaki, Y; Takayama, T; Tanaka, S; Yamanaka, N; Yodono, H | 1 |
| Honda, T; Imai, N; Ishigami, M; Ishizu, Y; Ito, T; Yamamoto, K; Yokoyama, S | 1 |
| Cheng, K; Duan, F; Feng, DP; Fu, JX; Wang, MQ; Xin, H; Ye, HY; Yu, HK; Yuan, B; Zhang, JL; Zhang, XJ | 1 |
| Liang, B; Lu, H; Xiong, B; Zheng, C | 1 |
| Huang, M; Ji, JS; Li, HL; Li, X; Lu, J; Shao, GL; Teng, GJ; Tu, JF; Yang, ZQ; Zeng, CH; Zhao, XY; Zhou, JM; Zhu, HD | 1 |
| He, F; Jiang, W; Li, B; Li, H; Lian, J; Ma, T; Sun, L; Wang, W; Wu, Y; Xiao, Y; Yan, X | 1 |
| Cai, C; Cai, S; Chen, J; Hong, X; Li, D; Li, J; Li, P; Lin, E; Wang, B; Yin, Z; Zeng, G; Zhang, M; Zhao, J; Zou, B | 1 |
| Cai, S; Chen, J; Chen, P; Fang, Z; Tang, Y; Wu, S; Zhou, Y | 1 |
| Bacis, G; Baldan, A; Butera, R; Contessa, G; Eleftheriou, G; Fagiuoli, S; Faraoni, L; Gallo, M; Giampreti, A; Lucà, M; Schranz, M | 1 |
| Bai, X; Chen, J; Gu, Z; Hu, W; Jia, X; Li, J; Liu, Y; Wang, J; Wang, W; Wu, X; Xu, Y; Yuan, G; Zhang, X; Zhu, XM | 1 |
| Guo, Z; Hao, K; He, X; Xiang, Y; Xu, J; You, Y; Zhao, P; Zhao, W | 1 |
| Huang, M; Li, M; Wang, H; Xiang, Z; Yan, H; Zhao, C | 1 |
| Fukuno, S; Ito, T; Konishi, H; Murayama, R; Nagai, K; Tamura, M | 1 |
| Basilico, F; Bezzi, M; Catalano, C; Corona, M; De Rubeis, G; Ginanni Corradini, L; Lucatelli, P | 1 |
| Cao, G; Chen, Y; Du, H; Fang, J; Gu, W; Guo, X; Han, J; Hou, Q; Hu, H; Hu, T; Hu, W; Huang, J; Ji, J; Ji, W; Li, L; Li, T; Luo, J; Peng, Z; Shao, G; Shi, C; Sun, J; Sun, Z; Wu, X; Xie, X; Xu, H; Ying, S; Yu, W; Yu, Z; Zhang, X; Zheng, J; Zhou, G; Zhou, J; Zhu, D | 1 |
| Albrecht, T; Gross, A | 1 |
| Iseki, K; Kobayashi, M; Nakai, M; Ogawa, K; Saito, Y; Sakamoto, T; Sugawara, M; Takekuma, Y; Yamada, T | 1 |
| Chen, S; Ji, R; Shi, X; Wang, Z; Zhu, D | 1 |
| Tang, Q; Yuan, P; Zheng, A | 1 |
| Iwamoto, H; Kamachi, N; Koga, H; Kuromatsu, R; Nakano, M; Niizeki, T; Noda, Y; Nomiyama, M; Okamura, S; Sakai, M; Shimose, S; Shirono, T; Suzuki, H; Tanaka, M; Torimura, T | 1 |
| Akashi, H; Ando, K; Furuya, D; Kawada, H; Kawai, H; Ogawa, Y; Suzuki, R | 1 |
| Cheng, DL; Gao, ZG; Hao, YH; Ji, CS; Jia, WD; Liu, KC; Lv, WF; Shi, CS; Su, MX; Xu, SB; Zhou, CZ | 1 |
| Dong, J; Lin, X; Liu, Y; Ren, Z; Wang, T; Wei, Z; Yang, X; Yue, Y; Zhang, Y; Zhao, X; Zheng, Y | 1 |
| Chen, G; Peng, Z; Tao, W; Wang, Z; Ying, Y; Zhang, D; Zhang, J; Zhu, H | 1 |
| Asayama, Y; Fujita, N; Honda, H; Ishigami, K; Nishie, A; Okamoto, D; Takayama, Y; Ushijima, Y | 1 |
| Ji, C; Ji, Y; Li, W; Ling, N; Qi, Z; Zhou, X | 1 |
| Fukuoka, Y; Kichikawa, K; Marugami, N; Masada, T; Nishiofuku, H; Sato, T; Tanaka, T; Tatsumoto, S | 1 |
| Chang, PM; Chen, IS; Chen, YC; Chiang, CL; Chou, NH; Hsiao, JH; Liang, HL; Liang, TJ; Tsai, CC; Wang, BW | 1 |
| Aikata, H; Horio, H; Ikeda, K; Ikeda, M; Ishii, H; Kawai, I; Kudo, M; Kumada, H; Morimoto, M; Nagamatsu, H; Okusaka, T; Sato, T; Torimura, T; Yamashita, T; Yokosuka, O | 1 |
| He, F; Huang, G; Li, B; Li, X; Lian, J; Lyu, X; Ni, Z; Wu, Y; Xiong, H; Yan, X; Zeng, Y; Zhang, N; Zhang, Y | 1 |
| Huang, Y; Jia, Z; Jiang, G; Shen, T; Tian, F; Tu, J | 1 |
| Goda, Y; Irie, K; Kobayashi, S; Maeda, S; Morimoto, M; Morinaga, S; Moriya, S; Numata, K; Ohkawa, S; Tanaka, K; Tezuka, S; Ueno, M | 1 |
| Kawamoto, C; Kumita, SI; Miki, I; Murakami, R; Murata, S; Saito, H; Sugihara, F; Uchida, E; Uchiyama, F; Ueda, T; Yamaguchi, H; Yasui, D | 1 |
| Du, Z; Li, X; Wang, X; Xia, Y | 1 |
| Bredt, C; Jakobs, T; Rieger, J; Rust, C; Sattler, T; Surwald, S | 1 |
| Bai, Z; Deng, G; Guo, J; He, S; Qin, Y; Zhao, G; Zhu, G | 1 |
| Paraluppi, G; Patrono, D; Romagnoli, R | 1 |
| Bie, B; Duan, B; Guo, Y; Huang, C; Li, J; Li, Z; Sun, J; Yang, J; Yang, S; Zhou, R | 1 |
| Haochen, W; Jian, W; Li, S; Tianshi, L; Xiaoqiang, T; Yinghua, Z | 1 |
| Chen, R; Hu, H; Wu, X; Zheng, W | 1 |
| Chen, LM; Chen, SQ; Han, J; Nie, CH; Sun, JH; Wang, BQ; Wang, HL; Wang, WL; Yu, ZN; Zhang, YL; Zheng, SS; Zhou, GH; Zhou, TY; Zhu, TY | 1 |
| Iwamoto, H; Kamachi, N; Koga, H; Kuromatsu, R; Kuwano, T; Nakano, M; Niizeki, T; Noda, Y; Nomiyama, M; Okamura, S; Sakai, M; Satani, M; Shimose, S; Shirono, T; Tanaka, M; Torimura, T | 1 |
| Cui, R; Dong, Y; Fan, H; Gu, J; Jia, Y; Li, Y; Liu, C; Ma, X; Miao, R; Niu, W; Qu, K; Ren, L; Wang, H; Wang, Z; Zhang, J; Zhang, X | 1 |
| Argirò, R; Bezzi, M; Catalano, C; Corona, M; Corradini, SG; Corsi, A; De Rubeis, G; Fiorentino, F; Lucatelli, P; Mennini, G; Nardis, PG; Rocco, B; Saba, L | 1 |
| Hashizume, T; Ohta, K; Sawada, Y; Shibamoto, Y; Shimohira, M; Suzuki, K | 1 |
| Basilico, F; Bezzi, M; Cannavale, A; Catalano, C; Corona, M; De Rubeis, G; Ginnani Corradini, L; Lucatelli, P; Nardis, PG; Rocco, B; Saba, L | 1 |
| Chen, J; Li, Z; Pan, Z; Yao, J; Yao, Z; Zhang, Y | 1 |
| Davies, H; Jiang, L; Shi, K; Xu, X | 1 |
| Hidaka, H; Inoue, T; Koizumi, W; Kubota, K; Nakazawa, T; Onoue, M; Shibuya, A; Tanaka, Y; Uojima, H; Wada, N | 1 |
| Adhoute, X; Bayle, O; Beaurain, P; Bourlière, M; Bronowicki, JP; Cassagneau, P; Castellani, P; Monnet, O; Muller, C; Oules, V; Pénaranda, G; Perrier, H; Pietri, O; Pol, B; Raoul, JL | 1 |
| Hamamoto, S; Hamuro, M; Jogo, A; Kageyama, K; Miki, Y; Minami, T; Nakano, MM; Nishida, N; Sohgawa, E; Yamamoto, A | 1 |
| Fujiwara, H; Gobara, H; Hiraki, T; Iguchi, T; Kanazawa, S; Komaki, T; Matsui, Y; Tanaka, T; Yagi, T | 1 |
| Chen, M; Guo, R; He, M; Lai, J; Li, Q; Shen, J; Shi, M; Tan, G; Wei, W; Zhang, Y; Zou, R | 1 |
| Akada, K; Aoshima, K; Koyama, N; Miura, Y; Taniguchi, S | 1 |
| Fan, W; Huang, G; Li, J; Tian, M; Zhang, X; Zhang, Y | 1 |
| Brüning, R; Habbel, VSA; Oldhafer, KJ; Rodt, T; Stavrou, GA; Wacker, F; Zeile, M | 1 |
| Asari, R; Ba-Ssalamah, A; Birner, P; Datler, P; Hejna, M; Pluschnig, U; Preusser, M; Schoppmann, SF; Schwameis, K; Zacherl, J | 1 |
| Harada, M; Hayashi, T; Hyodo, I; Kato, Y; Kinoshita, T; Koga, Y; Kuroda, J; Matsumura, Y; Ohkohchi, N; Saito, H; Takahashi, A; Takigahira, M; Yamamoto, Y; Yasunaga, M | 1 |
| Fujita, Y; Fukuda, K; Fuwa, S; Iizuka, Y; Ishii, N; Matsuda, M; Omata, F; Saida, Y; Suzuki, S; Uemura, M | 1 |
| Bao, LW; Jiang, XF; Jin, XJ; Lin, JJ; Lu, LJ; Wu, W | 1 |
| Duan, F; Fan, QS; Liu, FY; Song, P; Wang, MQ; Wang, Y | 1 |
| Amesty, MV; Chenu, BG; Chocarro, G; Gámez, M; Hernández, F; Hernández, S; Ortíz, R; Sánchez, A; Santamaría, ML; Tovar, JA | 1 |
| Bae, SH; Choi, JY; Chun, HJ; Kim, HY; Lee, HG; Lee, SW; Lee, YJ; Oh, JS; Song, DS; Song, MJ; Yoon, SK | 1 |
| Boukovinas, I; Christophyllakis, C; Georgoulias, V; Kakolyris, S; Malamos, N; Mavroudis, D; Papakotoulas, P; Politaki, E; Polyzos, A; Tryfonidis, K; Xenidis, N | 1 |
| Kimura, T; Kita, R; Komekado, H; Nasu, A; Nishiguchi, S; Nishijima, N; Nishikawa, H; Ohara, Y; Osaki, Y; Saito, S; Sakamoto, A; Takeda, H | 1 |
| Namikawa, K; Oashi, K; Omata, W; Tanaka, R; Tsutsumida, A; Yamamoto, Y; Yamazaki, N | 1 |
| Bae, SH; Choi, JY; Lee, JE; Lee, MA; Yoon, SK; You, YK | 1 |
| Chang, KL; Chang, WT; Cheng, HL; Hsieh, BS; Lee, KT | 1 |
| Hu, DG; Mackenzie, PI; Rogers, A | 1 |
| Chi, Y; Song, Y; Wang, J; Yang, L; Zhou, A | 1 |
| Kazem, A; Nafee, N; Nasr, M; Saad, H | 1 |
| Chen, N; Ji, YB; Li, WL; Ling, N; Mao, YX; Zhou, XJ | 1 |
| Chang, KL; Chang, WT; Cheng, HL; Chiu, CC; Hsieh, BS; Lee, KT | 1 |
| Bae, SH; Cho, SB; Chung, WJ; Jang, JY; Kim, YS; Lee, SH; Park, JY; Park, SY; Song, DS; Song, MJ; Yang, JM; Yim, HJ | 1 |
| Bai, B; Cui, Y; Lu, C; Luo, Z | 1 |
| Cao, J; Guo, W; Huang, M; Ji, D; Li, J; Liu, X; Peng, W; Sun, S; Wang, C; Yin, J; Yu, H; Zhao, X; Zhu, X | 1 |
| Clasen, S; Claussen, CD; Hoffmann, R; Ketelsen, D; Pereira, PL; Rempp, H; Syha, R | 1 |
| Gao, QG; Li, B; Li, W; Qin, ZH; Wu, HR; Xie, JM; Yu, HP | 1 |
| Fujii, K; Irie, T; Koizumi, W; Matsunaga, K; Minamino, T; Murano, J; Ogasawara, G; Shibuya, A; Watanabe, M; Woodhams, R | 1 |
| Huang, J; Li, B; Li, Q; Shen, J; Wang, J; Yuan, Y; Zheng, Y; Zou, R | 1 |
| Fujii, T; Ikeda, T; Kimura, H; Nakayama, H; Sakai, Y | 1 |
| Abdullah, LN; Chow, EK; Ho, D; Hou, W; Low, XC; Mohd Abdul Rashid, M; Toh, TB; Wang, X | 1 |
| Bo, L; Jianyong, L; Jiaying, Y; Lunan, Y; Minqing, X; Tianfu, W; Wentao, W; Yong, Z | 1 |
| Fischer, K; Göke, B; Kolligs, FT; op den Winkel, M; Paprottka, PM; Rauch, B; Schmidt, L; Straub, G | 1 |
| Kimura, T; Kita, R; Nishikawa, H; Osaki, Y | 1 |
| Abergel, A; Aho, S; Boulin, M; Boyer, L; Chabrot, P; Fagnoni, P; Guiu, B; Hillon, P; Sautou, V; Tavernier, J; Vadot, L | 1 |
| Chiba, T; Kanai, F; Kanogawa, N; Motoyama, T; Ogasawara, S; Ooka, Y; Saito, T; Suzuki, E; Tawada, A; Yokosuka, O; Yoshikawa, M | 1 |
| Chen, Y; Huang, X; Liu, C; Qu, K; Qu, P; Wu, Y; Xing, J; Xu, X; Yan, Z; Yuan, P; Zhang, H; Zhang, J | 1 |
| Baba, H; Beppu, T; Fujiyama, S; Haraoka, K; Komori, H; Okabe, K; Ouchida, Y; Sano, O; Yamanaka, T | 1 |
| Bian, Q; Hu, XG; Jin, G; Jing, W; Li, G; Liu, AA; Liu, R; Shao, CH; Song, B; Zhang, YJ; Zhou, YQ | 1 |
| Lau, WY; Lei, Z; Li, J; Shen, F; Si, A; Wan, X; Wang, K; Wang, Q; Wang, Y; Wu, D; Wu, M; Xia, Y; Yan, Z | 1 |
| Chang, CY; Guo, WY; Lee, RC; Lin, YY; Liu, CA; Tseng, HS | 1 |
| Aghemo, A; Colombo, M; Crespi, S; Iavarone, M; La Mura, V; Manini, MA; Martinetti, L; Nicolini, A; Sangiovanni, A; Viganò, D | 1 |
| D'Angelo, R; Fiore, F; Gatta, G; Grassi, R; Serra, N; Somma, F | 1 |
| Ohi, H; Ozaki, T; Seki, H; Yabusaki, H | 1 |
| Beck, S; Horger, M; Horger, T; Kaufmann, S; Ketelsen, D; Nikolaou, K; Oelker, A; Schulze, M | 1 |
| Azmi, S; Fadavi, H; Ferdousi, M; Malik, I; Malik, RA; Mansoor, W; Marshall, A; Petropoulos, IN; Ponirakis, G; Tavakoli, M | 1 |
| Hori, S; Seki, A; Shimono, C | 1 |
| Guo, QY; Liang, HY; Lu, ZM; Mao, XN; Shan, M; Sun, W; Wang, XH; Wen, F; Zhao, G | 1 |
| Chen, WJ; Ge, XC; Li, WT; Liu, JW; Tan, GQ; Wang, BL; Wu, F; Yan, L; Zhu, XJ | 1 |
| Di-Wen, S; Hao, L; Pan, GZ; Wang, P; Xue, QZ; Yuan, QZ; Zhang, J | 1 |
| Kanada, Y; Kobayashi, H; Maruyama, T; Matsuzaki, H; Miyazaki, A; Natsume, T; Note, H; Sato, Y; Sawada, H; Senba, Y; Suzuki, K; Tanaka, H; Yoshioka, T | 1 |
| Gao, M; Hua, R; Ji, B; Li, G; Liu, X; Yang, Y; Zhang, L; Zhou, Y | 1 |
| Lao, XM; Li, SP; Lin, XJ; Shi, M | 1 |
| Baresic, T; Buonadonna, A; Canzonieri, V; Corona, G; Lara, DP; Miolo, G; Santeufemia, DA; Viel, A | 1 |
| Goda, Y; Irie, K; Kobayashi, S; Morimoto, M; Moriya, S; Ohkawa, S; Tezuka, S; Ueno, M | 1 |
| Chen, R; Fan, X; Jia, R; Jing, W; Li, B; Liu, G; Tang, M; Wang, H; Wei, H; Yang, Y; Yin, F; Zhao, J; Zhou, X | 1 |
| Kinoshita, S; Shimada, T; Takeyama, H; Uchida, K | 1 |
| Higashihara, H; Hori, M; Kim, T; Maeda, N; Mikami, K; Nakamura, H; Nakaya, Y; Onishi, H; Osuga, K; Tatsumi, M; Tomoda, K | 1 |
| Codecà, C; Di Maria, G; Fazio, N; Ferrari, D; Fiore, J; Foa, P; Luciani, A; Maggioni, M; Oldani, S | 1 |
| Dogan, S; Goke, B; Graf, H; Helmberger, T; Hoffmann, RT; Jakobs, T; Jüngst, C; Jüngst, D; Reiser, M; Seidel, D; Straub, G; Waggershauser, T; Walli, A; Walter, A | 1 |
| Okita, K; Saeki, I; Sakaida, I; Shiraishi, R; Terai, S; Uchida, K; Yamaguchi, Y; Yamasaki, T | 1 |
| Bae, SH; Choi, IB; Choi, JY; Han, CW; Jang, JW; Jung, HS; Kay, CS; Kim, CW; Yoon, SK; You, CR | 1 |
| Chung, H; Hagiwara, S; Hatanaka, K; Hayaishi, S; Inoue, T; Ishikawa, E; Kitai, S; Kudo, M; Maekawa, K; Minami, Y; Takahashi, S; Tatsumi, C; Ueda, T; Ueshima, K; Xia, Y | 1 |
| Funada, T; Kaiga, T; Kochi, M; Mamiya, T; Ohkubo, R; Takayama, T; Yoshida, N | 1 |
| Mamori, S; Tajiri, H | 1 |
| Feng, B; Liang, SN; Liu, LL; Su, HY; Xu, K; Zhao, GS | 1 |
| Kolluri, RB; Raouf, S; Tipples, K | 1 |
| Berry, H; Dodwell, DJ; Gillibrand, A; Kumar, S; Perren, TJ; Velikova, G; Waters, SH | 1 |
| Ashley, S; Chau, I; Cunningham, D | 1 |
| Biondo, D; D'Antoni, A; Fili', D; Gridelli, B; Luca, A; Maruzzelli, L; Miraglia, R; Petridis, I; Pietrosi, G; Riccardo, V; Vizzini, GB | 1 |
| Dong, S; Sun, ZC; Xiao, XS; Xu, LC; Ye, XD; Yuan, Z | 1 |
| Li, QY; Wang, Y; Wu, FC; Yin, ZF | 1 |
| Hayashi, N; Hiramatsu, N; Ishida, H; Kanto, T; Kohga, K; Miyagi, T; Ohkawa, K; Takehara, T; Tatsumi, T | 1 |
| Buccellato, A; Cottone, M; Di Piazza, S; Fusco, G; Madonia, S; Marrone, C; Olivo, M; Orlando, A; Scala, L; Sciarrino, E; Valenza, F; Virdone, R | 1 |
| Aoki, T; Hamada, H; Katsuki, Y; Kenno, S; Takada, J | 1 |
| Crespi, S; Maggioni, M; Martinetti, L; Nicolini, A; Sangiovanni, A | 1 |
| Arii, S; Ikai, I; Kojiro, M; Kudo, M; Makuuchi, M; Matsuyama, Y; Takayasu, K | 1 |
| Kawasaki, Y; Nakazora, T; Shinohara, K; Suzukawa, M; Tominaga, T | 1 |
| Chen, JM; Chen, Y; Gong, GQ; Liu, QX; Luo, JJ; Qian, S; Wang, JH; Wang, XL; Yan, ZP | 1 |
| Ikeda, K; Kawamura, Y; Kumada, H | 1 |
| Morimoto, N; Shibaki, T | 1 |
| Ikoma, A; Kawai, N; Minamiguchi, H; Nakai, M; Nakata, K; Sahara, S; Sato, M; Sawa, N; Shirai, S; Sonomura, T; Takasaka, I | 1 |
| Baba, Y; Hiramine, Y; Hiwaki, T; Imamura, Y; Sho, Y; Tahara, K; Tsubouchi, H; Uto, H | 1 |
| Chan, HH; Cheng, JT; Chien, HF; Chu, TH; Hu, TH; Kuo, HM; Lai, KH; Pan, HB; Sun, CK; Tai, MH; Wang, EM | 1 |
| Hori, S; Kobayashi, K; Narumiya, S; Seki, A | 1 |
| Igarashi, Y; Kanayama, M; Matsui, T; Momiyama, K; Nagai, H; Sumino, Y; Wakui, N; Watanabe, M | 1 |
| Higashi, S; Ikushima, I; Iryo, Y; Ishii, A; Ota, Y; Seguchi, K; Shima, M | 1 |
| Higashihara, H; Maeda, N; Mikami, K; Nakamura, H; Nakazawa, T; Osuga, K; Tomiyama, N; Tomoda, K | 1 |
| Chun, CL; Dormady, S; Eisenstat, S; Lombard, C; Triadafilopoulos, G | 1 |
| Adamus, R; Loose, RW; Uder, M; Wilhelm, M | 1 |
| Matsuo, K; Shinohara, A; Yodono, H | 1 |
| Boc, M; Hlebanja, Z; Ocvirk, J; Reberšek, M; Skof, E | 1 |
| Fujise, Y; Kakite, S; Kato, J; Koda, M; Matono, T; Murawaki, Y; Nagahara, T; Sugihara, T; Tokunaga, S; Ueki, M; Yamashita, E | 1 |
| Altomare, E; Bargellini, I; Bartolozzi, C; Bertini, M; Bertoni, M; Bozzi, E; Bresci, G; Capria, A; Cicorelli, A; Cioni, R; Federici, G; Ginanni, B; Metrangolo, S; Parisi, G; Romano, A; Sacco, R; Tumino, E | 1 |
| Hori, S; Seki, A | 1 |
| Blijham, GH; Erdkamp, FL; Knibbeler-van Rossum, CT; Lalisang, RI; Loosveld, OJ; Nortier, JW; Rodenburg, CJ; Schouten, HC; Slee, PH; Smals, AE; Tjan-Heijnen, VC; van Bochove, A; Voest, EE; Wals, J; Wils, JA | 1 |
| Hayami, S; Ozawa, S; Shigekawa, Y; Tani, M; Uchiyama, K; Ueno, M; Yamaue, H | 1 |
| Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Imai, N; Kawamura, Y; Kobayashi, M; Kumada, H; Saitoh, S; Seko, Y; Sezaki, H; Suzuki, F; Suzuki, Y | 1 |
| Jung, G; Kim, BH; Kim, JS; Kim, NY; Lee, KJ; Park, SJ; Park, YM; Yeon, JW; Yun, HK | 1 |
| Iwazawa, J; Kitayama, T; Mitani, T; Ohue, S; Sassa, S | 1 |
| Honda, J; Kamatani, N; Kubo, M; Nakamura, Y; Sasa, M; Srinivasan, Y; Takahashi, A; Uno, S; Zembutsu, H | 1 |
| Chen, SH; Chuang, WL; Hsieh, MY; Lin, ZY | 1 |
| Cao, B; Ding, X; Gao, J; Gao, K; Ke, S; Li, M; Qian, X; Sun, W | 1 |
| Enomoto, K; Sakurai, K | 1 |
| Chen, SH; Chuang, WL; Hsieh, MY; Huang, CF; Lin, CI; Lin, ZY | 1 |
| Hashimoto, M; Matsui, O; Miyayama, S; Shibata, Y; Toshima, F; Tsuji, K; Yamashiro, M; Yoshida, M | 1 |
| Hirohara, J; Ikeda, H; Kaibori, M; Kariya, S; Koreeda, C; Kwon, AH; Nakahashi, Y; Okazaki, K; Sawada, S; Seki, T; Tanigawa, N | 1 |
| Cui, YF; Jiang, GX; Tai, S; Wang, ZD; Xu, XX; Yu, JH; Yu, Y; Zhong, XY | 1 |
| Ikoma, A; Kawai, N; Minamiguchi, H; Nakai, M; Nakata, K; Sahara, S; Sanda, H; Sato, M; Shirai, S; Sonomura, T; Tanaka, T | 1 |
| Higashi, S; Ikushima, I; Iryo, Y; Ishii, A; Seguchi, K; Yamashita, Y | 1 |
| Henmi, S; Inuzuka, T; Ishikawa, T; Kimura, T; Kita, R; Matsuda, F; Nakajima, J; Nishikawa, H; Osaki, Y; Saito, S; Sakamoto, A; Takeda, H | 1 |
| Bae, SH; Cha, JH; Choi, BG; Choi, JY; Chun, HJ; Jang, JW; Kim, HL; Woo, HY; Yoon, SK; Youn, JM | 1 |
| Bernardo, G; Di Cesare, P; Imbriani, M; Leoni, E; Minoia, C; Montagna, B; Poggi, G; Quaquarini, E; Quaretti, P; Regazzi, M; Riccardi, A; Sottani, C | 1 |
| Fukushima, M; Hatano, E; Iguchi, K; Ishii, T; Sumi, E; Taura, K; Teramukai, S; Uemoto, S; Yamamoto, K; Yamanaka, K; Yokode, M | 1 |
| Hatamaru, K; Henmi, S; Inuzuka, T; Kimura, T; Kita, R; Matsuda, F; Nakajima, J; Nasu, A; Nishikawa, H; Osaki, Y; Saito, S; Sakamoto, A; Takeda, H | 1 |
| Hu, Y; Li, H; Li, N; Zhou, Y | 1 |
| Abotouk, N; Halim, A | 1 |
| Chung, KW; Jang, JW; Jung, HS; Kay, CS; Kwon, JH; Oh, BS; You, CR | 1 |
| Ooi, H; Ozaki, T; Seki, H | 1 |
| Arnould, T; De Backer, O; Flamant, L; Hayez, A; Michiels, C; Pierre, M; Poumay, Y; Roegiers, E; Sterpin, C | 1 |
| Chen, MS; Fang, WQ; Guo, RP; Li, Y; Lin, XJ; Lu, LG; Luo, J; Shi, M; Xu, L; Zhang, YQ; Zou, RH | 1 |
| Hashimoto, N; Iwazawa, J; Mitani, T; Ohue, S | 1 |
| Cao, JM; Chen, B; Huang, XE; Kong, WD; Li, J; Lu, GM; Xu, J; Xu, TT; Yang, T | 1 |
| Arimoto, A; Kimura, T; Kita, R; Nishikawa, H; Osaki, Y; Wakasa, T | 1 |
| Chen, H; Chen, SP; Li, J; Lin, YC; Long, Y; She, ZG; Wu, JH; Yang, B; Zhong, LL; Zhu, X | 1 |
| Alessandroni, P; Catalano, G; Catalano, V; Fedeli, A; Giordani, P; Graziano, F; Luzi Fedeli, S; Rossi, D; Testa, E | 1 |
| Chen, Y; He, XF; Li, YH; Lu, W; Qiu, YR; Zeng, QL | 1 |
| Boucher, E; Boudjema, K; Brissot, P; Corbinais, S; Raoul, JL | 1 |
| Aitini, E; Cantore, M; Guadagni, S; Rabbi, C; Zamagni, D | 1 |
| Colombo, M; De Fazio, C; Del Ninno, E; Fasani, P; Lovaria, A; Nicolini, A; Ronchi, G; Saccheri, S; Sangiovanni, A | 1 |
| Andreesen, R; Bodenstein, H; Clemens, M; Fehnle, K; Fischer, JT; Heidemann, E; Hirschmann, WD; Kaufmann, M; König, M; Mahlke, M; Oberhoff, C; Scharl, A; Schulze, M; Souchon, R; Stoeger, H | 1 |
| Hamada, H; Katsuki, Y; Takada, J; Tsuji, Y | 2 |
| Harao, M; Hishinuma, S; Igarashi, S; Ishihara, M; Jindou, O; Kojima, K; Kotake, K; Matsui, T; Tsukioka, T; Yamamoto, T | 1 |
| Esumi, K; Furukawa, H; Imamura, H; Inoue, Y; Ishida, H; Katoh, H; Kitani, K; Masuda, N; Masutani, S; Onishi, H; Shimizu, J; Tatsuta, M; Tomotsu, K; Tsuda, K; Usui, T | 1 |
| Grubert, M; Hilger, R; Mross, K; Müller, HJ; Port, R; Richly, H; Scheulen, M | 1 |
| Akuta, K; Emoto, T; Kigami, Y; Kobayashi, H; Umeoka, S | 1 |
| Bighin, C; Colozza, MA; Contu, A; Del Mastro, L; Durando, A; Garrone, O; Genta, F; Lambiase, A; Stevani, I; Venturini, M | 1 |
| Furuse, J; Ishii, H; Maru, Y; Mera, K; Mikami, S; Nose, H; Onaya, H; Sakai, H; Satake, M; Yoshino, M | 1 |
| Ando, E; Fukumori, K; Sata, M; Shakado, S; Sumie, S; Tanaka, M; Yamashita, F; Yano, Y | 1 |
| Dobbs, NA; Ralph, LD; Thomson, AH; Twelves, C | 1 |
| Bighin, C; Del Mastro, L; Lunardi, G; Schettini, G; Stevani, I; Vannozzi, MO; Venturini, M | 1 |
| Ando, E; Fukumori, K; Sata, M; Sumie, S; Tanaka, M; Yamashita, F; Yano, Y | 1 |
| Maruyama, S | 1 |
| Hirakawa, K; Kosaka, K; Nishihara, T; Nishino, H; Ohira, M; Yamada, N | 1 |
| Blouin, P; Branchereau, S; Brugières, L; De Kraker, J; Leverger, G; Rubie, H; Tabone, MD | 1 |
| Al-Mufti, R; Towu, E; Winslet, M | 1 |
| Hong, YS; Kang, JH; Lee, KS; Lee, MA; Woo, IS | 1 |
| Benda, N; Claussen, CD; Duda, SH; Huppert, PE; Kloska, SP; Lauchart, W; Pereira, P; Torkler, C; Weinlich, M | 1 |
| Danenberg, K; Danenberg, P; Formentini, A; Hillenbrand, A; Kornmann, M; Salonga, D; Sander, S; Staib, L | 1 |
| Ho, HS; Ong, HS | 1 |
| Haq, TU | 1 |
| Bae, SH; Chang, UI; Choi, JY; Jang, JW; Kim, BS; Nam, SW; Park, YM; Yoon, SK | 1 |
| Chen, XM; Fu, L; Li, WK; Lin, HH; Luo, PF; Shao, PJ; Zhou, ZJ | 1 |
| Ito, C; Kobayashi, M; Kozaka, K; Matsui, O; Minami, T; Miyayama, S; Notsumata, K; Shinmura, R; Takamatsu, S; Taki, K; Tanaka, N; Toya, D | 1 |
| Akeboshi, M; Hamada, A; Nakatsuka, A; Takaki, H; Takeda, K; Yamakado, K | 1 |
| Cui, Y; Li, WH; Zhu, JR | 1 |
| Jassem, J; Sosińska-Mielcarek, K; Zaucha, R | 1 |
| Ahn, BM; Bae, SH; Cho, SH; Choi, JY; Chung, KW; Jang, JW; Kim, CW; Lee, CD; Lee, YS; Sun, HS; Yang, JM; Yoon, SK | 1 |
| Akimaru, K; Hirakata, A; Kato, S; Kawano, Y; Mamada, Y; Mineta, S; Tajiri, T; Taniai, N; Yokomuro, S; Yoshida, H | 1 |
| Gofuku, J; Ikeda, N; Kawasaki, K; Nishi, T; Yagyu, T; Yayoi, E | 1 |
| Ebisui, C; Fujimoto, T; Fukuchi, N; Hasuike, Y; Hayashi, N; Izawa, H; Koshino, T; Sakita, I; Soma, I; Yoshida, T | 1 |
| Chen, Y; Gan, YH; Ge, NL; Ren, ZG; Wang, YH; Xia, JL; Yang, BW; Yie, SL; Zhang, BH | 1 |
| Amoroso, V; Ferrari, VD; Fusi, A; Mambrini, A; Marini, G; Marpicati, P; Montini, E; Rangoni, G; Simoncini, E; Valcamonico, F; Vasalli, L | 1 |
| Abumiya, K; Kamachi, H; Kamiyama, N; Kamiyama, T; Khor, LW; Kobayashi, H; Kurauchi, N; Matsushita, M; Nakagawa, T; Nakajima, H; Nakanishi, K; Taguchi, K; Takahashi, H; Takahashi, M; Todo, S; Tsukahara, M; Watanabe, K | 1 |
| Cai, L; Cui, NJ; Gu, MF; Li, GH; Li, JQ; Li, Q; Liu, H; Liu, MZ; Wang, XS; Zhang, YQ | 1 |
| Asahara, S; Fujita, N; Fujita, R; Ikari, T; Kamei, A; Sato, E; Shimizu, M; Takano, K | 1 |
| Bernardeschi, P; Cantore, M; De Simone, M; Dentico, P; Fiorentini, G; Guadagni, S; Poddie, DB; Rossi, G; Rossi, S; Tumolo, S; Valori, VM | 1 |
| Ahn, SH; Cho, KB; Choi, JS; Chung, WJ; Hwang, JS; Hwang, JY; Jang, BK; Kim, GC; Kim, YH; Kwon, JH; Kwon, KM; Park, KS | 1 |
| Chen, Z; Feng, YL; Li, B; Ling, CQ; Yu, CQ; Zhu, DZ | 1 |
| Ishizuka, D; Kobayashi, K; Ueki, K; Wakakuwa, R | 1 |
| Araki, K; Haruno, M; Ogawa, Y; Sakai, K; Shimamura, R; Tanaka, H | 1 |
| Bonde, CT; Kirkegaard, P; Mogensen, AM; Nielsen, K; Rasmussen, A | 1 |
| Andersen, PK; Dombernowsky, P; Nielsen, D; Osterlind, K; Ryberg, M; Skovsgaard, T | 1 |
| Choi, CW; Choi, IK; Choi, JG; Kim, BS; Kim, JS; Kim, SJ; Kim, YH; Oh, SC; Park, KH; Seo, HY; Seo, JH; Shin, SW; Sul, HR; Sung, HJ; Yoon, SY | 1 |
| Chang, CM; Tzeng, WS; Wu, RH | 1 |
| Lui, J; Xu, S; Yang, W | 1 |
| Ciglar, S; Kukura, V; Radić, V | 1 |
| Heinemann, V; Kahlert, S; Kolb, HJ; Lindhofer, H; Menzel, H; Salat, C; Stemmler, HJ | 1 |
| Carrara, G; Doriguzzi, A; Gandini, G; Moretto, P; Pagano, E; Veltri, A | 1 |
| Andreone, P; Bernardi, M; Biselli, M; Cammà, C; Cursaro, C; Gasbarrini, G; Gramenzi, A; Lorenzini, S; Ricca Rosellini, S; Rossi, C; Stefanini, GF; Trevisani, F | 1 |
| Bighin, C; Cappuzzo, F; Del Mastro, L; Durando, A; Lambiase, A; Monfardini, S; Nicoletto, O; Olmeo, N; Puglisi, F; Venturini, M | 1 |
| Fischer, T; Fleischer, B; Galle, PR; Lohse, AW; Schattenberg, JM; Schuchmann, M; Schulze-Bergkamen, H; Siebler, J; Strand, S; Teufel, A; Weinmann, A; Wörns, M | 1 |
| Chen, RC; Chen, WT; Chiang, LC; Lii, JM; Tu, HY | 1 |
| Behrmann, C; Brauckhoff, K; Brauckhoff, M; Dralle, H; Gimm, O; Lorenz, K; Sekulla, C; Ukkat, J | 1 |
| Liu, FY; Shao, RH; Wang, MQ; Wang, ZP; Wang, ZQ; Ye, HY | 1 |
| Chen, D; Cheng, HY; Jia, YC; Xu, AM; Xu, W; Yang, YF | 1 |
| Hoki, M; Hori, S; Ito, T; Iwase, K; Kainuma, S; Kanou, T; Mizuno, H; Mizushima, T; Nakamori, Y; Ozawa, H; Souma, Y; Sugiura, T; Yamanaka, H | 1 |
| Chuang, WL; Chuang, YH; Hsieh, MY; Lin, ZY; Tsai, JF; Wang, LY; Yu, ML | 1 |
| Akimoto, M; Ebara, M; Fukuda, H; Kondo, F; Saisho, H; Sato, T; Yoshikawa, M | 1 |
| Li, X; Pan, W; Qiu, F; Qiu, ZY; Tian, KL | 1 |
| Bae, SH; Byun, JY; Cha, SB; Chang, UI; Choi, BG; Choi, JY; Chun, HJ; Jang, JW; Kim, CW; Kim, MS; Lee, SY; Lee, YJ; Nam, SW; Oh, HJ; Yoon, SK | 1 |
| Bernardeschi, P; Biancalani, M; De Simone, M; Dentico, P; Fiorentini, G; Palomba, A; Rossi, S; Scuderi, S; Vaira, M | 1 |
| Fujii, M; Hirota, S; Maruta, T; Matsumoto, S; Nakanishi, K; Ohno, Y; Saigo, K; Sugimura, K; Takenaka, D; Yoshikawa, T | 1 |
| Chen, YX; Jiang, GM; Tian, F; Zhao, JW | 1 |
| Chen, Z; Cheng, WW; Jiang, GL; Lin, JH; Liu, LM; Meng, ZQ; Zhang, XJ; Zhou, ZH | 1 |
| Chen, Y; Cheng, JM; Gong, GQ; Liu, QX; Liu, R; Luo, JJ; Qian, S; Wang, JH; Wang, XL; Yan, ZP | 1 |
| Li, X; Pan, W; Qiu, F; Qiu, ZY | 1 |
| Amano, M; Fujita, M; Hayashida, H; Higaki, N; Nakagawa, S; Niinobu, T; Nishikawa, Y; Sakon, M; Yamashita, S | 1 |
| Giommoni, E; Grifoni, R; Mercatelli, A; Neri, B; Pantaleo, P; Pantalone, D; Paoletti, C; Rotella, V; Taddei, A; Tonelli, P | 1 |
| Seemann, MD | 1 |
| Furuse, J; Gotohda, N; Ishii, H; Kinoshita, T; Kobayashi, A; Konishi, M; Nakagohri, T; Satake, M; Takahashi, S | 1 |
| Chen, Z; Feng, YL; Gu, W; Li, B; Ling, CQ | 1 |
| Baruch, NB; Biran, H; Dinerman, M; Idelevich, E; Karminsky, N; Katsenelson, RL; Man, S; Shani, A; Zvi, NB | 1 |
| Deguchi, K; Hamaguchi, J; Kamiyama, N; Kamiyama, T; Kudo, T; Nakagawa, H; Nakagawa, T; Nakanishi, K; Nishimura, S; Takahashi, M; Todo, S; Yokoo, H | 1 |
| Hagihara, A; Ikeda, M; Iwasa, S; Morizane, C; Ogura, T; Okusaka, T; Tanaka, T; Ueno, H | 1 |
| Bae, SH; Cho, SH; Choi, JY; Han, JY; Jang, JW; Kim, CW; Kim, DG; Lee, YS; Yang, JM; Yoon, SK | 1 |
| Caruso, S; Gridelli, B; Luca, A; Mamone, G; Marrone, G; Maruzzelli, L; Miraglia, R; Petridis, I; Pietrosi, G; Vizzini, G | 1 |
| Hirashita, T; Nakashima, K; Sakai, I; Sakai, M | 1 |
| Ishiguro, A; Itoh, J; Munakata, A; Munakata, M; Sakata, Y; Shitara, K; Suzuki, K; Takahata, T | 1 |
| Guan, JH; Huan, HY; Mao, F; Sun, Q; Zhou, YD | 1 |
| Asakura, T; Mamori, S; Ohkawa, K; Tajiri, H | 1 |
| Imai, M; Ishikawa, T; Kamimura, H; Kamimura, T; Ohta, H; Seki, K; Togashi, T; Tsuchiya, A; Watanabe, K; Yoshida, T | 1 |
| Hidaka, Y; Higashi, S; Ikushima, I; Ishii, A; Kanemaru, M; Ota, Y; Seguchi, K; Shima, M | 1 |
| Chang, HM; Kang, YK; Kim, KM; Kim, MK; Kim, TW; Lee, JL; Lee, JS; Lee, SS; Ryu, MH; Sym, SJ | 1 |
| Couban, S; Crump, M; Dancey, J; Girouard, C; Gluck, S; Kirkbride, P; Levine, M; Marlin, S; O'Reilly, S; Pritchard, KI; Shepherd, L; Shore, T; Stewart, D; Tu, D | 1 |
| Kakeda, S; Korogi, Y; Miyamoto, W; Moriya, J; Nishino, K; Oda, N; Ohnari, N | 1 |
| Hagihara, A; Ikeda, M; Iwasa, S; Kojima, Y; Morizane, C; Okusaka, T; Ueno, H | 1 |
| Baldan, A; Burra, P; Cardin, R; Cillo, U; Cristofori, C; Farinati, F; Giacomin, A; Girardi, L; Pivetta, G; Ragazzi, R; Sergio, A | 1 |
| Chen, Y; Liu, QX; Luo, JJ; Wang, JH; Yan, ZP | 1 |
| Kawaguchi, K; Ku, Y; Matsuda, T; Takamatsu, M | 1 |
| Calzolari, F; Cecconetto, L; Giampalma, E; Golfieri, R; Milandri, C; Passardi, A; Tison, C | 1 |
| Alvarez, A; Dirix, L; Dumez, H; Latz, J; Melemed, A; Oliveira, CT; Paridaens, R; Prové, A; Simms, L; Wildiers, H | 1 |
| Chang, SC; Chen, JJ; Chou, CK; Lin, CH; Lin, CY; Tzeng, WS; Wu, RH; Yang, SC | 1 |
| Li, T; Li, ZW; Wen, HC | 1 |
| Camaggi, CM; Canova, N; Giovannini, M; Lafelice, G; Marraro, D; Martini, A; Martoni, A; Pannuti, F; Strocchi, E; Tamassia, V | 1 |
| Cunningham, D; Ellis, PA; Hickish, T; Hill, A; Nicolson, M; Norman, A; O'Brien, ME | 1 |
| Endou, K; Makita, F; Matsumoto, T; Matsuzaki, Y; Saitou, S; Satou, K; Shimoda, R; Takehara, K; Yamada, T; Yuasa, K | 1 |
| Hayashi, S; Inoue, J; Kawai, S; Kawarada, Y; Kusano, M; Monden, M; Ogawa, M; Ohashi, Y; Okamura, J; Tani, M | 1 |
| Higuchi, T; Kikuchi, M; Okazaki, M | 1 |
| Brambs, HJ; Claussen, CD; Dette, S; Dietz, K; Duda, SH; Geissler, F; Huppert, PE; Lauchart, W | 1 |
| Bader, R; Bigard, MA; Boissel, P; Boudjema, K; Bronowicki, JP; Doffoel, M; Dumas, F; Vetter, D; Weiss, AM; Wenger, JJ | 1 |
| Kosmidis, P; Kyparidou, E; Lygidakis, NJ; Parissis, J; Ziras, N | 1 |
| Furukawa, J; Kinuta, M; Maruyama, H; Okamura, J; Ooi, H; Sekimoto, M; Tateishi, H; Yayoi, E | 1 |
| Ariga, T; Kinoshita, H; Maruyama, T; Ooshima, I; Ozaki, M; Shimada, H; Shouko, T; Takeda, A; Yoshimura, S | 1 |
| Hojyo, M; Koizumi, T; Kosaka, A; Maruo, H; Mori, K; Osaku, M; Watahiki, Y | 1 |
| Akiyama, J; Hyogo, H; Ito, K; Kida, M; Kido, S; Kojima, K; Matsuda, M; Matsuura, M; Nakajima, N; Yamamoto, K | 1 |
| Fukuma, E; Goto, S; Imai, I; Ishiyama, J; Kano, N; Kasugai, H; Kera, J; Miyajima, N; Takeuchi, S; Yamakawa, T | 1 |
| Hiraoka, M; Itani, K; Kondo, M; Miura, K; Noguchi, M; Tanaka, Y; Watanabe, N; Yoshikawa, T | 1 |
| Nabeyama, A; Nakajima, A; Nakao, A; Okada, Y; Sakagami, K; Sato, S | 1 |
| Kamiyama, T; Matsushita, M; Misawa, K; Shimamura, T; Uchino, J; Une, Y | 1 |
| Gu, Q; Ji, T; Sun, J | 1 |
| Egami, I; Onda, M; Yoshida, Y | 1 |
| Hiroshige, K; Ikeda, T; Korenaga, D; Nishizaki, T; Sugimachi, K; Takenaka, K; Yoshida, K | 1 |
| Shi, ZH; Wang, ZY; Zai, RY | 1 |
| Ikeda, T; Nishizaki, T; Sugimachi, K; Takenaka, K; Yoshida, K | 1 |
| Kanematsu, M | 1 |
| Miura, T; Shinohara, K | 1 |
| Casarrubea, G; Cecchetto, A; Chiesura-Corona, M; Feltrin, GP; Miotto, D; Savastano, S | 1 |
| Bokemeyer, C; Harstrick, A; Kynast, B; Laage, E; Schmoll, E; Schmoll, HJ; von Wussow, P | 1 |
| Dal Monte, PR; Milandri, GL; Ricci, S; Rossi, G; Roversi, R | 1 |
| Higashi, S; Iwata, K; Nakashima, T; Setoguchi, T; Shimizu, M; Tamura, S; Tateno, S; Uchiyama, F | 1 |
| Abe, R; Hatakeyama, Y; Hoshino, M; Igarashi, W; Koyama, Y; Ohtake, T; Ono, T; Sato, N | 1 |
| Imai, M; Katsuki, Y; Nishimura, A; Tsuji, Y; Yasuda, T | 1 |
| Furukawa, H; Hiratsuka, M; Imaoka, S; Ishikawa, O; Kabuto, T; Kameyama, M; Kishimoto, S; Nakano, H; Ohigashi, H; Sasaki, Y | 1 |
| Hori, S; Inoue, Y; Masuike, M; Murakami, T; Nakamura, H; Nakanishi, K; Oi, H; Tomoda, K; Tsukaguchi, I; Watanabe, H | 1 |
| Inagaki, Y; Miyakawa, A; Nakamura, J; Nakasato, Y; Ogawa, R; Okamoto, T; Onda, K; Ono, M; Shiino, Y; Yokota, T | 1 |
| Fujisawa, J; Satoh, Y; Uchino, J; Une, Y | 1 |
| Morita, S; Motohara, T; Ozawa, Z | 1 |
| Ikenaga, M; Kikkawa, N; Kobayashi, K; Mishima, H; Morita, T; Shin, E; Takatsuka, Y; Tamaki, Y; Touno, T; Yagyu, T | 1 |
| Ichikawa, T; Kobayashi, Y; Matsuura, K; Miyata, M; Nagai, J; Shimanuki, K; Shinohara, K; Tanaka, O; Touru, M; Uraguchi, T | 1 |
| Fehske, W; Fischer, HP; Hartlapp, JH; Reichel, C | 1 |
| Boese-Landgraf, J; Chen, Y; Fobbe, F; Reichel, M; Schmoll, E; Wolf, KJ | 1 |
| Akashi, H; Inoue, Y; Mizumoto, S; Nakamura, H; Yamasaki, K; Yano, M | 1 |
| Dobbs, NA; Johnson, PJ; Metivier, EM; Rizzi, P; Twelves, CJ; Warwick, JD; Williams, R | 1 |
| Iwasaki, N; Teshima, Y | 1 |
| Ishiguro, J; Kato, T; Niwa, M; Ogoshi, K; Saito, Y | 1 |
| Iwamiya, T; Ohta, Y; Sawada, S | 1 |
| Ebara, M; Endo, F; Iijima, T; Iwama, S; Kimura, M; Nakano, T; Saisho, H; Shimamura, Y; Suzuki, Y; Yoshikawa, M | 1 |
| Asakura, H; Hayakawa, A; Ichida, T; Ito, S; Kato, M; Mori, S; Sato, H; Sato, T; Sugitani, S; Watanabe, M | 1 |
| Ito, S; Nishioka, M; Ogawa, N; Ohta, Y; Watanabe, S; Yamamoto, Y | 1 |
| Bailey, S; Beningfield, SJ; Geddes, C; Krige, JE; Madden, MV; Terblanche, J; Werner, ID | 1 |
| Kunii, Y; Mashiko, H; Momono, S; Muto, I; Nakagawa, K; Ouchi, A; Shiiba, K; Wada, M; Yamamoto, K; Yamazaki, T | 2 |
| Fujimoto, T; Kitada, M; Murotani, M; Okumura, Y; Saito, M; Shibata, T; Takada, T; Takami, M; Tsukahara, Y; Watanabe, T | 1 |
| Ishikawa, A; Ito, K; Matsuda, M; Matsuura, M; Nakajima, N; Ozawa, M; Suzuki, K; Toyama, K | 1 |
| Alam, S; Hata, Y; Nagabuchi, E; Sato, Y; Uchino, J; Une, Y | 1 |
| Lauchart, W; Pirschel, J | 2 |
| Abo, H; Kantoh, T; Tomotsu, K; Usui, T | 1 |
| Akimoto, K; Fujita, M; Katsumori, T; Kohda, Y; Maeda, T; Nakano, Y; Ohno, K; Satoh, O; Takahashi, T | 1 |
| Hiratsuka, M; Imaoka, S; Ishikawa, O; Iwamoto, S; Kameyama, M; Kishimoto, S; Masutani, S; Nakamori, S; Ohigashi, H; Sasaki, Y | 1 |
| Kosaka, A; Maruo, H | 3 |
| Kono, H; Minami, K; Nagata, N; Sato, Y; Yamamoto, T | 1 |
| Aoyagi, H; Horiguchi, J; Iino, Y; Ishida, T; Maemura, M; Morishita, Y; Sugamata, N; Takai, Y; Yokoe, T | 1 |
| Hall, KS | 1 |
| Kim, T; Kishimoto, H; Matsushita, M; Murakami, T; Nakamura, H; Oi, H | 1 |
| Bhattacharya, S; Dick, R; Dusheiko, GM; Hilson, AJ; Hobbs, KE; Novell, JR | 1 |
| Klüppelberg, U; Lienemann, A; Reiser, MF; Schnarkowski, P | 1 |
| Andreyev, HJ; Cunningham, D; Hill, AS; Norman, AR; Padhani, AR; Ross, PJ; Webb, A | 1 |
| Masuko, Y; Misawa, K; Shimamura, T; Une, Y; Yasuhara, M | 1 |
| Bezzi, M; Broglia, L; Iacari, V; Iacobelli, D; Maccioni, F; Rossi, M; Rossi, P | 1 |
| Deguchi, S; Fujita, M; Honda, K; Kikuchi, T; Miyata, A | 1 |
| Fukui, H; Hoshino, K; Ikeda, M; Kawaguchi, H; Nitta, K; Tsujitani, S; Unate, H | 1 |
| Nakamura, H | 1 |
| Hojyo, M; Hoshiya, Y; Kaneko, T; Kosaka, A; Mori, K; Ohara, M; Shikata, A; Watabiki, Y; Yamada, S; Yamamoto, N; Yamazaki, M; Yorozuya, K | 1 |
| Furukawa, J; Kinuta, M; Maruhashi, S; Maruyama, H; Masuda, N; Matsui, S; Okamura, J; Ooi, H; Takiguchi, S; Tateishi, H; Tokunaga, M; Yano, H; Yayoi, E | 1 |
| Iwasaki, T; Kitagawa, T; Ku, Y; Kuroda, Y; Kusunoki, N; Maeda, I; Saitoh, Y; Sugimoto, T | 1 |
| Dodds, HM; Pond, SM; Rivory, LP; Strong, RW; Walpole, ET | 1 |
| Bower, M; Habib, N; Newlands, ES | 1 |
| Clausen, OP; De Angelis, P; Lehne, G; Rugstad, HE | 2 |
| Hejna, M; Kornek, GV; Müller, C; Pfeffel, F; Pidlich, J; Raderer, M; Scheithauer, W | 1 |
| Belli, L; Colombo, E; Cornalba, GP; Damiani, G; Magistretti, G; Puricelli, GP | 1 |
| Castaneda, F; Hasse, F; Jäger, H; Löhlein, D; Mathias, KD; Mehring, UM | 1 |
| Adamus, R; Georgi, M; Tesdal, IK | 1 |
| Hayashi, T; Kohno, H; Nagasue, N; Ono, T; Uchida, M; Yamanoi, A; Yukaya, H | 1 |
| Nakamura, S; Tanaka, K | 1 |
| Hayashi, S; Inoue, J; Jinno, K; Kawai, S; Kawarada, Y; Kubo, Y; Kuroda, C; Kusano, M; Makino, M; Masuzawa, M; Monden, M; Mori, T; Nagasue, N; Nakanishi, Y; Oda, T; Ogawa, M; Ohashi, Y; Okamura, J; Sakata, Y; Shimamura, Y; Takahashi, A; Takayasu, K; Tamura, K; Tani, M; Yumoto, Y | 1 |
| Kinuta, M; Maruyama, H; Masuda, N; Matsui, S; Oi, H; Okamura, J; Tateishi, H; Yano, H; Yayoi, E | 1 |
| Hirai, T; Hirashima, N; Itazu, I; Kano, H; Kumada, K; Matsuura, H; Nemoto, A; Nojiri, O; Sakakibara, K | 1 |
| Kato, Y; Maeyama, S; Mamada, Y; Mizuno, H; Okabe, K; Sakuyama, K; Sato, A; Shinagawa, T; Suemori, S; Suga, M; Suzuki, H; Suzuki, M; Tominaga, T; Yamamoto, T; Yamanouchi, E | 1 |
| Hasebe, S; Honda, M; Kuniyasu, Y; Matsuoka, S; Obuchi, M; Takizawa, K; Yamada, M | 1 |
| Harada, A; Kurokawa, T; Nakao, A; Nonami, T; Takagi, H; Takeuchi, Y; Taniguch, K; Yasui, M | 1 |
| Cagol, PP; Carrabetta, S; Civalleri, D; Cosimelli, M; De Cian, F; Mondini, G; Pellicci, R; Simoni, G | 1 |
| Nakamura, H; Oi, H | 1 |
| Ebara, M; Endo, T; Kimura, K; Nakamura, H; Saisho, H; Yasuhara, K; Yoshikawa, M | 1 |
| Aitini, E; Amadori, M; Bertani, M; Bezzi, A; Campo, S; Cantore, M; Cavazzini, G; Mambrini, A; Pari, F; Pulica, C; Rabbi, C; Smerieri, F; Zamagni, D | 1 |
| Beger, HG; Butzer, U; Danenberg, KD; Danenberg, PV; Kornmann, M; Leder, GH; Lenz, HJ; Link, KH; Metzger, R; Pillasch, J; Safi, F; Weindel, M | 1 |
| Hattori, K; Izumi, N; Marumo, F; Sakai, H; Sakai, Y; Sato, C; Tazawa, J; Tozuka, S; Yauchi, T; Yoshida, T | 1 |
| Furuse, J; Iwasaki, M; Kanemoto, H; Moriyama, N; Okumura, H; Yoshino, M | 1 |
| Ikeuchi, T; Kogawa, T; Kokawa, A; Maeda, S; Tanaka, K; Yamamoto, K; Yamamura, H; Yoshii, T | 1 |
| Baba, S; Ishida, H; Kawasaki, T; Masutani, S; Miya, A; Morimoto, O; Satomi, T; Shiozaki, K; Tatsuta, M; Tsuji, Y | 1 |
| Awane, Y; Maeshiro, T; Miyamoto, S; Umekita, N | 1 |
| Hamada, H; Hashimoto, M; Katsuki, Y; Kawata, S; Kon, H; Sasaki, R; Tomita, I; Tsuji, Y; Yasuda, T | 1 |
| Ebisui, C; Hirai, T; Kanai, T; Kouro, T; Miyamoto, A; Murai, N; Murata, A; Okazaki, M; Tada, M | 1 |
| Hoshiya, Y; Kosaka, A; Mori, K; Ohara, M; Shikata, A; Watabiki, Y; Yamada, S; Yamazaki, M | 1 |
| Ayabe, H; Hara, S; Hashizume, S; Itoyanagi, N; Oka, T; Shinguu, H; Tagawa, Y; Tooyama, H; Tou, K; Tsuji, H; Yamamoto, S; Yamazumi, K | 1 |
| Arai, K; Imai, R; Ito, K; Kojima, K; Muro, H; Nakagami, K; Nakajima, N; Nishimura, K; Onogawa, S; Suzuki, M; Tohyama, K; Umeda, Y | 1 |
| Hayashi, N; Iihara, K; Ikeda, K; Ishida, T; Kitada, M; Niinobu, T; Ogawa, M; Shibata, N; Shibata, T; Takada, T; Takami, M; Tsukahara, Y | 1 |
| Bachellier, P; Bazin, C; Bigard, MA; Boissel, P; Boudejma, K; Bronowicki, JP; Chone, L; Doffoel, M; Gaucher, P; Jaeck, D; Nisand, G; Pflumio, F; Uhl, G; Vetter, D; Wenger, JJ; Wolf, P | 1 |
| Dziewulska-Bokiniec, A; Rolka-Stempniewicz, G; Wojtacki, J | 1 |
| Kiba, T; Kitamura, T; Kondo, M; Morita, K; Nakamura, S; Numata, K; Okazaki, H; Saito, S; Sekihara, H; Tanaka, K | 1 |
| Bertulezzi, G; Bobbio-Pallavicini, E; Civelli, L; Moroni, M; Nastasi, G; Porta, C; Pugliese, P | 1 |
| Sakata, Y; Tsushima, K | 1 |
| Armillotta, N; Bartolozzi, C; Cicorelli, A; Cioni, D; Di Giulio, M; Donati, F; Lencioni, R; Moretti, M; Paolicchi, A; Pinto, F | 1 |
| Ebara, M; Fukuda, H; Saisho, H; Sugiura, N; Yoshikawa, M | 1 |
| Iwai, S; Kono, S; Takano, S | 1 |
| Ametani, M; Ihaya, T; Matsusue, E | 1 |
| Andersson, H; Horvath, G | 1 |
| Arai, Y; Cantone, M; Colopi, S; Gallo, E; Molani, L; Morandi, C; Troiso, A | 1 |
| Ashida, K; Kaibara, N; Kaneko, T; Mizusawa, K; Naka, T; Takahashi, S | 1 |
| Bäthge, IM; Berger, H; Boos, KS; Rudolphi, A; Seidel, D; Vielhauer, S | 1 |
| An, M; Hamada, E; Ikawa, M; Matsumoto, Y; Miura, T; Murata, M; Nakasato, S; Takagi, S; Terakado, H; Watanabe, K | 1 |
| Hasegawa, K; Ichikawa, T; Kawai, S; Kirihara, M; Kume, S; Maruo, H; Tominaga, S | 1 |
| Akagi, K; Kimura, H; Murata, T; Nagata, K; Nasu, R; Tanaka, Y; Uokawa, K | 1 |
| Arisawa, J; Hosoki, T; Inoue, Y; Masuzawa, M; Monden, M; Monden, T; Nakamura, H; Nakao, N; Ohi, H; Ohsaki, Y; Sakon, M; Seki, K; Shimizu, T; Todo, A; Tomono, N; Yayoi, E | 1 |
| Jiang, XT; Xu, FH | 1 |
| Hasegawa, S; Kikuchi, E; Miyakita, M; Shimizu, K; Tanomogi, H; Yamataka, K | 1 |
| Chang, CS; Chen, GH; Lien, HC; Poon, SK; Yang, SS; Yeh, HZ | 1 |
| Memis, A; Oran, I | 1 |
| Abe, T; Hashimoto, Y; Kojima, A; Mori, M; Nagamine, T; Sohara, N; Takagi, H; Takahashi, H | 1 |
| Higashi, S; Kondo, KH; Maeda, Y; Nakashima, T; Setoguchi, T; Shimizu, M; Tabata, N | 1 |
| Ardizzoia, A; Barni, S; Giani, L; Lissoni, P; Malugani, F; Mandalà, M; Paolorossi, F; Tancini, G | 1 |
| Adachi, M; Ishii, H; Kawaguchi, C; Miura, S; Mori, M; Suzuki, H | 1 |
| Fittipaldo, A; Grasso, S; Poggesi, I; Regazzi, MB; Riggi, M; Seematter, RJ | 1 |
| Aoki, J; Endo, K; Ishijima, H; Ishizaka, H; Kawano, T; Koyama, Y; Nakajima, T | 1 |
| Fujitake, S; Kataoka, S; Maeda, Y; Nozaki, H; Shimizu, M; Tohyama, M | 1 |
| Chiba, T; Ito, K; Kojima, K; Nakajima, N; Seno, H | 1 |
| Emi, Y; Kai, S; Kano, T; Nishijima, N; Rai, Y | 1 |
| Hada, M; Hagiwara, J; Kamiya, K; Koshizuka, K; Muto, S; Nakagomi, H; Tada, Y; Takano, K | 1 |
| Arai, Y; Ariyoshi, Y; Itoh, K; Kumada, T; Nakamura, K; Tajima, K; Takayasu, Y | 1 |
| Hoshiya, Y; Kosaka, A; Mori, K; Ohara, M; Oohata, K; Shikata, A; Tukamoto, H; Watabiki, Y; Yamada, S; Yamazaki, M; Yoneyama, Y | 1 |
| Asano, M; Higashi, S; Hosono, Y; Kane, T; Kato, C; Matsumoto, K; Sakoda, M; Sakumoto, H; Sumiyoshi, K; Takahahsi, T; Takahashi, M; Yamamoto, A | 1 |
| Aoki, T; Ito, K; Kasuya, K; Katayanagi, S; Koyanagi, Y; Sasaki, Y; Suzuki, K; Takagi, Y; Tsuchida, A; Yamazaki, T | 1 |
| Hiraoka, T; Kanno, A; Nakata, T; Ooshita, H; Saitou, S; Suhara, T; Tanaka, S; Tanemura, H; Wakahara, M; Yamamoto, M | 1 |
| Kawasaki, K; Kishibuchi, M; Nishi, T; Yagyu, T; Yamasaki, M; Yasui, M; Yayoi, E | 1 |
| D'Ottavio, AM; Fabi, A; Garufi, C; Milella, M; Nisticò, C; Terzoli, E; Vaccaro, A | 1 |
| Balestreri, L; Morassut, S | 1 |
| Choi, S; Higashi, M; Hosoki, T; Matsubara, T; Minamitani, K; Mitomo, M; Ohtani, M; Tono, T; Yosioka, Y | 1 |
| Abe, S; Ejiri, Y; Kume, K; Okubo, Y; Otsuki, M | 1 |
| Haglund, U; Jacobson, G; Karlson, BM; Löfberg, AM; Lörelius, LE | 1 |
| Abe, K; Ashizawa, T; Inoue, S; Kakiuchi, H; Katsumata, K; Koizumi, K; Saguchi, T; Yamamoto, K | 1 |
| Chang, FY; Chau, GY; Chiang, JH; Huang, YH; Huo, TI; King, KL; Lee, SD; Lui, WY; Tsay, SH; Wu, JC | 1 |
| Enomoto, Y; Itsubo, M; Kawabe, T; Koike, K; Komuro, O; Onoda, H; Toda, G; Tsuno, S | 1 |
| Beger, HG; Butzer, U; Danenberg, KD; Danenberg, PV; Kornmann, M; Leder, G; Link, KH; Pillasch, J; Salonga, D; Sunelaitis, E | 1 |
| Kawata, S; Murakami, T; Nakamura, H; Osuga, K; Takamura, M | 1 |
| Ikeda, J; Takayasu, Y; Yamamoto, S | 1 |
| Inoue, H; Ito, T; Nakano, T; Oomori, S; Sakai, T; Siraki, K; Sugimoto, K; Takase, K | 1 |
| Matsuno, S; Ogasawara, T; Suzuki, M; Unno, M; Yamazaki, H; Yoshida, H | 1 |
| Kosaka, A; Matsuda, I; Mori, K; Ohara, M; Shikata, A; Tukamoto, H; Yamada, S; Yamazaki, M; Yoneyama, Y | 1 |
| Harada, K; Ikeda, R; Maeda, M; Nasu, J; Takata, N; Yoshinaka, I | 1 |
| Fukushima, Y; Fuzita, J; Hata, S; Hayashida, H; Ikeda, K; Ishida, T; Kitada, M; Nakamura, T; Niinobu, T; Shibata, T; Shimano, T; Suzuki, R; Takahashi, Y; Takami, M; Tukahara, Y | 1 |
| Hata, T; Iwazawa, T; Kano, T; Kinuta, M; Matsui, S; Matsushita, M; Monden, T; Nakano, Y; Okada, K; Okamura, J; Takahashi, H; Tono, T; Yano, H; Yasue, A | 1 |
| Esumi, K; Furukawa, H; Hashimoto, K; Ikeda, M; Imamura, H; Inoue, Y; Ishida, H; Kawasaki, T; Makino, S; Masutani, S; Miya, A; Ohta, H; Satomi, T; Tatsuta, M; Tsuda, K | 1 |
| Azama, T; Furukawa, J; Hashimoto, T; Katsumoto, Y; Nakaguchi, K; Okajima, S; Shingai, T; Sue, F; Takekuni, K; Yukawa, M | 1 |
| Higashi, S; Setoguchi, T | 1 |
| Egawa, Y; Itabashi, T; Iwakura, K; Izumiya, T; Katsu, K; Kurisu, Y; Matsuo, T; Morita, S; Murano, N; Nomura, T; Sasaki, Y; Tanigawa, N | 1 |
| Ding, H; Kudo, M; Maekawa, K; Minami, Y; Onda, H; Suetomi, Y | 1 |
| Bastert, G; Egerer, G; Goerner, R; Grischke, EM; Haas, R; Hensel, M; Ho, AD; Hohaus, S; Khbeis, T; Schneeweiss, A; Solomayer, E | 1 |
| Akiyama, N; Ishizaki, M; Motegi, M; Nakajima, M; Osawa, H; Sasamoto, H; Tanaka, S; Wada, W | 1 |
| Bauer, J; Borner, M; Crivellari, D; Goldhirsch, A; Graffeo, R; Hess, D; Lombardi, D; Martinelli, G; Nolè, F; Pagani, O; Sessa, C; Thürlimann, B; Veronesi, A | 1 |
| Kohno, H; Nagasue, N; Nazmy El Assal, O; Ono, T; Yamanoi, A | 1 |
| Bafaloukos, D; Brountzos, EN; Kelekis, DA; Magoulas, D; Panagiotou, IE | 1 |
| Ishitobi, M; Kikkawa, N; Shin, E | 1 |
| Majima, T; Nakajima, T; Nozu, S; Okayasu, K; Saitou, AY; Yagi, A | 1 |
| Horikiri, N; Ishii, T; Matsushima, N; Nakatsuka, A; Takeda, K; Tanaka, N; Yamakado, K | 1 |
| Hirakawa, K; Nakazawa, K; Nishihara, T; Nishino, H; Tamamori, Y; Tanaka, H; Yamada, N | 1 |
| Ebara, M; Saisho, H; Ueda, S; Yoshikawa, M | 1 |
| Takayasu, Y | 1 |
| Maeda, M; Tazawa, J | 1 |
| Fischer, L; Foss, HD; Koch, HC; Korfel, A; Thiel, E | 1 |
| Airoldi, M; Bumma, C; Cattel, L; Marchionatti, S; Pedani, F; Recalenda, V; Tagini, V | 1 |
| Hara, Y; Hikosaka, Y; Iwase, H; Kobayashi, S; Toyama, T; Yamashita, H | 1 |
| Hongfang, W; Jianmin, Z; Meifu, F | 1 |
| Ikeda, T; Kitajima, M; Tokura, H | 1 |
| Conte, PF; Dani, D; Donati, S; Gennari, A; Giorgetti, A; Landucci, E; Mariani, G; Pisani, P; Poli, M; Puccini, G; Salvadori, B; Salvadori, PA; Sorace, O | 1 |
| Aiba, N; Aoyama, K; Higuchi, K; Miyabayashi, C; Nambu, S; Okada, K; Tsuchida, T; Tsukishiro, T; Watanabe, A; Yasuyama, T | 1 |
| Asakura, H; Doya, Y; Hata, K; Hayakawa, A; Ichida, T; Igarashi, K; Kato, M; Miura, M; Sato, H; Watanabe, M | 1 |
| Obayashi, H; Sakaguchi, H; Uchino, R; Yamaguchi, T; Yasugawa, T | 1 |
| Ikami, I; Kanehira, J; Noda, H; Sasaki, T; Shibutani, K; Shinohara, A; Takahashi, S; Takekawa, D; Tarusawa, K; Yodono, H | 1 |
| Kajanti, M; Mäntylä, M; Pyrhönen, S; Rissanen, P | 1 |
| Chan, M; Leung, N; Leung, WT; Li, AK; Metreweli, C; Shiu, WC; Tao, M | 1 |
| Böhmer, G; Galanski, M; Prokop, M; Reichelt, S; Ringe, B; Schaefer, C; Schmidt, FW; Schmoll, E; Schmoll, HJ; Schüler, A | 1 |
| Eto, T; Ishinoda, Y; Iwaki, Y; Kawano, T; Kitamura, M; Kitamura, T; Komura, K; Maruyama, T; Shimada, Y; Tamaki, N | 1 |
| Handagoon, P; Nakamura, H; Phornphutkul, K; Senarat, S; Sirivanichai, C | 1 |
| Hashimoto, M; Iwamiya, T; Kawasaki, H; Kobayashi, M; Morioka, N; Nakamura, K; Ohta, Y; Okuda, Y; Sawada, S; Tanigawa, N | 1 |
| Hori, S; Hosoki, T; Kozuka, T; Matsushita, M; Mitani, T; Murakami, T; Nakamura, H; Nakanishi, K; Oi, H; Tsukaguchi, I | 1 |
| Inoue, J; Kawai, S; Kawarada, Y; Kubo, Y; Kuroda, C; Kusano, M; Ogawa, M; Ohashi, Y; Okamura, J; Tani, M | 1 |
| Hashimoto, S; Hiramatsu, K; Ido, K; Ka, WJ; Kobayashi, S; Miura, H; Nakatsuka, S; Narimatsu, Y; Ogawa, K; Ohzono, H | 1 |
| Cannito, F; Castellan, L; Chiesura-Corona, M; el Khatib, AB; Feltrin, GP; Miotto, D; Roman, E; Sandri, P; Savastano, S; Torraco, A | 1 |
| Gombe-Mbalawa, C; Holland, J; Kiire, CF; Luande, J; Menenses, LV; Okoth, J; Olweny, CL; Tsega, E | 1 |
| Görich, J; Hartlapp, JH; Hasan, I; Reiser, M; Wickenhöfer, R | 1 |
| Hartlapp, JH; Hasan, I; Reiser, M; Schüller, H; Wickenhöfer, R | 1 |
| Dobbs, NA; Gregory, W; Harper, PG; Michael, Y; Richards, MA; Rubens, RD; Summers, LA; Twelves, CJ | 1 |
| Shiu, WC | 1 |
| Fukawa, M; Hiroyoshi, M; Imaizumi, N; Matsumoto, S; Okushima, K; Tabuchi, M; Takeda, T; Yakushiji, H | 1 |
| Adachi, W; Haba, Y; Hanasaki, K; Horigome, N; Kajikawa, S; Kaneko, G; Kobayashi, M; Koide, N; Koike, S; Shiohara, E | 1 |
| Awane, Y; Maeshiro, T; Matsumine, T; Miyamoto, S; Umekita, N; Yamada, F | 1 |
| Hayashi, T; Kimoto, T; Kohno, H; Makino, Y; Nagasue, N; Ohiwa, K; Ono, T; Takemoto, Y; Taniura, H; Uchida, M | 1 |
| Dick, R; Dusheiko, G; Hobbs, KE; Markham, NI; Novell, JR; Reddy, K | 1 |
| Kajanti, MJ; Pyrhönen, SO | 1 |
| Richards, MA; Rubens, RD; Smith, P; Twelves, CJ | 1 |
| Yamada, S | 1 |
| Kimura, M; Konno, T; Mizumachi, R; Oda, T; Ohtsuka, N | 1 |
| Dommasck, J; Friedmann, G; Gross-Fengels, W; Huber, R; Kuhn, M; Neufang, KF | 1 |
| Abe, R; Hoshino, M; Koyama, Y; Satou, N | 1 |
| Dal Fior, S; Favretto, S; Gasparini, G; Panizzoni, GA; Pozza, F | 1 |
| Döhring, W; Dralle, H; Grote, R; Reimer, P; Rosenthal, H; Schmoll, E | 1 |
| Hartlapp, J; Heidemann, E; Hossfeld, D; Kunz, S; Neeser, E; Possinger, K; Schumacher, K; Steinke, B; von Ingersleben, G; Waldmann, R | 1 |
| Bokemeyer, B; Freise, J; Galanski, M; Grote, R; Schmidt, FW; Schmoll, E; Schmoll, HJ; Schüler, A | 1 |
| Bokemeier, B; Grote, R; Rosenthal, H; Schmoll, E | 1 |
| Coleman, RE; O'Reilly, SM; Richards, MA; Rubens, RD; Twelves, CJ | 1 |
| Leung, N; Leung, WT; Li, AK; Li, M; Shiu, W | 1 |
| Camaggi, CM; Pannuti, F; Strocchi, E | 1 |
| Blum, R; Fazzini, E; Green, MD; Hochster, HS; Muggia, FM; Speyer, J | 1 |
| Cersosimo, RJ; Hong, WK | 1 |
| Angelelli, B; Camaggi, CM; Cola, B; Comparsi, R; Del Prete, P; Franchini, A; Pannuti, F; Rossi, AP; Strocchi, E | 1 |
| Leung, N; Li, A; Martin, C; Mok, SD; O, SK; Shiu, W; Tsao, SY; Woo, KS | 1 |
| Wils, JA | 1 |
| Lim, F; Tan, YO | 1 |
| Ando, K; Hirai, K; Kubo, Y; Kuroda, C; Nagasue, N; Okamura, J; Okita, K; Tamura, K; Tanikawa, K; Yukaya, H | 1 |
| Civalleri, D; Muggianu, M; Nobile, MT; Percivale, PL; Razzi, S; Repetto, M; Simoni, G; Tatarek, R; Vidili, MG | 1 |
| Bona, X; Codes, M; Duque, A; Iglesias, L; Jimeno, J; Moreno Nogueira, J; Murillo, E; Romero, F | 1 |
| Gunvén, P; Peterson, C; Theve, NO | 1 |
| Andersson, M; Domellöf, L; Eksborg, S; Lönroth, U | 1 |
| Aronne, T; Codacci Pisanelli, G; D'Amelio, R; Franchi, F; Manfredi, D; Mulieri, M; Seminara, P | 1 |
| Angelelli, B; Camaggi, CM; Comparsi, R; Franchini, A; Pannuti, F; Rossi, AP; Strocchi, E | 1 |
| Bresadola, F; Farris, A; Masia, S; Padula, G; Soro, P; Spissu, M; Trignano, M; Virdis, A | 1 |
| Durrant, KD; Jones, AC; Robinson, MH | 1 |
| Lee, YT | 1 |
| Kolarić, K; Potrebica, V; Stanovnik, M | 1 |
| Angelelli, B; Camaggi, CM; Comparsi, R; Martoni, A; Pannuti, F; Strocchi, E | 1 |
| Hurteloup, P; Iliadis, A; Mauriac, L; Nguyen-Ngoc, T; Robert, J; Vrignaud, P | 1 |
21 review(s) available for epirubicin and Liver Neoplasms
| Article | Year |
|---|---|
Super-selective transcatheter vesical arterial chemoembolization with drug-loaded beads for muscle-invasive bladder cancer with hematuria.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Hematuria; Humans; Liver Neoplasms; Muscles; Quality of Life; Retrospective Studies; Treatment Outcome; Urinary Bladder; Urinary Bladder Neoplasms | 2023 |
Efficacy and safety of epirubicin applied in transcatheter arterial chemoembolization for hepatocellular carcinoma: A meta-analysis.
Topics: Antibiotics, Antineoplastic; Arteries; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Humans; Liver Neoplasms; Odds Ratio; Publication Bias; Risk Factors; Treatment Outcome | 2018 |
Partial hepatectomy for liver metastases from nasopharyngeal carcinoma: a comparative study and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Disease Progression; Disease-Free Survival; Epirubicin; Ethiodized Oil; Female; Follow-Up Studies; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate | 2014 |
Transcatheter arterial embolic therapies for hepatocellular carcinoma: a literature review.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Doxorubicin; Epirubicin; Ethiodized Oil; Humans; Liver; Liver Neoplasms; Organoplatinum Compounds; Treatment Outcome | 2014 |
Changes of HBV DNA After Chemoembolization for Hepatocellular Carcinoma and the Efficacy of Antiviral Treatment.
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Antiviral Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; DNA, Viral; Doxorubicin; Epirubicin; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Rituximab; Virus Activation | 2016 |
[Complications of hepatic artery chemotherapy for liver metastases in colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Arterial Occlusive Diseases; Cholangitis, Sclerosing; Cisplatin; Colorectal Neoplasms; Epirubicin; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Nausea; Peptic Ulcer; Vomiting | 2003 |
Carboplatin-epirubicin regimen for the treatment of hepatoblastoma.
Topics: Adolescent; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Epirubicin; Hepatoblastoma; Humans; Infant; Liver Neoplasms; Lung Neoplasms; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Prospective Studies; Survival Rate; Treatment Outcome | 2004 |
Contributions to the treatment of primary liver cancer. 4'-epidoxorubicin and cisplatin studied in hepatocarcinoma cell cultures and in partially hepatectomized rats.
Topics: Animals; Cisplatin; Drug Resistance; Epirubicin; Hepatectomy; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Rats; Tumor Cells, Cultured | 1993 |
Chemoembolization for hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Epirubicin; Humans; Iodized Oil; Liver Neoplasms; Maleic Anhydrides; Polystyrenes; Zinostatin | 1996 |
[Percutaneous alcohol instillation therapy (PAI) and chemoembolization in extensive hepatocellular carcinoma].
Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Contrast Media; Epirubicin; Ethanol; Humans; Instillation, Drug; Iodized Oil; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Tomography, X-Ray Computed | 1997 |
[Treatment of recurrent gastric cancer].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Fluorouracil; Humans; Immunologic Factors; Irinotecan; Liver Neoplasms; Lymphatic Metastasis; Methotrexate; Mitomycin; Neoplastic Cells, Circulating; Peritoneal Neoplasms; Stomach Neoplasms | 1998 |
[Hepatic chemoembolization in a patient allergic to iodinated contrast media: the use of Gd-DTPA].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoembolization, Therapeutic; Contrast Media; Drug Hypersensitivity; Epirubicin; Female; Gadolinium DTPA; Humans; Iodized Oil; Liver; Liver Neoplasms; Magnetic Resonance Angiography; Mitomycin | 1999 |
Hepatic arterial injection chemotherapy for hepatocellular carcinoma with epirubicin aqueous solution as numerous vesicles in iodinated poppy-seed oil microdroplets: clinical application of water-in-oil-in-water emulsion prepared using a membrane emulsifi
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Emulsions; Epirubicin; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Particle Size | 2000 |
Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: metaanalysis of three randomized controlled trials.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Administration Schedule; Drug Tolerance; Epirubicin; Female; Fluorouracil; Hepatectomy; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Multivariate Analysis; Neoplasm Recurrence, Local; Prognosis; Survival Rate; Tegafur; Treatment Outcome | 2001 |
[A case of gastric cancer with multiple liver metastases that were completely responsive to hepatic arterial infusion chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Epirubicin; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Remission Induction; Stomach Neoplasms | 2001 |
[Hepatic arterial infusion chemotherapy (anthracycline)].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheters, Indwelling; Clinical Trials as Topic; Drug Delivery Systems; Drug Resistance, Neoplasm; Epirubicin; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Treatment Outcome | 2001 |
[Hepatic arterial infusion chemotherapy for hepatocellular carcinoma by EEP regimen].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheters, Indwelling; Cisplatin; Drug Administration Schedule; Epirubicin; Etoposide; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Treatment Outcome | 2001 |
[Radiation therapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Neoplastic Cells, Circulating; Portal Vein; Prognosis; Radiotherapy Planning, Computer-Assisted; Survival Rate | 2001 |
[Intra-arterial infusion chemotherapy for breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lung Neoplasms; Mitomycin | 2002 |
[Techniques, results and risks of chemoembolization of malignant liver tumors].
Topics: Adult; Aged; Diatrizoate; Drug Combinations; Embolization, Therapeutic; Epirubicin; Fatty Acids; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycins; Polyvinyls; Propylene Glycols; Proteins; Risk; Zein | 1991 |
Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue.
Topics: Bone Marrow; Breast Neoplasms; Carcinoma, Renal Cell; Carcinoma, Small Cell; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Head and Neck Neoplasms; Heart; Humans; Kidney Neoplasms; Kinetics; Leukemia; Liver Neoplasms; Lung Neoplasms; Lymphoma; Male; Melanoma; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Rectal Neoplasms; Soft Tissue Neoplasms; Stomach Neoplasms; Urinary Bladder Neoplasms | 1986 |
116 trial(s) available for epirubicin and Liver Neoplasms
| Article | Year |
|---|---|
Arterial chemoembolisation with cisplatin versus epirubicin for hepatocellular carcinoma (ACE 500 study): A multicentre, randomised controlled phase 2/3 trial.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Epirubicin; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Liver; Liver Neoplasms; Male; Middle Aged; Survival Rate; Treatment Outcome | 2021 |
TACE with dicycloplatin in patients with unresectable hepatocellular carcinoma: a multicenter randomized phase II trial.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Humans; Liver Neoplasms; Treatment Outcome | 2022 |
Efficacy and Safety of Drug-Eluting Beads Transarterial Chemoembolization by CalliSpheres
Topics: Aged; Antineoplastic Agents; Bilirubin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; China; Creatinine; Doxorubicin; Drug Delivery Systems; Epirubicin; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Portal Vein; Progression-Free Survival; Prospective Studies; Serum Albumin, Human; Survival Rate; Treatment Outcome | 2020 |
Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Survival Analysis; Treatment Outcome | 2018 |
Switch to miriplatin for multinodular hepatocellular carcinoma unresponsive to transarterial chemoembolization with epirubicin: a prospective study.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Humans; Liver Neoplasms; Male; Organoplatinum Compounds; Prospective Studies; Treatment Outcome | 2017 |
Comprehensive Analysis of Factors Affecting Clinical Response and Short-Term Survival to Drug-Eluting Bead Transarterial Chemoembolization for Treatment in Patients With Liver Cancer.
Topics: Adult; Aged; Antineoplastic Agents; Chemoembolization, Therapeutic; Cohort Studies; Doxorubicin; Epirubicin; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Proportional Hazards Models; Treatment Outcome | 2018 |
Efficacy and safety profile of drug-eluting beads transarterial chemoembolization by CalliSpheres® beads in Chinese hepatocellular carcinoma patients.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asian People; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Drug Delivery Systems; Epirubicin; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged | 2018 |
[Clinical outcomes of radiofrequency ablation combined with transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: a single-center experience].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Survival Rate; Tumor Burden | 2013 |
A multicenter phase I-II study of docetaxel plus epirubicin plus bevacizumab as first-line treatment in women with HER2-negative metastatic breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Anemia; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Diarrhea; Disease-Free Survival; Docetaxel; Epirubicin; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Middle Aged; Neoplastic Cells, Circulating; Neutropenia; Receptor, ErbB-2; Survival Rate; Taxoids; Thrombocytopenia; Young Adult | 2013 |
Epirubicin combined with oxaliplatin and 5-day continuous infusion of 5-fluorouracil as a first-line treatment for metastatic gastric cancer: treatment outcomes and analysis of prognostic factors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prognosis; Retroperitoneal Neoplasms; Retrospective Studies; Stomach Neoplasms; Survival Rate; Young Adult | 2015 |
Chemoembolization combined with pravastatin improves survival in patients with hepatocellular carcinoma.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Epirubicin; Female; Germany; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Pravastatin; Prospective Studies | 2008 |
Randomized prospective phase II study to compare the combination chemotherapy regimen epirubicin, cisplatin, and 5-fluorouracil with epirubicin, cisplatin, and capecitabine in patients with advanced or metastatic gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Peritoneal Neoplasms; Prognosis; Prospective Studies; Stomach Neoplasms; Survival Rate; Young Adult | 2012 |
Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Epirubicin; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Paclitaxel; Survival Rate; Treatment Outcome; Young Adult | 2011 |
Potential risk factors for the reactivation of the replication of hepatitis B and C viruses after transcatheter arterial chemoembolization of hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; DNA, Viral; Epirubicin; Female; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Leukocyte Count; Liver Neoplasms; Male; Middle Aged; Mitomycin; Odds Ratio; Risk Factors; RNA, Viral; ROC Curve; Viral Load; Virus Activation; Virus Replication | 2011 |
A prospective randomized controlled trial of preoperative whole-liver chemolipiodolization for hepatocellular carcinoma.
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheterization; Chemotherapy, Adjuvant; Disease-Free Survival; Epirubicin; Ethiodized Oil; Female; Hepatectomy; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Outcome and Process Assessment, Health Care; Postoperative Complications; Preoperative Care; Treatment Outcome | 2012 |
Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Angiography; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chi-Square Distribution; Cisplatin; Contrast Media; Endpoint Determination; Epirubicin; Female; Fluorouracil; Humans; Iohexol; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Ultraselective transcatheter infusion of epirubicin in water-in-oil-in-water emulsion for small hepatocellular carcinoma.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Catheterization, Peripheral; Delayed-Action Preparations; Disease-Free Survival; Emulsions; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Oils; Treatment Outcome; Water | 2012 |
Methotrexate-paclitaxel-epirubicin-carboplatin as second-line chemotherapy in patients with metastatic transitional cell carcinoma of the bladder pretreated with cisplatin-gemcitabine: a phase II study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Staging; Paclitaxel; Prognosis; Prospective Studies; Salvage Therapy; Survival Rate; Urinary Bladder Neoplasms | 2013 |
Roles played by chemolipiodolization and embolization in chemoembolization for hepatocellular carcinoma: single-blind, randomized trial.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; China; Cyclobutanes; Disease-Free Survival; Embolization, Therapeutic; Epirubicin; Ethiodized Oil; Female; Gelatin Sponge, Absorbable; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Organoplatinum Compounds; Single-Blind Method; Treatment Outcome | 2013 |
Initial safety and outcomes of miriplatin plus low-dose epirubicin for transarterial chemoembolisation of hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Humans; Liver Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Treatment Outcome | 2012 |
Efficacy of anthracyclines and paclitaxel as first line chemotherapy in patients with visceral metastases of breast cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Epirubicin; Female; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Paclitaxel; Peritoneal Neoplasms | 2002 |
Effect of dosage of anticancer agents during transcatheter arterial chemoembolization on T cell subsets in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; T-Lymphocyte Subsets | 2002 |
Treatment of hepatocellular carcinoma (HCC) with systemic chemotherapy combining epirubicin, cisplatinum and infusional 5-fluorouracil (ECF regimen).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Cohort Studies; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Survival Rate; Treatment Outcome | 2002 |
Intra-arterial hepatic chemotherapy combined with continuous infusion of 5-fluorouracil in patients with metastatic cholangiocarcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cholangiocarcinoma; Cisplatin; Disease Progression; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Survival; Treatment Outcome | 2002 |
Segmental transcatheter arterial chemoembolization treatment in patients with cirrhosis and inoperable hepatocellular carcinomas.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Gelatin Sponge, Absorbable; Hepatic Artery; Humans; Iodized Oil; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Survival Rate | 2002 |
Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Germany; Humans; Liver Neoplasms; Logistic Models; Lung Neoplasms; Middle Aged; Mitoxantrone; Neoplasm Staging; Probability; Proportional Hazards Models; Quality of Life; Risk Assessment; Sensitivity and Specificity; Statistics, Nonparametric; Survival Analysis; Treatment Outcome | 2002 |
The influence of elevated liver function parameters on the pharmacokinetics of doxorubicin and epirubicin--a population based pharmacokinetic study of CESAR-APOH. Central European Society for Anticancer Drug Research. Working Group for Pharmacology in Onc
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Doxorubicin; Epirubicin; Female; Humans; Infusions, Intravenous; Liver; Liver Neoplasms; Male; Middle Aged; Prospective Studies | 2002 |
Capecitabine in combination with docetaxel and epirubicin in patients with previously untreated, advanced breast carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Capecitabine; Deoxycytidine; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Middle Aged; Paclitaxel; Taxoids; Treatment Outcome | 2003 |
Pilot study of transcatheter arterial chemoembolization with degradable starch microspheres in patients with hepatocellular carcinoma.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Hepatic Artery; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Pilot Projects; Prospective Studies; Starch; Survival Analysis | 2003 |
Influence of trastuzumab on epirubicin pharmacokinetics in metastatic breast cancer patients.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Epirubicin; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Liver Neoplasms; Lung Neoplasms; Middle Aged; Neoplasm Staging; Probability; Prospective Studies; Receptor, ErbB-2; Risk Assessment; Soft Tissue Neoplasms; Statistics, Nonparametric; Survival Rate; Trastuzumab; Treatment Outcome | 2003 |
Epirubicin, cisplatin, and protracted infusion of 5-FU (ECF) in advanced intrahepatic cholangiocarcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cholangiocarcinoma; Cisplatin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Liver Neoplasms; Male; Middle Aged; Survival Analysis; Treatment Outcome | 2004 |
Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma.
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Epirubicin; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Recurrence; Retrospective Studies; Virus Activation | 2004 |
[Prospective randomized trial of RFA and chemotherapy for unresectable small hepatocellular carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheter Ablation; Cisplatin; Combined Modality Therapy; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Ultrasonography, Interventional | 2004 |
Epirubicin, cisplatin, and raltitrexed in patients with advanced gastric and hepatobiliary carcinoma: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Cisplatin; Epirubicin; Female; Humans; Liver Neoplasms; Male; Middle Aged; Quinazolines; Stomach Neoplasms; Survival Analysis; Thiophenes | 2004 |
[External radiation and combined transcatheter arterial chemoembolization for unresectable primary liver cancer].
Topics: Adult; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Epirubicin; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Particle Accelerators; Survival Rate; Treatment Outcome | 2005 |
Hepatic intra-arterial chemotherapy (HIAC) of high dose mitomycin and epirubicin combined with caval chemofiltration versus prolonged low doses in liver metastases from colorectal cancer: a prospective randomized clinical study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Epirubicin; Filtration; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Prospective Studies; Survival Rate | 2004 |
[Ginsenosides combined with dexamethasone in preventing and treating postembolization syndrome following transcatheter arterial chemoembolization: a randomized, controlled and double-blinded prospective trial].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemoembolization, Therapeutic; Dexamethasone; Double-Blind Method; Epirubicin; Female; Fluorouracil; Ginsenosides; Humans; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Vomiting | 2005 |
Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis of 579 patients treated with epirubicin-based chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Cisplatin; Epirubicin; Female; Humans; Incidence; L-Lactate Dehydrogenase; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Prognosis; Prospective Studies; Receptors, Estrogen; Risk Factors; Vindesine | 2005 |
Phase II study with a combination of epirubicin, cisplatin, UFT, and leucovorin in advanced hepatocellular carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antidotes; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Dose-Response Relationship, Drug; Epirubicin; Female; Hematologic Diseases; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Survival Analysis; Tegafur; Tomography, X-Ray Computed; Treatment Outcome; Uracil | 2006 |
Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Docetaxel; Epirubicin; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Receptor, ErbB-2; Taxoids; Trastuzumab | 2006 |
Selective arterial chemoembolization for hepatic metastases from medullary thyroid carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Medullary; Chemoembolization, Therapeutic; Epirubicin; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Palliative Care; Prospective Studies; Thyroid Neoplasms; Treatment Outcome | 2005 |
A combination therapy with transarterial chemo-lipiodolization and systemic chemo-infusion for large extensive hepatocellular carcinoma invading portal vein in comparison with conservative management.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Case-Control Studies; Cause of Death; Cisplatin; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Portal Vein; Prognosis; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Venous Thrombosis | 2007 |
Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Colorectal Neoplasms; Epirubicin; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Prognosis; Survival Rate | 2007 |
[Ginsenosides and dexamethasone in managing the liver injury and renal function after transcatheter arterial chemoembolization for hepatic carcinoma patient].
Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Bilirubin; Blood Urea Nitrogen; Chemoembolization, Therapeutic; Creatinine; Dexamethasone; Drug Therapy, Combination; Epirubicin; Female; Fluorouracil; Ginsenosides; Glucocorticoids; Humans; Iodized Oil; Kidney; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Topotecan | 2006 |
Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Follow-Up Studies; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Peritoneal Neoplasms; Stomach Neoplasms; Survival Analysis; Tegafur; Time Factors; Treatment Outcome; Uracil | 2007 |
A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
Topics: Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Catheterization, Peripheral; Disease-Free Survival; Embolization, Therapeutic; Emulsions; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Middle Aged | 2008 |
Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: a p
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Chemotherapy, Cancer, Regional Perfusion; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Portal Vein; Prospective Studies; Severity of Illness Index; Tablets, Enteric-Coated; Tegafur; Time Factors; Treatment Outcome; Uracil; Venous Thrombosis | 2007 |
Transarterial infusion chemotherapy with epirubicin in water-in-oil-in-water emulsion for recurrent hepatocellular carcinoma in the residual liver after hepatectomy.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Drug Carriers; Emulsions; Epirubicin; Female; Hepatectomy; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Oils; Radiography; Treatment Outcome; Water | 2009 |
Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Quality of Life; Treatment Outcome | 2008 |
Intra-arterial chemotherapy of advanced pancreatic cancer: a single center experience.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Cancer, Regional Perfusion; Disease Progression; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Treatment Outcome | 2007 |
Phase I/II pharmacokinetic study of pemetrexed and epirubicin in patients with locally advanced or metastatic breast cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Glutamates; Guanine; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Pemetrexed; Treatment Outcome | 2007 |
Ionic versus nonionic contrast media solvents used with an epirubicin-based agent for transarterial chemoembolization of hepatocellular carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Emulsions; Epirubicin; Female; Humans; Iodized Oil; Ionic Liquids; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Solvents; Tomography, X-Ray Computed | 2008 |
[Study on the efficacy and safety of high dose thymopentin combined with trans-artery chemoembolization for primary liver cancer].
Topics: Adjuvants, Immunologic; Adult; Aged; Asthenia; CD4-Positive T-Lymphocytes; Chemoembolization, Therapeutic; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Female; Fever; Fluorouracil; Humans; Iodized Oil; Liver Neoplasms; Lymphocyte Count; Male; Middle Aged; Nausea; Organoplatinum Compounds; Oxaliplatin; Remission Induction; Survival Rate; Thymopentin | 2007 |
Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Cisplatin; Epirubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Survival Rate | 1995 |
Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma--a comparison between L-TAE with farmorubicin and L-TAE with adriamycin: preliminary results (second cooperative study). Cooperative Study Group for Liver Cancer Treat
Topics: Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Survival Analysis | 1994 |
Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year study of 127 French patients.
Topics: Aged; alpha-Fetoproteins; Antineoplastic Agents; Carcinoma, Hepatocellular; Cause of Death; Chemoembolization, Therapeutic; Cisplatin; Doxorubicin; Epirubicin; Female; France; Hepatic Artery; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Survival Rate | 1994 |
Combined transarterial targeting locoregional immunotherapy-chemotherapy for patients with unresectable hepatocellular carcinoma: a new alternative for an old problem.
Topics: Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Interferon-gamma; Interleukin-2; Leucovorin; Liver; Liver Neoplasms; Male; Middle Aged; Mitomycin; Necrosis; Pilot Projects; Spleen; Survival Rate; Tomography, Emission-Computed | 1995 |
[A comparison of intra-arterial chemoembolization and infusion chemotherapy for liver metastases of breast cancer].
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemoembolization, Therapeutic; Epirubicin; Female; Hepatic Artery; Humans; Infant, Newborn; Infusion Pumps, Implantable; Iodized Oil; Liver Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Prognosis | 1995 |
[Experience in intra-hepatic-arterial chemotherapy and hepatic resection for metastatic colorectal cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Prognosis | 1995 |
[Outcomes of effective treatment of cases of metastatic liver tumors by intra-arterial infusion chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Stomach Neoplasms; Treatment Outcome | 1995 |
[A prospective randomized clinical trial comparing intra-arterial chemotherapy alone and when combined with hyperthermia for metastatic liver cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Hyperthermia, Induced; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Stomach Neoplasms | 1995 |
[Effects of intraarterial chemotherapy after hepatectomy in hepatic cancer patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Epirubicin; Hepatectomy; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Postoperative Period; Retrospective Studies | 1995 |
Influence of lipiodolization on a cirrhotic liver.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Carcinoma, Hepatocellular; Epirubicin; Female; Humans; Iodized Oil; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged | 1995 |
No synergistic activity of epirubicin and interferon-alpha 2b in the treatment of hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Combined Modality Therapy; Drug Synergism; Epirubicin; Female; Humans; Interferon alpha-2; Interferon-alpha; Liver Neoplasms; Male; Middle Aged; Recombinant Proteins; Remission Induction | 1995 |
Arterial-injection chemotherapy for hepatocellular carcinoma using monodispersed poppy-seed oil microdroplets containing fine aqueous vesicles of epirubicin. Initial medical application of a membrane-emulsification technique.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Drug Carriers; Drug Compounding; Epirubicin; Fat Emulsions, Intravenous; Female; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Plant Oils; Treatment Outcome | 1995 |
[Efficacy of intrahepatic arterial chemotherapy to prevent recurrence of residual liver in metastatic liver cancer patients after hepatectomy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Epirubicin; Female; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual | 1994 |
[Doses of epirubicin used in oily chemoembolization of hepatocellular carcinoma].
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Humans; Iodized Oil; Leukocyte Count; Liver; Liver Neoplasms; Male; Middle Aged | 1994 |
[Evaluation of local treatment for unresectable primary liver tumor].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Epirubicin; Female; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Rate | 1994 |
[Intra-arterial chemotherapy for the treatment of advanced hepatocellular carcinoma through implantable port (reservoir)].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Injections, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Survival Analysis | 1994 |
Epirubicin in hepatocellular carcinoma: pharmacokinetics and clinical activity.
Topics: Adult; Aged; Aspartate Aminotransferases; Carcinoma, Hepatocellular; Chromatography, High Pressure Liquid; Epirubicin; Female; Half-Life; Hepatic Artery; Humans; Injections, Intra-Arterial; Injections, Intravenous; Lidocaine; Liver Function Tests; Liver Neoplasms; Male; Metabolic Clearance Rate; Middle Aged | 1994 |
Combination therapy of transcatheter chemoembolization and percutaneous ethanol injection therapy for unresectable hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Doxorubicin; Embolization, Therapeutic; Epirubicin; Ethanol; Female; Follow-Up Studies; Humans; Injections, Subcutaneous; Liver Neoplasms; Male; Middle Aged | 1994 |
A randomized trial of intrahepatic arterial infusion of 4'-epidoxorubicin with Lipiodol versus 4'-epidoxorubicin alone in the treatment of hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Emulsions; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Survival Rate | 1994 |
Prospective and randomized controlled study of chemoembolization therapy in patients with advanced hepatocellular carcinoma. Cooperative Study Group for Liver Cancer Treatment in Shikoku area.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Prognosis; Prospective Studies | 1994 |
Randomised trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma.
Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Drug Carriers; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged | 1993 |
[A randomized trial of intrahepatic infusion chemotherapy for unresectable colorectal liver metastases. Sendai Study Group].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate | 1993 |
[The efficacy of intra-arterial infusion chemotherapy in patients with non-resectable liver metastasis from colorectal cancer--a randomized study comparing FAM versus FEM].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate | 1993 |
Epirubicin-Lipiodol chemotherapy versus 131iodine-Lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma.
Topics: Actuarial Analysis; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Case-Control Studies; Catheterization, Peripheral; Contrast Media; Epirubicin; Female; Femoral Artery; Follow-Up Studies; Hepatic Artery; Humans; Injections, Intra-Arterial; Iodine Radioisotopes; Iodized Oil; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Pharmaceutical Vehicles; Prospective Studies; Remission Induction; Survival Rate | 1995 |
[Efficacy of intra-arterial chemotherapy with reservoir for patients with unresectable hepatocellular carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Embolization, Therapeutic; Epirubicin; Female; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Survival Rate | 1996 |
[Clinical evaluation of hepatic arterial infusion chemotherapy in patients with liver metastases from colorectal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Doxorubicin; Drug Administration Schedule; Epirubicin; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Survival Rate | 1996 |
Disposition of epirubicin after intraarterial administration in Lipiodol to patients with hepatocellular carcinoma.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chromatography, High Pressure Liquid; Epirubicin; Hepatic Artery; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Suspensions | 1996 |
A phase I/II trial of epirubicin and high dose tamoxifen as a potential modulator of multidrug resistance in advanced hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Female; Humans; Liver Neoplasms; Male; Middle Aged; Tamoxifen | 1996 |
[Comparison of liver resection with sequential transarterial chemoembolization in stage pT3 or pT4 hepatocellular carcinoma].
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Epirubicin; Female; Hepatectomy; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Survival Rate | 1996 |
Adjuvant chemotherapy with epirubicin and carmofur after radical resection of hepatocellular carcinoma: a prospective randomized study.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Epirubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Prospective Studies; Survival Rate | 1997 |
Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment
Topics: Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Survival Rate | 1997 |
Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Colorectal Neoplasms; Drug Administration Schedule; Drug Resistance, Neoplasm; Epirubicin; Female; Floxuridine; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Male; Middle Aged; Mitoxantrone; Polymerase Chain Reaction; Predictive Value of Tests; Prognosis; RNA, Messenger; Survival Rate; Thymidylate Synthase; Transcription, Genetic | 1997 |
Treatment for advanced hepatocellular carcinoma by transarterial chemotherapy using reservoirs or one-shot arterial chemotherapy.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Catheters, Indwelling; Cost-Benefit Analysis; Epirubicin; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Japan; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Treatment Outcome | 1997 |
[Evaluation of intra-arterial infusion chemotherapy for liver metastasis from gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Mitomycin; Stomach Neoplasms; Survival Rate | 1997 |
[Usefulness of CA 15-3 antigen determination for evaluation of response to second-line chemotherapy in patients with breast cancer: preliminary study].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Mucin-1; Remission Induction | 1997 |
Epirubicin and etoposide combination chemotherapy to treat hepatocellular carcinoma patients: a phase II study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Survival Analysis; Survival Rate; Treatment Outcome | 1997 |
[Effect on hepatic function of hepatic artery infusion chemotherapy using epirubicin and mitoxantrone for advanced hepatocellular carcinoma].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Drug Administration Schedule; Epirubicin; Female; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver; Liver Neoplasms; Male; Middle Aged; Mitoxantrone | 1998 |
[Results of clinical study with epirubicin hydrochloride injectable solution in hepatoma].
Topics: Adult; Aged; Alopecia; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Drug Administration Schedule; Epirubicin; Fever; Hepatic Artery; Humans; Injections, Intra-Arterial; Leukopenia; Liver Neoplasms; Male; Middle Aged; Neutropenia; Thrombocytopenia | 1998 |
Size of lipid microdroplets effects results of hepatic arterial chemotherapy with an anticancer agent in water-in-oil-in-water emulsion to hepatocellular carcinoma.
Topics: Alanine Transaminase; alpha-Fetoproteins; Antibiotics, Antineoplastic; Aspartate Aminotransferases; Carcinoma, Hepatocellular; Emulsions; Epirubicin; Female; Hepatic Artery; Humans; Infusions, Intravenous; L-Lactate Dehydrogenase; Liver Neoplasms; Male; Middle Aged; Solutions; Time Factors; Water | 1999 |
Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Breast Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Liver Neoplasms; Lung Neoplasms; Melatonin; Middle Aged; Platelet Count; Remission Induction; Thrombocytopenia; Time Factors; Treatment Outcome | 1999 |
Serum vascular endothelial growth factor in the course of transcatheter arterial embolization of hepatocellular carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Endothelial Growth Factors; Epirubicin; Female; Hepatitis C; Humans; Iodized Oil; Liver Cirrhosis; Liver Neoplasms; Lymphokines; Male; Middle Aged; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1999 |
Phase II study of combined administration of 5-fluorouracil, epirubicin and mitomycin-C by hepatic artery infusion in patients with liver metastases of gastric cancer.
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Japan; Liver Neoplasms; Male; Middle Aged; Mitomycin; Stomach Neoplasms; Survival Analysis; Treatment Outcome | 1999 |
[Efficacy of intra-arterial chemotherapy on life prolongation in patients with hepatic metastasis from colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Epirubicin; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Survival Rate | 1999 |
[Arterial infusion therapy with implantable port for inoperable hepatobiliary tumors].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Cisplatin; Colonic Neoplasms; Drug Administration Schedule; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Stomach Neoplasms | 1999 |
Weekly epirubicin plus lonidamine in advanced breast carcinoma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Drug Synergism; Epirubicin; Female; Humans; Indazoles; Injections, Intravenous; Liver Neoplasms; Middle Aged | 1999 |
Focal therapeutic efficacy of transcatheter arterial infusion of styrene maleic acid neocarzinostatin for hepatocellular carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Male; Maleic Anhydrides; Middle Aged; Polystyrenes; Zinostatin | 2000 |
[Prediction of the clinical efficacy of hepatic arterial chemotherapy for metastatic hepatic cancer by intraarterial infusion of 99mTc-MIBI].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2000 |
Prospective case-controlled trial of adjuvant chemotherapy after resection of hepatocellular carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Case-Control Studies; Chemotherapy, Adjuvant; Epirubicin; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Prospective Studies; Survival Rate | 2000 |
Thymidylate synthase quantitation and in vitro chemosensitivity testing predicts responses and survival of patients with isolated nonresectable liver tumors receiving hepatic arterial infusion chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Female; Fluorouracil; Folic Acid; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitoxantrone; Predictive Value of Tests; Prospective Studies; Thymidylate Synthase; Treatment Outcome; Tumor Stem Cell Assay | 2000 |
[Arterial infusion chemotherapy for liver metastases from colorectal cancer--therapeutic effects of different protocols].
Topics: Antineoplastic Agents; Cisplatin; Colorectal Neoplasms; Doxorubicin; Drug Administration Schedule; Epirubicin; Fluorouracil; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Survival Rate | 2000 |
High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Disease Progression; Docetaxel; Epirubicin; Female; Humans; Incidence; Liver Neoplasms; Middle Aged; Paclitaxel; Receptor, ErbB-2; Receptors, Estrogen; Retrospective Studies; Taxoids | 2001 |
Evaluation of transcatheter arterial embolization with epirubicin-lipiodol emulsion for hepatocellular carcinoma.
Topics: Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Emulsions; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Survival Rate | 1992 |
Treatment of hepatocellular carcinoma with a CDDP-epirubicin-lipiodol suspension: a pilot clinico-pharmacological study.
Topics: Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Epirubicin; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Pilot Projects; Solubility; Survival Rate; Suspensions | 1992 |
Intra-arterial and intravenous use of 4' epidoxorubicin combined with 5-fluorouracil in primary hepatocellular carcinoma. A randomized comparison.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Injections, Intra-Arterial; Injections, Intravenous; Liver Neoplasms; Male; Middle Aged; Remission Induction; Survival Analysis | 1992 |
Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma--a comparison of L-TAE with Farmorubicin and L-TAE with adriamycin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Epirubicin; Female; Humans; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Survival Rate | 1992 |
Multicentre study of the treatment of primary liver cancer in Africa with two anthracycline drugs.
Topics: Africa; Carcinoma, Hepatocellular; Doxorubicin; Epirubicin; Humans; Liver Neoplasms; Survival Analysis | 1992 |
Weekly epirubicin versus doxorubicin as second line therapy in advanced breast cancer. A randomized clinical trial.
Topics: Adult; Aged; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Gastrointestinal Diseases; Heart Diseases; Hematologic Diseases; Humans; Liver Neoplasms; Middle Aged; Remission Induction; Survival Rate | 1991 |
Randomized clinical trial comparing mitoxantrone with epirubicin and with doxorubicin, each combined with cyclophosphamide in the first-line treatment of patients with metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Mitoxantrone; Quality of Life; Randomized Controlled Trials as Topic; Survival Rate | 1990 |
Phase II trial of epirubicin in hepatoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Clinical Trials as Topic; Doxorubicin; Drug Evaluation; Epirubicin; Humans; Liver Neoplasms; Middle Aged; Stereoisomerism | 1986 |
Epirubicin in advanced gastrointestinal (GI) cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Clinical Trials as Topic; Colonic Neoplasms; Combined Modality Therapy; Dose-Response Relationship, Drug; Doxorubicin; Epirubicin; Esophageal Neoplasms; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Pancreatic Neoplasms; Random Allocation; Rectal Neoplasms; Stomach Neoplasms | 1986 |
4'-Epidoxorubicin (Epirubicin) as a single agent in advanced primary hepatocellular carcinoma--a preliminary experience.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Clinical Trials as Topic; Doxorubicin; Epirubicin; Female; Humans; Liver Neoplasms; Male; Middle Aged | 1986 |
Controlled phase III clinical study of 4-epi-doxorubicin + 5-fluorouracil versus 5-fluorouracil alone in metastatic gastric and rectosigmoid cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Doxorubicin; Epirubicin; Female; Fluorouracil; Heart Diseases; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Rectal Neoplasms; Sigmoid Neoplasms; Stomach Neoplasms | 1986 |
Comparative pharmacokinetics and metabolism of doxorubicin and epirubicin in patients with metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Epirubicin; Female; Glucuronates; Half-Life; Humans; Kinetics; Liver Neoplasms; Middle Aged; Neoplasm Metastasis | 1985 |
382 other study(ies) available for epirubicin and Liver Neoplasms
| Article | Year |
|---|---|
13,28-Epoxy triterpenoid saponins from Ardisia japonica selectively inhibit proliferation of liver cancer cells without affecting normal liver cells.
Topics: Antineoplastic Agents, Phytogenic; Ardisia; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Hep G2 Cells; Humans; Liver Neoplasms; Molecular Conformation; Saponins; Structure-Activity Relationship; Triterpenes | 2012 |
Safety and Efficacy of Glass Membrane Pumping Emulsification Device in Transarterial Chemoembolization for Hepatocellular Carcinoma: First Clinical Outcomes.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Drug Delivery Systems; Emulsions; Epirubicin; Equipment Design; Ethiodized Oil; Female; Glass; Humans; Liver Neoplasms; Male; Membranes, Artificial; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Time Factors; Treatment Outcome; Tumor Burden | 2021 |
Prostate arterial chemoembolization for treatment of refractory hematuria and urinary retention in patients with localized advanced prostate cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Docetaxel; Epirubicin; Hematuria; Humans; Liver Neoplasms; Male; Middle Aged; Prostate; Prostatic Neoplasms; Quality of Life; Treatment Outcome; Urinary Retention | 2023 |
Efficacy and Safety of Lobaplatin-TACE in the Treatment of Primary Hepatocellular Carcinoma: A Retrospective Study.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Humans; Liver Neoplasms; Retrospective Studies; Treatment Outcome | 2023 |
(-)-Gossypol enhances the anticancer activity of epirubicin via downregulating survivin in hepatocellular carcinoma.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Chemoembolization, Therapeutic; Epirubicin; Gossypol; Humans; Inhibitor of Apoptosis Proteins; Liver Neoplasms; Male; Mice; Mice, Nude; Survivin; Xenograft Model Antitumor Assays | 2022 |
Combined Treatment of Tanshinone I and Epirubicin Revealed Enhanced Inhibition of Hepatocellular Carcinoma by Targeting PI3K/AKT/HIF-1α.
Topics: Abietanes; Actins; Animals; Carcinoma, Hepatocellular; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Epirubicin; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; Mice; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt | 2022 |
Dexrazoxane for rapid extended livedo reticularis-like skin reaction due to systemic epirubicin diffusion during transcatheter arterial chemoembolization procedure for hepatocellular carcinoma.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Humans; Liver Neoplasms; Male; Middle Aged; Topoisomerase II Inhibitors | 2022 |
Autophagy-Targeted Calcium Phosphate Nanoparticles Enable Transarterial Chemoembolization for Enhanced Cancer Therapy.
Topics: Animals; Calcium Phosphates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Emulsions; Epirubicin; Ethiodized Oil; Liver Neoplasms; Nanoparticles; Rabbits; Tumor Microenvironment | 2023 |
Thermoresponsive hydrogel for transcatheter arterial chemoembolization of hepatocellular carcinoma.
Topics: Arteries; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Ethiodized Oil; Humans; Hydrogels; Liver Neoplasms | 2023 |
Idarubicin versus epirubicin in drug-eluting beads-transarterial chemoembolization for treating hepatocellular carcinoma: A real-world retrospective study.
Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Humans; Idarubicin; Liver Neoplasms; Retrospective Studies; Treatment Outcome | 2023 |
Development of multi-drug resistance to anticancer drugs in HepG2 cells due to MRP2 upregulation on exposure to menthol.
Topics: Antineoplastic Agents; Cisplatin; Drug Resistance, Multiple; Epirubicin; Hep G2 Cells; Humans; Liver Neoplasms; Menthol; Multidrug Resistance-Associated Protein 2; Proto-Oncogene Proteins c-akt; Up-Regulation | 2023 |
Sequential dual-phase cone-beam CT is able to intra-procedurally predict the one-month treatment outcome of multi-focal HCC, in course of degradable starch microsphere TACE.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cone-Beam Computed Tomography; Epirubicin; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Prognosis; Prospective Studies; Radiography, Interventional; Response Evaluation Criteria in Solid Tumors; ROC Curve; Sensitivity and Specificity; Starch; Statistics, Nonparametric; Time Factors; Treatment Outcome | 2019 |
Transarterial Chemoembolisation (TACE) with Degradable Starch Microspheres (DSM) and Anthracycline in Patients with Locally Extensive Hepatocellular Carcinoma (HCC): Safety and Efficacy.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Multimodal Imaging; Prognosis; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Starch; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Effect of palonosetron and dexamethasone administration on the prevention of gastrointestinal symptoms in hepatic arterial chemoembolization with epirubicin.
Topics: Abdominal Pain; Adult; Aged; Antibiotics, Antineoplastic; Antiemetics; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Dexamethasone; Epirubicin; Female; Gastrointestinal Diseases; Humans; Liver Neoplasms; Male; Middle Aged; Nausea; Palonosetron; Retrospective Studies; Vomiting | 2020 |
Retrospective analysis of efficacy, safety, and prognostic factors in a cohort of Chinese hepatocellular carcinoma patients treated with drug-eluting bead transarterial chemoembolization.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cohort Studies; Epirubicin; Female; Humans; Liver Neoplasms; Male; Middle Aged; Prognosis; Retrospective Studies; Survival Analysis; Treatment Outcome | 2019 |
Tripartite motif protein 25 is associated with epirubicin resistance in hepatocellular carcinoma cells via regulating PTEN/AKT pathway.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Resistance, Neoplasm; Epirubicin; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; PTEN Phosphohydrolase; Signal Transduction; Tripartite Motif Proteins | 2020 |
Increased Arterio-Portal Shunt Formation after Drug-Eluting Beads TACE for Hepatocellular Carcinoma.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Arteriovenous Fistula; Carcinoma, Hepatocellular; Catheterization; Chemoembolization, Therapeutic; Drug Delivery Systems; Epirubicin; Female; Humans; Liver Neoplasms; Male; Middle Aged; Progression-Free Survival; Retrospective Studies | 2020 |
Successful Treatment of Therapy-related Acute Promyelocytic Leukemia with All-trans-retinoic acid Following Epirubicin for Hepatocellular Carcinoma and Docetaxel and Pembrolizumab Therapies for Lung Carcinoma: A Triple Malignancy Case.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Hepatocellular; Docetaxel; Epirubicin; Humans; Leukemia, Promyelocytic, Acute; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Treatment Outcome; Tretinoin | 2020 |
Transarterial Chemoembolization Combined with Sorafenib in Patients with BCLC Stage C Hepatocellular Carcinoma.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Epirubicin; Female; Fluorouracil; Glycosides; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Oxaliplatin; Retrospective Studies; Sorafenib | 2020 |
Changes in the Peripheral Blood Treg Cell Proportion in Hepatocellular Carcinoma Patients After Transarterial Chemoembolization With Microparticles.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Case-Control Studies; CD4-CD8 Ratio; Chemoembolization, Therapeutic; Drug Carriers; Epirubicin; Female; Flow Cytometry; Humans; Liver Neoplasms; Male; Middle Aged; Particle Size; T-Lymphocytes, Regulatory; Time Factors; Treatment Outcome | 2021 |
[Clinical investigation on transarterial chemoembolization with indigenous drug-eluting beads in treatment of unresectable hepatocellular carcinoma].
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Comparative Effectiveness Research; Drug Delivery Systems; Epirubicin; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Microspheres; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome | 2017 |
Predictors of therapeutic effect of transarterial chemoembolisation using drug-eluting beads for hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
Immuno-modulatory and cellular antioxidant activities of κ-selenocarrageenan in combination with Epirubicin in H22 hepatoma-bearing mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Carcinoma, Hepatocellular; Carrageenan; Cell Line, Tumor; Cell Proliferation; Epirubicin; Female; Glutathione; Immunologic Factors; Interleukin-2; Killer Cells, Natural; Leukocyte Count; Liver; Liver Neoplasms; Male; Malondialdehyde; Mice; Organoselenium Compounds; Spleen; Thymus Gland; Tumor Necrosis Factor-alpha | 2017 |
Techniques to Form a Suitable Lipiodol-Epirubicin Emulsion by Using 3-Way Stopcock Methods in Transarterial Chemoembolization for Liver Tumor.
Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Emulsions; Epirubicin; Ethiodized Oil; Humans; Iopamidol; Liver Neoplasms; Treatment Outcome; Viscosity | 2017 |
Adjuvant hepatic arterial infusion chemotherapy is beneficial for selective patients with Hepatocellular carcinoma undergoing surgical treatment.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Hepatectomy; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Patient Selection; Retrospective Studies; Survival Rate; Treatment Outcome | 2017 |
HSF1 upregulates ATG4B expression and enhances epirubicin-induced protective autophagy in hepatocellular carcinoma cells.
Topics: Adenine; Animals; Antibiotics, Antineoplastic; Autophagy; Autophagy-Related Proteins; Carcinoma, Hepatocellular; Cell Line, Tumor; Chloroquine; Cysteine Endopeptidases; DNA-Binding Proteins; Drug Synergism; Epirubicin; Heat Shock Transcription Factors; Hep G2 Cells; Humans; Liver Neoplasms; Male; Mice; Mice, Nude; RNA, Messenger; Transcription Factors; Transfection; Up-Regulation; Xenograft Model Antitumor Assays | 2017 |
Supplemental conventional transarterial embolization/chemoembolization therapy via extrahepatic arteries for hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Arteries; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Humans; Liver Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Survival Rate; Tomography, X-Ray Computed | 2017 |
Evaluation of the relationship between hepatocellular carcinoma location and transarterial chemoembolization efficacy.
Topics: Aged; Aged, 80 and over; Angiography; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Epirubicin; Ethiodized Oil; Female; Femoral Artery; Hepatic Artery; Humans; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multidetector Computed Tomography; Portal Vein; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Survival Rate | 2017 |
Treatment of Uterine Sarcoma with rAd-p53 (Gendicine) Followed by Chemotherapy: Clinical Study of TP53 Gene Therapy.
Topics: Adenoviridae; Adult; Bleomycin; Cisplatin; Combined Modality Therapy; Epirubicin; Female; Genetic Therapy; Humans; Liver Neoplasms; Middle Aged; Progression-Free Survival; Recombinant Proteins; Sarcoma; Tumor Suppressor Protein p53; Uterine Neoplasms | 2018 |
Efficacy and Safety of Drug Eluting Bead TACE with Microspheres <150 μm for the Treatment of Hepatocellular Carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Drug Delivery Systems; Epirubicin; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Microspheres; Prognosis; Retrospective Studies; Safety; Survival Rate | 2018 |
Disease-free survival after radical resection followed by adjuvant chemotherapy for primary hepatic synovial sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Epirubicin; Hepatectomy; Humans; Ifosfamide; Liver Neoplasms; Male; Progression-Free Survival; Sarcoma, Synovial; Young Adult | 2018 |
Baicalein sensitizes hepatocellular carcinoma cells to 5-FU and Epirubicin by activating apoptosis and ameliorating P-glycoprotein activity.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Autophagy; bcl-X Protein; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cytoprotection; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Flavanones; Fluorouracil; Hepatocytes; Humans; Liver Neoplasms; Rhodamine 123; Transcription, Genetic | 2018 |
Transarterial chemoembolization plus multi-imaging-guided radiofrequency ablation for elimination of hepatocellular carcinoma nodules measuring 3.1 to 5.0 cm: a single-center study.
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Child; Combined Modality Therapy; Epirubicin; Ethiodized Oil; Female; Hepatic Artery; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Retrospective Studies; Treatment Outcome | 2018 |
Epirubicin is More Effective than Miriplatin in Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Ethiodized Oil; Female; Humans; Liver Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Retrospective Studies; Survival Rate | 2019 |
Prognostic predictors for patients with hepatocellular carcinoma receiving adjuvant transcatheter arterial chemoembolization.
Topics: Alanine Transaminase; Alkaline Phosphatase; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Aspartate Aminotransferases; Camptothecin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Disease-Free Survival; Epirubicin; Female; Fluorouracil; gamma-Glutamyltransferase; Hepatectomy; Hepatitis B, Chronic; Humans; Hypertension, Portal; Leukocyte Count; Liver Neoplasms; Lymphocyte Count; Male; Middle Aged; Monocytes; Neoplasm Staging; Neutrophils; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Rate; Tumor Burden | 2019 |
Polyethylene Glycol Epirubicin-Loaded Transcatheter Arterial Chemoembolization Procedures Utilizing a Combined Approach with 100 and 200 μm Microspheres: A Promising Alternative to Current Standards.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Biopsy; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Disease Progression; Drug Carriers; Epirubicin; Feasibility Studies; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Particle Size; Polyethylene Glycols; Progression-Free Survival; Prospective Studies; Rome; Time Factors; Tomography, X-Ray Computed; Tumor Burden | 2019 |
Identification of the feeding arteries of hepatocellular carcinomas by performing dual arterial phase CT during pre-transarterial chemoembolization angiography.
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Computed Tomography Angiography; Contrast Media; Epirubicin; Ethiodized Oil; Female; Humans; Liver Neoplasms; Male; Middle Aged; Retrospective Studies | 2019 |
Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Balloon Occlusion; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Follow-Up Studies; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Microspheres; Middle Aged; Multimodal Imaging; Polyethylene Glycols; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2019 |
Polyethylenimine (PEI)-Mediated E1A Increases the Sensitivity of Hepatocellular Carcinoma Cells to Chemotherapy.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Deoxycytidine; Docetaxel; Epirubicin; Fluorouracil; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Polyethyleneimine; Viral Proteins | 2019 |
The effect of ifosfamide, epirubicin, and recombinant human endostatin therapy on a cardiac angiosarcoma: A case report.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Endostatins; Epirubicin; Heart Neoplasms; Hemangiosarcoma; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Recombinant Proteins | 2019 |
A suspected case of Clostridium perfringens sepsis with intravascular hemolysis after transhepatic arterial chemoembolization: a case report.
Topics: Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Clostridium perfringens; Embolization, Therapeutic; Epirubicin; Fatal Outcome; Hemolysis; Humans; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Sepsis | 2019 |
Hepatocellular carcinoma macroscopic gross appearance on imaging: predictor of outcome after transarterial chemoembolization in a real-life multicenter French cohort.
Topics: Aged; alpha-Fetoproteins; Antineoplastic Agents; Aspartate Aminotransferases; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cohort Studies; Contrast Media; Epirubicin; Ethiodized Oil; Female; France; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Multiple Primary; Prognosis; Progression-Free Survival; Proportional Hazards Models; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2019 |
Risk factors for local recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization with drug-eluting beads (DEB-TACE).
Topics: Adult; Aged; Aged, 80 and over; Angiography, Digital Subtraction; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Epirubicin; Female; Humans; Iohexol; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Radiographic Image Enhancement; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome | 2019 |
Histological findings in non-tumoral liver and tumor after chemoembolization with drug-eluting beads.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Drug Carriers; Epirubicin; Female; Hepatectomy; Humans; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Polyvinyl Alcohol; Retrospective Studies; Treatment Outcome | 2020 |
Predictive factors for the benefit of triple-drug transarterial chemoembolization for patients with unresectable hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Clinical Trials, Phase III as Topic; Cyclobutanes; Emulsions; Epirubicin; Ethiodized Oil; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Organoplatinum Compounds; Retrospective Studies; Survival Analysis; Treatment Outcome; Young Adult | 2019 |
Database analysis of patients with hepatocellular carcinoma and treatment flow in early and advanced stages.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Comorbidity; Databases, Factual; Epirubicin; Female; Humans; Japan; Liver Neoplasms; Male; Neoplasm Staging; Organoplatinum Compounds; Retrospective Studies | 2019 |
Alpha-fetoprotein assessment for hepatocellular carcinoma after transarterial chemoembolization.
Topics: Adult; Aged; alpha-Fetoproteins; Biomarkers, Tumor; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Disease Progression; Epirubicin; Ethiodized Oil; Female; Humans; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Survival Rate | 2019 |
Correlation between SACE (Subjective Angiographic Chemoembolization Endpoint) score and tumor response and its impact on survival after DEB-TACE in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Epirubicin; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Tomography, X-Ray Computed | 2019 |
Modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for gastroesophageal adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Epirubicin; Esophagogastric Junction; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Palliative Care; Stomach Neoplasms | 2013 |
NC-6300, an epirubicin-incorporating micelle, extends the antitumor effect and reduces the cardiotoxicity of epirubicin.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Epirubicin; Female; Heart; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Micelles; Proteins; Random Allocation; Tissue Distribution; Xenograft Model Antitumor Assays | 2013 |
Prognosis of patients with hepatocellular carcinoma treated solely with transcatheter arterial chemoembolization: risk factors for one-year recurrence and two-year mortality (preliminary data).
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Catheterization, Peripheral; Cohort Studies; Embolization, Therapeutic; Epirubicin; Female; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome | 2013 |
Hepatocellular carcinoma associated with Budd-Chiari syndrome: imaging features and transcatheter arterial chemoembolization.
Topics: Adult; alpha-Fetoproteins; Angiography; Angioplasty; Antineoplastic Combined Chemotherapy Protocols; Budd-Chiari Syndrome; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Ethiodized Oil; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mitomycin; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies; Stents; Tomography, X-Ray Computed | 2013 |
Embryonal sarcoma of the liver.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Doxorubicin; Epirubicin; Female; Humans; Ifosfamide; Infant; Liver; Liver Neoplasms; Male; Retrospective Studies; Sarcoma; Survival Analysis; Treatment Outcome; Vincristine | 2013 |
Hepatic arterial infusion chemotherapy in hepatocellular carcinoma with portal vein tumor thrombosis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chi-Square Distribution; Cisplatin; Disease Progression; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Portal Vein; Proportional Hazards Models; Risk Factors; Time Factors; Treatment Outcome; Tumor Burden; Venous Thrombosis | 2013 |
Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Ethiodized Oil; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Mitomycin; Retrospective Studies; Treatment Outcome | 2014 |
Combination chemotherapy for metastatic extramammary Paget disease.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Bone Neoplasms; Carboplatin; Combined Modality Therapy; Epirubicin; Female; Fluorouracil; Genital Neoplasms, Male; Humans; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Paget Disease, Extramammary; Retrospective Studies; Treatment Outcome; Vincristine; Vulvar Neoplasms | 2014 |
Epirubicin, cisplatin, 5-FU combination chemotherapy in sorafenib-refractory metastatic hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Disease Progression; Drug Resistance, Neoplasm; Epirubicin; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Proportional Hazards Models; Protein Kinase Inhibitors; Retrospective Studies; Sorafenib; Time Factors; Treatment Outcome | 2014 |
Progesterone augments epirubicin-induced apoptosis in HA22T/VGH cells by increasing oxidative stress and upregulating Fas/FasL.
Topics: Antibiotics, Antineoplastic; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Epirubicin; Fas Ligand Protein; fas Receptor; Fas-Associated Death Domain Protein; Humans; Liver Neoplasms; Oxidative Stress; Progesterone; Progestins; Up-Regulation | 2014 |
Epirubicin upregulates UDP glucuronosyltransferase 2B7 expression in liver cancer cells via the p53 pathway.
Topics: Antibiotics, Antineoplastic; Base Sequence; Cell Line, Tumor; DNA Primers; Epirubicin; Glucuronosyltransferase; Humans; Liver Neoplasms; Promoter Regions, Genetic; Real-Time Polymerase Chain Reaction; RNA, Small Interfering; Tumor Suppressor Protein p53; Up-Regulation | 2014 |
[Treatment and prognosis of 117 patients with advanced urothelial carcinoma of the bladder].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Cyclophosphamide; Deoxycytidine; Disease-Free Survival; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Retrospective Studies; Survival Rate; Thrombocytopenia; Urinary Bladder Neoplasms; Urothelium | 2014 |
Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cardiotoxicity; Cell Survival; Chitosan; Disease Models, Animal; Drug Delivery Systems; Epirubicin; Glutathione; Heart; Hep G2 Cells; Hepatocytes; Humans; Lactic Acid; Lipid Peroxidation; Liver; Liver Neoplasms; Mice; Nanoparticles; Neovascularization, Pathologic; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Superoxide Dismutase; Tocotrienols; Tumor Suppressor Protein p53 | 2014 |
Schedule-dependent effects of kappa-selenocarrageenan in combination with epirubicin on hepatocellular carcinoma.
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Carrageenan; cdc25 Phosphatases; Cell Cycle; Cyclin A; Cyclin-Dependent Kinase 2; Drug Administration Schedule; Epirubicin; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Organoselenium Compounds; S Phase Cell Cycle Checkpoints; Xenograft Model Antitumor Assays | 2014 |
Progesterone increases apoptosis and inversely decreases autophagy in human hepatoma HA22T/VGH cells treated with epirubicin.
Topics: Antibiotics, Antineoplastic; Apoptosis; Autophagy; Carcinoma, Hepatocellular; Caspase 3; Cell Line, Tumor; Cell Proliferation; Epirubicin; Humans; Liver Neoplasms; Multidrug Resistance-Associated Proteins; Progesterone; RNA, Messenger | 2014 |
A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Disease Progression; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Portal Vein; Retrospective Studies; Sorafenib; Treatment Outcome; Venous Thrombosis | 2015 |
[Feasibility analysis of endostatin combined with chemotherapy in the treatment of metastatic angiosarcoma].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Docetaxel; Endostatins; Epirubicin; Feasibility Studies; Female; Follow-Up Studies; Hemangiosarcoma; Humans; Liver Neoplasms; Male; Middle Aged; Pubic Bone; Taxoids | 2014 |
Transarterial chemoembolization using drug eluting beads and subsequent percutaneous MR-guided radiofrequency ablation in the therapy of intermediate sized hepatocellular carcinoma.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Combined Modality Therapy; Contrast Media; Epirubicin; Female; Humans; Iohexol; Liver Neoplasms; Magnetic Resonance Imaging, Interventional; Male; Microspheres; Organometallic Compounds; Retrospective Studies; Survival Rate; Treatment Outcome | 2014 |
TIGAR has a dual role in cancer cell survival through regulating apoptosis and autophagy.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Cell Line, Tumor; Cell Survival; Epirubicin; Female; Gene Knockdown Techniques; Hep G2 Cells; Heterografts; Humans; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Lung Neoplasms; Mice; Mice, Nude; Phosphoric Monoester Hydrolases; Transfection | 2014 |
Benefits and problems of transarterial therapy in patients with hepatocellular carcinoma and chronic kidney disease.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Cohort Studies; Combined Modality Therapy; Epirubicin; Ethiodized Oil; Feasibility Studies; Female; Gelatin Sponge, Absorbable; Humans; Kidney Failure, Chronic; Liver Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Survival Rate; Treatment Outcome | 2014 |
An on-chip small intestine-liver model for pharmacokinetic studies.
Topics: Animals; Caco-2 Cells; Camptothecin; Computer Simulation; Cyclophosphamide; Drug Screening Assays, Antitumor; Epirubicin; Hep G2 Cells; Humans; Intestine, Small; Irinotecan; Lab-On-A-Chip Devices; Liver; Liver Neoplasms; Lung; Lung Neoplasms; Organ Culture Techniques; Stomach Neoplasms | 2015 |
Epirubicin-adsorbed nanodiamonds kill chemoresistant hepatic cancer stem cells.
Topics: Animals; Antineoplastic Agents; Biological Transport; Cell Line, Tumor; Cell Proliferation; Drug Carriers; Drug Liberation; Drug Resistance, Neoplasm; Epirubicin; Humans; Hydrogen-Ion Concentration; Liver Neoplasms; Mice; Models, Molecular; Molecular Conformation; Nanodiamonds; Neoplastic Stem Cells; Particle Size; Proteins; Surface Properties | 2014 |
Barcelona clinic liver cancer stage B hepatocellular carcinoma: transarterial chemoembolization or hepatic resection?
Topics: Adult; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; China; Epirubicin; Ethiodized Oil; Female; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Survival Rate; Treatment Outcome | 2014 |
Addition of local hepatic therapy to sorafenib in patients with advanced hepatocellular carcinoma (stage BCLC C).
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Case-Control Studies; Chemoembolization, Therapeutic; Combined Modality Therapy; Embolization, Therapeutic; Epirubicin; Ethiodized Oil; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Niacinamide; Phenylurea Compounds; Retrospective Studies; Sorafenib; Tumor Burden | 2014 |
Comparison of two transarterial chemoembolization strategies for hepatocellular carcinoma.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Ethiodized Oil; Female; Humans; Idarubicin; Infusions, Intra-Arterial; Liver Neoplasms; Male; Retrospective Studies; Treatment Outcome | 2014 |
Transarterial chemoembolization with miriplatin plus epirubicin in patients with hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Anemia; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Disease-Free Survival; Epirubicin; Female; Humans; Leukopenia; Liver Neoplasms; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Retrospective Studies; Treatment Outcome | 2015 |
Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma.
Topics: Adult; Aged; Animals; Carcinoma, Hepatocellular; Cell Hypoxia; Chemoembolization, Therapeutic; Disease Models, Animal; Disease Progression; Epirubicin; Female; Fibrosis; Fluorouracil; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Infusions, Intra-Arterial; Liver; Liver Cirrhosis, Experimental; Liver Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Rats, Sprague-Dawley | 2015 |
[Postoperative cholangitis of balloon-occluded transarterial chemoembolization (B-TACE) for hepatocellular carcinoma].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Balloon Occlusion; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cholangitis; Cisplatin; Epirubicin; Ethiodized Oil; Female; Humans; Liver Neoplasms; Male; Middle Aged; Postoperative Complications | 2014 |
Ulinastatin reduces the resistance of liver cancer cells to epirubicin by inhibiting autophagy.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Autophagy; Biomarkers, Tumor; Blotting, Western; Carcinoma, Hepatocellular; Drug Resistance, Neoplasm; Epirubicin; Glycoproteins; Humans; Liver Neoplasms; Male; Mice; Mice, Nude; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Trypsin Inhibitors; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2015 |
Adjuvant Transarterial Chemoembolization Following Liver Resection for Intrahepatic Cholangiocarcinoma Based on Survival Risk Stratification.
Topics: Adult; Aged; Chemoembolization, Therapeutic; Cholangiocarcinoma; Enbucrilate; Epirubicin; Female; Fluorouracil; Hepatectomy; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Risk Factors | 2015 |
Objective Measurement of Arterial Flow Before and After Transcatheter Arterial Chemoembolization: A Feasibility Study Using Quantitative Color-Coding Analysis.
Topics: Aged; Aged, 80 and over; Angiography, Digital Subtraction; Antibiotics, Antineoplastic; Antineoplastic Agents; Blood Flow Velocity; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Ethiodized Oil; Feasibility Studies; Female; Hepatic Artery; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Regional Blood Flow; Treatment Outcome | 2015 |
Transarterial chemoembolization with drug-eluting beads is effective for the maintenance of the Milan-in status in patients with a small hepatocellular carcinoma.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Decision Support Techniques; Disease Progression; Disease-Free Survival; Drug Carriers; Eligibility Determination; Epirubicin; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Liver Transplantation; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Proportional Hazards Models; Prospective Studies; Remission Induction; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Waiting Lists | 2015 |
Use of Ethanol in the Trans-Arterial Lipiodol Embolization (TAELE) of Intermediated-Stage HCC: Is This Safer than Conventional Trans-Arterial Chemo-Embolization (c-TACE)?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Ethanol; Ethiodized Oil; Female; Humans; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Treatment Outcome | 2015 |
Hepatic arterial infusion chemotherapy using fluorouracil, epirubicin, and mitomycin C for patients with liver metastases from gastric cancer after treatment failure of systemic S-1 plus cisplatin.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Catheters, Indwelling; Cisplatin; Disease Progression; Drug Combinations; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Oxonic Acid; Stomach Neoplasms; Survival Rate; Tegafur; Tomography, X-Ray Computed; Treatment Failure; Treatment Outcome | 2016 |
Volume perfusion computed tomography (VPCT)-based evaluation of response to TACE using two different sized drug eluting beads in patients with nonresectable hepatocellular carcinoma: Impact on tumor and liver parenchymal vascularisation.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cone-Beam Computed Tomography; Epirubicin; Female; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity | 2015 |
Corneal Confocal Microscopy Detects Small Fibre Neuropathy in Patients with Upper Gastrointestinal Cancer and Nerve Regeneration in Chemotherapy Induced Peripheral Neuropathy.
Topics: Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Cold Temperature; Cornea; Epirubicin; Erythromelalgia; Esophageal Neoplasms; Female; Hot Temperature; Humans; Hyperalgesia; Liver Neoplasms; Male; Microscopy, Confocal; Middle Aged; Nerve Fibers; Nerve Regeneration; Neural Conduction; Organoplatinum Compounds; Oxaliplatin; Pain Threshold; Stomach Neoplasms; Trastuzumab; Vibration | 2015 |
Management of vascular lake phenomenon on angiography during chemoembolization with superabsorbent polymer microspheres.
Topics: Aged; Aged, 80 and over; Angiography; Artifacts; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Epirubicin; Female; Humans; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Polymers; Retrospective Studies; Treatment Outcome | 2015 |
Sequential Use of Transhepatic Arterial Chemoembolization and Bipolar Radiofrequency Ablation in the Clinical Therapy of Hepatocellular Carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Combined Modality Therapy; Cyclobutanes; Epirubicin; Ethiodized Oil; Female; Humans; Liver Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Survival Rate; Tumor Burden | 2015 |
Mus81 knockdown improves chemosensitivity of hepatocellular carcinoma cells by inducing S-phase arrest and promoting apoptosis through CHK1 pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Checkpoint Kinase 1; Disease Models, Animal; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Endonucleases; Epirubicin; Gene Knockdown Techniques; Genetic Vectors; Humans; Lentivirus; Liver Neoplasms; Mice; Mice, Knockout; Protein Kinase Inhibitors; Protein Kinases; RNA, Small Interfering; S Phase Cell Cycle Checkpoints; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |
Improved antitumor activity of epirubicin-loaded CXCR4-targeted polymeric nanoparticles in liver cancers.
Topics: Animals; Antibiotics, Antineoplastic; Cell Survival; Drug Liberation; Epirubicin; Hep G2 Cells; Humans; Lactic Acid; Liver Neoplasms; Mice; Microscopy, Electron, Transmission; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Treatment Outcome; Vitamin E | 2016 |
[A Case of Locally-Advanced Breast Cancer with Liver Metastasis, Treated with Mastectomy of the Primary Tumor after Chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Estrogen Replacement Therapy; Female; Humans; Liver Neoplasms; Mastectomy; Neoplasm Staging; Tamoxifen | 2015 |
RGD-peptide conjugated inulin-ibuprofen nanoparticles for targeted delivery of Epirubicin.
Topics: Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Drug Delivery Systems; Drug Liberation; Endocytosis; Epirubicin; Humans; Ibuprofen; Intracellular Space; Inulin; Liver Neoplasms; Mice; Nanoparticles; Oligopeptides; Time Factors; Tissue Distribution | 2016 |
Association of the germline BRCA2 missense variation Glu2663Lys with high sensitivity to trabectedin-based treatment in soft tissue sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Bone Neoplasms; BRCA2 Protein; Dioxoles; Endometrial Neoplasms; Epirubicin; Female; Genes, BRCA2; Germ-Line Mutation; Humans; Ifosfamide; Liver Neoplasms; Middle Aged; Mutation, Missense; Sarcoma, Endometrial Stromal; Tetrahydroisoquinolines; Trabectedin | 2016 |
Short-term efficacy of transarterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres for hepatocellular carcinoma: comparison with conventional transarterial chemoembolization.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Humans; Liver Neoplasms; Male; Microspheres; Survival Rate; Treatment Outcome | 2017 |
Osteopontin induces autophagy to promote chemo-resistance in human hepatocellular carcinoma cells.
Topics: Antineoplastic Agents; Autophagy; Carcinoma, Hepatocellular; Cell Survival; Cisplatin; Drug Resistance, Neoplasm; Epirubicin; Forkhead Box Protein O3; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Integrin alphaVbeta3; Liver Neoplasms; Neoplastic Stem Cells; Osteopontin; Phenotype; Protein Stability; RNA Interference; Signal Transduction; Time Factors; Transfection | 2016 |
Usefulness of CTC and DTC-BM Detection for Adjuvant Therapy Effects and Prognosis Prediction in Early Breast Carcinoma: Results of 8-11 Years of Follow-up Evaluation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Carcinoma; Cell Count; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Liver Neoplasms; Middle Aged; Neoplasm Staging; Neoplastic Cells, Circulating; Prognosis; Tamoxifen; Treatment Outcome | 2017 |
Angiographic evaluation of hepatic arterial damage after transarterial chemoembolization for hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Epirubicin; Female; Gelatin Sponge, Absorbable; Hemostatics; Hepatic Artery; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Survival Rate; Treatment Outcome | 2008 |
Complete pathological response of hepatocellular carcinoma with systemic combination chemotherapy.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Female; Fluorouracil; Humans; Liver Function Tests; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2008 |
Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Balloon Occlusion; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Combined Modality Therapy; Epirubicin; Female; Follow-Up Studies; Hepatic Artery; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin; Pilot Projects; Prospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Simultaneous multitarget irradiation using helical tomotherapy for advanced hepatocellular carcinoma with multiple extrahepatic metastases.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Combined Modality Therapy; Epirubicin; Feasibility Studies; Female; Humans; Iodized Oil; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Survival Rate | 2009 |
Response evaluation of transcatheter arterial chemoembolization in hepatocellular carcinomas: the usefulness of sonazoid-enhanced harmonic sonography.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Epirubicin; Female; Ferric Compounds; Humans; Iodized Oil; Iron; Liver Neoplasms; Male; Middle Aged; Oxides; Tomography, X-Ray Computed; Ultrasonography | 2008 |
[Elderly patient with metastatic gallbladder cancer treated by cisplatin, epirubicin and continuous infusion 5-fluorouracil].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Epirubicin; Female; Fluorouracil; Gallbladder Neoplasms; Humans; Infusions, Intravenous; Liver Neoplasms; Lung Neoplasms; Time Factors; Tomography, X-Ray Computed | 2008 |
Ets-1 is increased in anticancer drug-containing media and hypoxic cultures, similar to TACE.
Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Cell Culture Techniques; Cell Line, Tumor; Chemoembolization, Therapeutic; Epirubicin; Humans; Hypoxia; Liver Neoplasms; Proto-Oncogene Protein c-ets-1 | 2009 |
[Analysis of severe complications after transcatheter arterial chemoembolization for primary hepatocellular carcinoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Fluorouracil; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Iodized Oil; Liver Failure; Liver Neoplasms; Male; Middle Aged; Mitomycin; Pulmonary Embolism; Young Adult | 2008 |
Encephalopathy secondary to capecitabine chemotherapy: a case report and discussion.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Capecitabine; Cisplatin; Deoxycytidine; Epirubicin; Esophageal Neoplasms; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Neurotoxicity Syndromes | 2009 |
Dose-finding study of weekly docetaxel, epirubicin and capecitabine, as first-line treatment in advanced breast cancer.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Capecitabine; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Liver Neoplasms; Lung Neoplasms; Middle Aged; Neoplasm Staging; Prognosis; Soft Tissue Neoplasms; Survival Rate; Taxoids; Treatment Outcome; Young Adult | 2009 |
Validation of the Royal Marsden hospital prognostic index in advanced esophagogastric cancer using individual patient data from the REAL 2 study.
Topics: Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Fluorouracil; Health Status Indicators; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Multicenter Studies as Topic; Organoplatinum Compounds; Oxaliplatin; Peritoneal Neoplasms; Prognosis; Randomized Controlled Trials as Topic; Stomach Neoplasms | 2009 |
Arterial chemoembolization/embolization and early complications after hepatocellular carcinoma treatment: a safe standardized protocol in selected patients with Child class A and B cirrhosis.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Comorbidity; Dose-Response Relationship, Drug; Epirubicin; Female; Fibrosis; Humans; Italy; Liver Neoplasms; Male; Middle Aged; Prevalence; Risk Assessment; Risk Factors; Survival Analysis; Survival Rate; Treatment Outcome | 2009 |
[Water mobility of diffusion MRI in prediction of response to chemoembolization in liver cancer].
Topics: Adult; Aged; Chemoembolization, Therapeutic; Cisplatin; Colonic Neoplasms; Diffusion Magnetic Resonance Imaging; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin; Predictive Value of Tests; Sensitivity and Specificity; Stomach Neoplasms; Treatment Outcome | 2009 |
[Role of DNA topoisomerase II alpha in intrinsic and acquired drug resistance of liver cancer].
Topics: Antigens, Neoplasm; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Colorimetry; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Resistance, Neoplasm; Epirubicin; Female; Fluorouracil; Humans; Immunohistochemistry; Liver Neoplasms; Male; Middle Aged; Predictive Value of Tests; RNA, Messenger | 2009 |
Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.
Topics: ADAM Proteins; ADAM10 Protein; ADAM17 Protein; Amyloid Precursor Protein Secretases; Antibiotics, Antineoplastic; Blotting, Western; Carcinoma, Hepatocellular; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Epirubicin; Flow Cytometry; Gene Expression Regulation, Neoplastic; Histocompatibility Antigens Class I; Humans; Hyaluronan Receptors; Immunoenzyme Techniques; Immunoprecipitation; Killer Cells, Natural; Liver Neoplasms; Membrane Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Tumor Cells, Cultured | 2009 |
Transcatheter arterial chemoembolisation for hepatocellular carcinoma in cirrhosis: survival rate and prognostic factors.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cohort Studies; Epirubicin; Female; Hemostatics; Hepatic Artery; Humans; Kaplan-Meier Estimate; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Palliative Care; Proportional Hazards Models | 2010 |
[A case in which intra-arterial chemotherapy for simultaneous hepatic metastases markedly improved AFP-producing gastric cancer].
Topics: Adenocarcinoma; Aged; alpha-Fetoproteins; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Female; Fluorouracil; Gastrectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Stomach Neoplasms | 2009 |
Transarterial chemoembolization with epirubicin-eluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma.
Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Combined Modality Therapy; Delayed-Action Preparations; Embolization, Therapeutic; Epirubicin; Female; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Premedication; Preoperative Care; Retrospective Studies; Treatment Outcome | 2010 |
Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chi-Square Distribution; Cisplatin; Combined Modality Therapy; Diagnostic Imaging; Doxorubicin; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Logistic Models; Male; Middle Aged; Mitomycin; Neoplasm Invasiveness; Neoplasm Staging; Proportional Hazards Models; Prospective Studies; Surveys and Questionnaires; Survival Rate; Treatment Outcome; Zinostatin | 2010 |
Massive ascites associated with all-trans retinoic acid treatment in therapy-related acute promyelocytic leukemia.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Ascites; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Humans; Leukemia, Promyelocytic, Acute; Liver Neoplasms; Male; Tretinoin | 2010 |
[Features of blood supply and results of transarterial infusion and embolization in spinal metastases].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Back Pain; Breast Neoplasms; Chemoembolization, Therapeutic; Combined Modality Therapy; Embolization, Therapeutic; Epirubicin; Female; Gelatin Sponge, Absorbable; Humans; Iodized Oil; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Remission Induction; Spinal Neoplasms | 2010 |
[Strategy for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization using epirubicin].
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Drug Resistance, Neoplasm; Epirubicin; Female; Humans; Liver Neoplasms; Male; Middle Aged; Platinum Compounds; Survival Rate | 2010 |
[A case of postoperative liver metastasis of mucinous carcinoma of the breast with complete response to sequential administration of FEC75, tamoxifen citrate, and letrozole].
Topics: Adenocarcinoma, Mucinous; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Letrozole; Liver Neoplasms; Mastectomy; Middle Aged; Nitriles; Tamoxifen; Triazoles | 2010 |
Prospective comparison of transcatheter arterial chemoembolization with Lipiodol-epirubicin and Lipiodol-cisplatin for treatment of recurrent hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Treatment Outcome | 2010 |
[Evaluation of transhepatic artery chemotherapy for highly advanced hepatocellular carcinoma].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Mitomycin; Treatment Outcome | 2010 |
Rapid induction of orthotopic hepatocellular carcinoma in immune-competent rats by non-invasive ultrasound-guided cells implantation.
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Cell Transplantation; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Epirubicin; Feasibility Studies; Immunocompetence; Liver Neoplasms; Rats; Rats, Sprague-Dawley; Ultrasonography | 2010 |
Transcatheter arterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres for 135 hepatocellular carcinoma patients: single-center experience.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Hepatic Artery; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Polymers; Treatment Outcome | 2011 |
Multimodal therapy for liver cirrhosis patients with advanced hepatocellular carcinoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Epirubicin; Ethiodized Oil; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Infusions, Intra-Arterial; Japan; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Neoplasms; Male; Prognosis | 2011 |
Transcatheter infusion of epirubicin in water-in-oil-in-water emulsion via a cystic artery for the treatment of hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Angiography; Antibiotics, Antineoplastic; Arteries; Carcinoma, Hepatocellular; Delayed-Action Preparations; Emulsions; Epirubicin; Ethiodized Oil; Female; Humans; Image Processing, Computer-Assisted; Infusions, Intra-Arterial; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Retreatment; Tomography, X-Ray Computed | 2011 |
Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Disease Progression; Emulsions; Epirubicin; Ethiodized Oil; Female; Humans; Liver Neoplasms; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Statistics, Nonparametric; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Esophageal adenocarcinoma presenting as pseudo-achalasia in a patient with juvenile polyposis syndrome: an enemy out of the blue.
Topics: Adenocarcinoma; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiemetics; Antineoplastic Agents; Antineoplastic Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Epirubicin; Esophageal Achalasia; Esophageal Neoplasms; Fatal Outcome; Fluorouracil; Humans; Intestinal Polyposis; Liver Neoplasms; Male; Neoplastic Syndromes, Hereditary; Peritoneal Neoplasms; Proton Pump Inhibitors; Taxoids; Trastuzumab | 2011 |
[Periinterventional cone-beam-CT: application at transarterial chemoembolization of liver tumors].
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Angiography, Digital Subtraction; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Cone-Beam Computed Tomography; Contrast Media; Embolization, Therapeutic; Epirubicin; Ethiodized Oil; Female; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Neovascularization, Pathologic; Phantoms, Imaging; Radiation Dosage; Sensitivity and Specificity | 2011 |
A retrospective comparative study of epirubicin-lipiodol emulsion and cisplatin-lipiodol suspension for use with transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Arteries; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Disease-Free Survival; Emulsions; Epirubicin; Ethiodized Oil; Female; Humans; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Survival Rate; Suspensions | 2011 |
Assessment of ablative margin after radiofrequency ablation for hepatocellular carcinoma; comparison between magnetic resonance imaging with ferucarbotran and enhanced CT with iodized oil deposition.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Dextrans; Epirubicin; Female; Humans; Iodized Oil; Iopamidol; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Prospective Studies; Tomography, Spiral Computed; Treatment Outcome | 2012 |
Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: a prospective cohort study.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chi-Square Distribution; Disease Progression; Epirubicin; Ethiodized Oil; Female; Humans; Liver Function Tests; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Patient Selection; Prospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Switching the loaded agent from epirubicin to cisplatin: salvage transcatheter arterial chemoembolization with drug-eluting microspheres for unresectable hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Drug Carriers; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome | 2012 |
Adjuvant chemolipiodolization reduces early recurrence derived from intrahepatic metastasis of hepatocellular carcinoma after hepatectomy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Case-Control Studies; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Combined Modality Therapy; Epirubicin; Ethiodized Oil; Female; Follow-Up Studies; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retrospective Studies | 2011 |
Previous chemoembolization response after transcatheter arterial chemoembolization (TACE) can predict the anti-tumor effect of subsequent TACE with miriplatin in patients with recurrent hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Epirubicin; Ethiodized Oil; Female; Humans; Injections, Intra-Arterial; Liver Neoplasms; Logistic Models; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Organoplatinum Compounds; Retrospective Studies; Treatment Outcome | 2011 |
Combination treatment with intrahepatic arterial infusion and intratumoral injection chemotherapy in patients with far-advanced hepatocellular carcinoma and arterioportal or arteriovenous shunts: preliminary results.
Topics: Aged; Angiography; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Epirubicin; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Injections, Intramuscular; Interferon-gamma; Liver Neoplasms; Male; Recombinant Proteins; Tomography, X-Ray Computed; Tumor Burden | 2011 |
C-arm CT for assessing initial failure of iodized oil accumulation in chemoembolization of hepatocellular carcinoma.
Topics: Aged; Antineoplastic Agents; Area Under Curve; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Epirubicin; Ethiodized Oil; Feasibility Studies; Female; Humans; Liver Neoplasms; Male; Radiographic Image Interpretation, Computer-Assisted; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Genome-wide association study of epirubicin-induced leukopenia in Japanese patients.
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Case-Control Studies; Cell Cycle Proteins; Cytoskeletal Proteins; Endometrial Neoplasms; Epirubicin; Female; Genome-Wide Association Study; Humans; Japan; Leukopenia; Linkage Disequilibrium; Liver Neoplasms; Male; Neoplasms; Nerve Tissue Proteins; Polymorphism, Single Nucleotide; Prognosis; Risk Factors | 2011 |
Risk factors for the leakage of chemotherapeutic agents into systemic circulation after transcatheter arterial chemoembolization of hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Catheterization; Chemoembolization, Therapeutic; Epirubicin; Ethiodized Oil; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Grading; Prospective Studies; Risk Factors; Taiwan | 2011 |
Solitary huge hepatocellular carcinomas 10 cm or larger may be completely ablated by repeated radiofrequency ablation combined with chemoembolization: Initial experience with 9 patients.
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Combined Modality Therapy; Epirubicin; Female; Humans; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
[A case of breast cancer postoperative metastases to the liver obtained cCR].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Middle Aged; Neoplasm Staging; Tomography, X-Ray Computed | 2011 |
Comparison of local control effects of superselective transcatheter arterial chemoembolization using epirubicin plus mitomycin C and miriplatin for hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chi-Square Distribution; Epirubicin; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Organoplatinum Compounds; Statistics, Nonparametric; Treatment Outcome | 2012 |
Clinical and biological significance of Cdk10 in hepatocellular carcinoma.
Topics: Aged; Base Sequence; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cyclin-Dependent Kinases; Down-Regulation; Drug Resistance, Neoplasm; Epirubicin; Female; Glucuronates; Humans; Immunohistochemistry; Liver Neoplasms; Male; Middle Aged; RNA, Messenger; RNA, Neoplasm | 2012 |
Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Amino Acids, Branched-Chain; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Humans; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Treatment Outcome | 2012 |
Efficacy and safety of metronomic chemotherapy for patients with advanced primary hepatocellular carcinoma with major portal vein tumor thrombosis.
Topics: Administration, Metronomic; Adult; Aged; alpha-Fetoproteins; Antineoplastic Agents; Carcinoma, Hepatocellular; Cisplatin; Epirubicin; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Portal Vein; Prognosis; Tomography, X-Ray Computed; Venous Thrombosis | 2012 |
Serum pharmacokinetics in patients treated with transarterial chemoembolization (TACE) using two types of epirubicin-loaded microspheres.
Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chromatography, High Pressure Liquid; Epirubicin; Female; Humans; Liver Neoplasms; Male; Microspheres; Quality Control | 2012 |
An eClinical trial system for cancer that integrates with clinical pathways and electronic medical records.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Clinical Protocols; Clinical Trials, Phase II as Topic; Critical Pathways; Electronic Health Records; Epirubicin; Humans; Liver Neoplasms; Pilot Projects; Randomized Controlled Trials as Topic; Research Design | 2012 |
Transcatheter arterial infusion chemotherapy prior to radiofrequency thermal ablation for single hepatocellular carcinoma reduces the risk of intrahepatic distant recurrence.
Topics: Aged; Carcinoma, Hepatocellular; Catheter Ablation; Chemotherapy, Adjuvant; Epirubicin; Ethiodized Oil; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Mitomycin; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome | 2012 |
Liver fibrosis and five year survival of hepatocellular cancer cases undergoing transcatheter arterial chemo embolization using small doses.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chi-Square Distribution; Collagen Type III; Collagen Type IV; Epirubicin; Female; Fluorouracil; Humans; Hyaluronic Acid; Iodized Oil; Kaplan-Meier Estimate; Laminin; Liver Cirrhosis; Liver Neoplasms; Male; Mitomycin; Transforming Growth Factor beta1; Treatment Outcome | 2012 |
Serum interleukin-6 and C-reactive protein as a prognostic indicator in hepatocellular carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; C-Reactive Protein; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Epirubicin; Female; Humans; Interleukin-10; Interleukin-4; Interleukin-6; Liver Neoplasms; Male; Middle Aged; Prognosis | 2012 |
Dual-phase CT angiography through the port-catheter system for hepatic arterial infusion chemotherapy using multislice CT: assessment of system dysfunction and impact on predicting clinical problems.
Topics: Aged; Aged, 80 and over; Angiography, Digital Subtraction; Antineoplastic Agents; Carcinoma, Hepatocellular; Cisplatin; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Predictive Value of Tests; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Vascular Access Devices; Vascular Patency | 2012 |
TMEM45A is essential for hypoxia-induced chemoresistance in breast and liver cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Cells, Cultured; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Kaplan-Meier Estimate; Keratinocytes; Liver Neoplasms; Membrane Proteins; Oligonucleotide Array Sequence Analysis; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Transcriptome | 2012 |
Impact of low versus conventional doses of chemotherapy during transcatheter arterial chemo-embolization on serum fibrosis indicators and survival of liver cancer patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chi-Square Distribution; Cisplatin; Collagen Type III; Collagen Type IV; Epirubicin; Ethiodized Oil; Female; Fluorouracil; Humans; Hyaluronic Acid; Kaplan-Meier Estimate; Laminin; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged | 2012 |
Effect of transcatheter arterial chemoembolization prior to surgical resection for hepatocellular carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Case-Control Studies; Chemoembolization, Therapeutic; Epirubicin; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Mitomycin; Neoplasm Staging; Prognosis; Survival Rate | 2013 |
Synthesis and antitumor activities of derivatives of the marine mangrove fungal metabolite deoxybostrycin.
Topics: Anthraquinones; Antineoplastic Agents; Ascomycota; Breast Neoplasms; Cell Line, Tumor; Colonic Neoplasms; Epirubicin; Female; HCT116 Cells; Hep G2 Cells; Humans; Inhibitory Concentration 50; Liver Neoplasms | 2012 |
[Evaluation of intra-arterial infusion chemotherapy for liver metastasis from gastric cancer FEM--combination therapy of 5 FU, Epirubicin and MMC].
Topics: Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Fluorouracil; Hepatectomy; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Stomach Neoplasms; Survival Rate | 2002 |
[Hepatic metastases from alpha-fetoprotein producing colorectal cancer that responded remarkably to transcatheter arterial chemo-embolization].
Topics: alpha-Fetoproteins; Antibiotics, Antineoplastic; Chemoembolization, Therapeutic; Colonic Neoplasms; Colorectal Neoplasms; Epirubicin; Female; Humans; Immunohistochemistry; Iodized Oil; Liver Neoplasms; Middle Aged | 2002 |
[A case report of hepatocellular carcinoma with portal thrombus responding to hepatic arterial infusion chemo-lipiodolization].
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Humans; Iodized Oil; Liver Neoplasms; Male; Mitomycin; Neoplasm Recurrence, Local; Portal Vein; Thrombosis | 2002 |
[Early effect of intra-arterial chemotherapy combined with degradable starch microspheres for malignant hepatic tumors].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Doxorubicin; Epirubicin; Female; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver; Liver Neoplasms; Male; Middle Aged; Mitomycin; Starch; Tomography, X-Ray Computed | 2003 |
[A case of advanced hepatocelluar carcinoma achieving a complete response following the hepatic arterial infusion chemotherapy and subsequent lipiodolization].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Drug Administration Schedule; Epirubicin; Fluorouracil; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Remission Induction | 2003 |
A population model of epirubicin pharmacokinetics and application to dosage guidelines.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Area Under Curve; Aspartate Aminotransferases; Breast Neoplasms; Clinical Trials as Topic; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Liver Neoplasms; Metabolic Clearance Rate; Middle Aged; Population Surveillance | 2003 |
Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chi-Square Distribution; Cisplatin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Radiography, Interventional; Statistics, Nonparametric; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
[Evaluation of intraarterial infusion chemotherapy for liver metastasis from gastric cancer FEM: combination therapy of 5-FU, epirubicin and MMC].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Gastrectomy; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Stomach Neoplasms; Survival Rate | 2003 |
[Validity of two-hour continuous hepatic arterial infusion chemotherapy with low-dose 5-FU for unresectable liver metastasis from colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Epirubicin; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Mitomycin; Prognosis; Reproducibility of Results; Survival Rate | 2003 |
Uptake of lipiodol-cytotoxics conjugates by hepatocellular carcinoma cells.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cells, Cultured; Cytoplasm; Doxorubicin; Drug Carriers; Drug Screening Assays, Antitumor; Epirubicin; Hepatocytes; Humans; Iodized Oil; Liver Neoplasms; Microscopy, Confocal; Microscopy, Electron; Microscopy, Fluorescence; Tumor Stem Cell Assay | 2004 |
[Chemoembolization of hepatocellular carcinomas: which factors determine therapeutic response and survival?].
Topics: Adult; Aged; Angiography; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chi-Square Distribution; Epirubicin; Ethiodized Oil; Female; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Meta-Analysis as Topic; Middle Aged; Multivariate Analysis; Patient Selection; Prognosis; Prospective Studies; Regression Analysis; Survival Analysis; Time Factors; Tomography, Spiral Computed; Tomography, X-Ray Computed | 2004 |
A longterm follow-up study of thymidylate synthase as a predictor for survival of patients with liver tumours receiving hepatic arterial infusion chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Prognosis; Survival Analysis; Thymidylate Synthase; Treatment Outcome | 2004 |
A rare life-threatening complication of migrated nitinol self-expanding metallic stent (Ultraflex).
Topics: Adenocarcinoma; Aged; Alloys; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deglutition Disorders; Device Removal; Epirubicin; Equipment Design; Esophageal Neoplasms; Fluorouracil; Foreign-Body Migration; Humans; Ileal Diseases; Intestinal Obstruction; Laparotomy; Liver Neoplasms; Male; Postoperative Complications; Stents | 2004 |
Transcatheter chemo-embolization for hepatocellular carcinoma and certain hepatic metastasis.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Epirubicin; Hepatic Artery; Humans; Liver Neoplasms; Treatment Outcome | 2004 |
Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma.
Topics: Administration, Cutaneous; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Epirubicin; Ethanol; Female; Fluorouracil; Humans; Infusions, Intravenous; Injections, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Retrospective Studies | 2004 |
[Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Epirubicin; Ethanol; Female; Follow-Up Studies; Humans; Injections, Subcutaneous; Liver Neoplasms; Male; Mitomycin; Retrospective Studies; Survival Rate | 2004 |
Transcatheter arterial chemoembolization for hepatocellular carcinoma fed by the reconstructed inferior phrenic artery: anatomical and technical analysis.
Topics: Adrenal Glands; Aged; Antibiotics, Antineoplastic; Arteries; Carcinoma, Hepatocellular; Catheters, Indwelling; Celiac Artery; Chemoembolization, Therapeutic; Collateral Circulation; Epirubicin; Female; Humans; Liver Neoplasms; Male; Mesenteric Artery, Superior; Middle Aged; Mitomycin; Pancreas; Retrospective Studies; Stomach; Treatment Outcome | 2004 |
Hepatic arterial infusion chemotherapy with use of an implanted port system in patients with advanced hepatocellular carcinoma: prognostic factors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheters, Indwelling; Cisplatin; Doxorubicin; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Prognosis; Retrospective Studies; Survival Analysis; Treatment Outcome | 2004 |
[Methylated oligonucleotide inhibiting expression of human MRP2 and reversing multidrug resistance in hepatocellular carcinoma Cell HepG2].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Camptothecin; Carboplatin; Carcinoma, Hepatocellular; Cell Line, Tumor; DNA Methylation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Humans; Inhibitory Concentration 50; Liver Neoplasms; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Oligonucleotides; RNA, Messenger; Transfection | 2004 |
Long-term survival of a patient with primarily chemo-resistant metastatic breast cancer treated with medroxyprogesterone acetate.
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease Progression; Drug Resistance, Neoplasm; Epirubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Mastectomy, Modified Radical; Medroxyprogesterone Acetate; Prognosis; Treatment Outcome | 2004 |
[Hepatic arterial infusion and occlusion technique for the evaluation of the hepatic resection to control the local liver tumor].
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Epirubicin; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Microspheres; Middle Aged; Mitomycin; Starch; Stomach Neoplasms | 2004 |
[Long-term survivors with liver metastasis from breast cancer who were received intra-arterial chemotherapy].
Topics: Adult; Aged; Breast Neoplasms; Combined Modality Therapy; Disease-Free Survival; Embolization, Therapeutic; Epirubicin; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Microspheres; Middle Aged; Starch | 2004 |
[A case of Vp3 hepatocellular carcinoma with a good QOL after multidisciplinary treatments].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality Therapy; Doxorubicin; Embolization, Therapeutic; Epirubicin; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Neoplastic Cells, Circulating; Quality of Life; Tomography, X-Ray Computed | 2004 |
[In vitro chemosensitivity test for hepatocellular carcinoma using collagen-gel droplet embedded cultures].
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma, Hepatocellular; Cisplatin; Collagen; Culture Media; Drug Screening Assays, Antitumor; Epirubicin; Fluorouracil; Gels; Humans; Liver Neoplasms; Paclitaxel; Tissue Embedding | 2004 |
[A case of diffuse type of hepatocellular carcinoma with tumor thrombosis of inferior vena cava (Vv3) and main trunk of portal vein (Vp4), showing marked response to transcatheter arterial chemoembolization with degradable starch microspheres (DSM-TACE)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Drug Administration Schedule; Epirubicin; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplastic Cells, Circulating; Portal Vein; Starch; Vena Cava, Inferior | 2004 |
[Efficacy of hepatic arterial infusion therapy for advanced hepatocellular carcinoma using 5-fluorouracil, epirubicin and mitomycin-C].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Epirubicin; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate | 2005 |
[Three cases of multiple colorectal liver metastases responding to hepatic arterial infusion chemotherapy undergoing liver resection].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Colon, Sigmoid; Colonic Neoplasms; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Male; Middle Aged; Sigmoid Neoplasms | 2005 |
[A case of hepatocellular carcinoma with tumor thrombi in the first branch of the portal vein and hepatic vein trunks treated by transcatheter hepatic arterial chemoembolization and hepatic arterial infusion chemotherapy--two years and six months follow-u
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Drug Administration Schedule; Epirubicin; Fluorouracil; Follow-Up Studies; Hepatic Artery; Hepatic Veins; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Mitomycin; Neoplastic Cells, Circulating; Portal Vein; Thrombosis | 2005 |
[Follicular dendritic cell sarcoma].
Topics: Abdominal Neoplasms; Adult; Antibiotics, Antineoplastic; Dendritic Cells, Follicular; Epirubicin; Humans; Liver Neoplasms; Liver Transplantation; Male; Neoplasm Recurrence, Local; Sarcoma | 2005 |
Iodized oil embolization to brain following transcatheter arterial embolization of liver.
Topics: Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Epirubicin; Fatal Outcome; Female; Humans; Intracranial Embolism; Iodized Oil; Liver Neoplasms; Pulmonary Embolism | 2005 |
[Experimental studies of anti-proliferative effects of marinesponge extracts S1 - S3 on human lung adenocarcinoma and hepatocarcinoma cells].
Topics: Adenocarcinoma; Alkaloids; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Epirubicin; Humans; Liver Neoplasms; Lung Neoplasms; Materia Medica; Porifera; Stomach Neoplasms | 2005 |
Adenosquamous carcinoma of the uterine cervix--adjuvant chemotherapeutic treatment with paclitaxel and carboplatin; a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenosquamous; Epirubicin; Ethanol; Fatal Outcome; Female; Gynecologic Surgical Procedures; Humans; Injections, Intralesional; Liver Neoplasms; Middle Aged; Neoplasm Staging; Paclitaxel; Sclerosing Solutions; Sclerotherapy; Treatment Outcome; Uterine Cervical Neoplasms | 2005 |
Lasting remission following multimodal treatment in a patient with metastatic breast cancer.
Topics: Adult; Antibodies; Antigens, Neoplasm; Breast Neoplasms; CD3 Complex; Cell Adhesion Molecules; Combined Modality Therapy; Epirubicin; Epithelial Cell Adhesion Molecule; Female; Humans; Leukapheresis; Liver Neoplasms; Paclitaxel; Remission Induction; Thiotepa; Treatment Outcome | 2005 |
Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC).
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Chi-Square Distribution; Combined Modality Therapy; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Male; Microspheres; Middle Aged; Survival Analysis; Treatment Outcome; Ultrasonography, Interventional | 2006 |
Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled study.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Case-Control Studies; Cause of Death; Chemoembolization, Therapeutic; Epirubicin; Female; Follow-Up Studies; Hepatic Artery; Humans; Italy; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prognosis; Survival Analysis; Time Factors; Treatment Outcome | 2005 |
Histone deacetylase inhibition by valproic acid down-regulates c-FLIP/CASH and sensitizes hepatoma cells towards CD95- and TRAIL receptor-mediated apoptosis and chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Hepatocellular; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 3; Caspases; Down-Regulation; Drug Resistance, Neoplasm; Epirubicin; fas Receptor; Histone Deacetylase Inhibitors; Humans; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Membrane Glycoproteins; Receptors, Tumor Necrosis Factor; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha; Valproic Acid | 2006 |
Transcatheter arterial chemoembolization in patients with hepatocellular carcinoma and coexisting hepatic cavernous hemangioma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheterization, Peripheral; Chemoembolization, Therapeutic; Contrast Media; Epirubicin; Female; Follow-Up Studies; Hemangioma, Cavernous; Humans; Iodized Oil; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mitomycin; Neoplasms, Multiple Primary; Retreatment; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
[Investigation of bile duct injury after transcatheter arterial chemoembolization].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bile Ducts; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cholangiography; Cisplatin; Dilatation, Pathologic; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Iodized Oil; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mitomycin; Ultrasonography | 2005 |
[Evaluation of transcatheter arterial chemoembolization in the prevention of postoperative recurrence in 1630 patients with hepatocellular carcinoma].
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Postoperative Period | 2005 |
[A case of postoperative liver metastasis from bile duct carcinoma responding to transarterial chemoembolization].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Chemoembolization, Therapeutic; Drug Administration Schedule; Epirubicin; Fluorouracil; Hepatic Artery; Humans; Liver Neoplasms; Male; Microspheres; Mitomycin; Polymers; Postoperative Period; Remission Induction | 2006 |
Discordant influence of amphotericin B on epirubicin cytotoxicity in primary hepatic malignant cells collected by a new primary culture technique.
Topics: Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biopsy, Fine-Needle; Carcinoma, Hepatocellular; Cell Culture Techniques; Cell Proliferation; Cholangiocarcinoma; Drug Interactions; Drug Therapy, Combination; Epirubicin; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Treatment Outcome; Tumor Cells, Cultured | 2006 |
Relationship between therapeutic efficacy of arterial infusion chemotherapy and expression of P-glycoprotein and p53 protein in advanced hepatocellular carcinoma.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Carboplatin; Carcinoma, Hepatocellular; Epirubicin; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Immunohistochemistry; Infusions, Intra-Arterial; Liver Neoplasms; Mitoxantrone; Retrospective Studies | 2006 |
[Differential expression of mitochondrial proteins in hepatoma cells analyzed using two-dimensional electrophoresis].
Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Cell Line, Tumor; Cells, Cultured; Electrophoresis, Gel, Two-Dimensional; Epirubicin; Humans; Liver; Liver Neoplasms; Mitochondria, Liver; Mitochondrial Proteins; Proteome; Proteomics | 2005 |
Efficacy of imatinib mesylate in patients with liver metastases from gastrointestinal stromal tumor failing intra-arterial hepatic chemotherapy with epirubicin.
Topics: Aged; Antineoplastic Agents; Benzamides; Epirubicin; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Piperazines; Pyrimidines | 2003 |
Anticoagulant-induced pseudothrombocytopenia occurring after transcatheter arterial embolization for hepatocellular carcinoma.
Topics: Aged; Antibiotics, Antineoplastic; Anticoagulants; Blood Platelets; Carcinoma, Hepatocellular; Disseminated Intravascular Coagulation; Edetic Acid; Embolization, Therapeutic; Epirubicin; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Neoplasm Invasiveness; Platelet Count; Portal Vein; Thrombocytopenia | 2006 |
[Blood supply of pulmonary metastases and its clinical significance].
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Camptothecin; Chemoembolization, Therapeutic; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Radiography; Remission Induction; Stomach Neoplasms; Young Adult | 2006 |
[Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiation Dosage; Radiotherapy, Conformal; Survival Rate | 2006 |
[Epirubicin in the treatment of malignant obstructive jaundice].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Bile Duct Neoplasms; Bilirubin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Follow-Up Studies; Humans; Iodized Oil; Jaundice, Obstructive; Liver Neoplasms; Male; Middle Aged; Recurrence; Survival Rate | 2006 |
[Proteomic approach to the effect of epirubicin on hepatoma cells at subcellular level].
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Nucleus; Electrophoresis, Gel, Two-Dimensional; Epirubicin; Humans; Liver Neoplasms; Mitochondria; Mitochondrial Proteins; Nuclear Proteins; Proteomics; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2006 |
[Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma providing a good QOL].
Topics: Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Epirubicin; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Quality of Life; Tegafur; Tomography, X-Ray Computed; Uracil | 2006 |
Diagnostic value of PET/CT for predicting of neoadjuvant chemotherapy response.
Topics: Breast Neoplasms; Cyclophosphamide; Drug Monitoring; Epirubicin; Female; Humans; Liver Neoplasms; Lymph Nodes; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Ribs; Tomography, X-Ray Computed | 2007 |
Factors predicting survival in advanced T-staged hepatocellular carcinoma patients treated with reduction hepatectomy followed by transcatheter arterial chemoembolization.
Topics: Adult; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Epirubicin; Female; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome | 2007 |
N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma.
Topics: Antibiotics, Antineoplastic; Carbohydrate Sequence; Carcinoma, Hepatocellular; Down-Regulation; Drug Resistance, Neoplasm; Drug Tolerance; Epirubicin; Fucosyltransferases; Glycosylation; Glycosyltransferases; Humans; Liver Neoplasms; Mitoxantrone; N-Acetylglucosaminyltransferases; Oligosaccharides, Branched-Chain; Polysaccharides; Tumor Cells, Cultured; Up-Regulation | 2007 |
The best candidates for transarterial chemotherapy in patients with hepatocellular carcinoma awaiting liver transplantation: a cohort-based characterization of dropout times.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Cohort Studies; Disease Progression; Epirubicin; Female; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Patient Dropouts; Patient Selection; Risk Factors; Waiting Lists | 2007 |
Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cohort Studies; Combined Modality Therapy; Contrast Media; Embolization, Therapeutic; Epirubicin; Female; Gelatin Sponge, Absorbable; Hemostatics; Humans; Iodized Oil; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Treatment Outcome | 2007 |
[Three cases of hepatocellular carcinoma, over 3 cm in diameter, with liver cirrhosis treated with combination of radiofrequency ablation and continuous hepatic arterial infusion chemotherapy].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hepatic Artery; Hepatitis B, Chronic; Humans; Infusions, Intra-Arterial; Liver Cirrhosis; Liver Neoplasms; Male; Remission Induction | 2007 |
[A case of unresectable advanced gallbladder cancer treated by systemic chemotherapy combined with hepatic arterial infusion].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Epirubicin; Female; Gallbladder Neoplasms; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Mitomycin; Oxonic Acid; Remission Induction; Tegafur | 2007 |
[Dose dense chemotherapy in the postoperative adjuvant treatment for breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Mastectomy; Middle Aged; Nausea; Neutropenia; Paclitaxel; Postoperative Period; Retrospective Studies; Taxoids | 2007 |
Survivin expression in early hepatocellular carcinoma and post-treatment with anti-cancer drug under hypoxic culture condition.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Biopsy; Carcinoma, Hepatocellular; Cell Hypoxia; Cell Line, Tumor; Epirubicin; Female; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Liver; Liver Neoplasms; Male; Microtubule-Associated Proteins; Middle Aged; Neoplasm Proteins; Survivin | 2007 |
Efficacy and safety of epirubicin and etoposide combination chemotherapy in advanced hepatocellular carcinoma: a retrospective analysis.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Epirubicin; Etoposide; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Retrospective Studies | 2008 |
Usefulness of cone-beam volume CT with flat panel detectors in conjunction with catheter angiography for transcatheter arterial embolization.
Topics: Aged; Aged, 80 and over; Angiography, Digital Subtraction; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Epirubicin; Equipment Design; Equipment Failure Analysis; Female; Gelatin Sponge, Absorbable; Hepatic Artery; Humans; Iodized Oil; Iopamidol; Liver Neoplasms; Male; Middle Aged; Radiographic Image Enhancement; Radiography, Interventional; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; X-Ray Intensifying Screens | 2007 |
Hepatic arterial infusion chemotherapy with epirubicin in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Epirubicin; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Portal Vein; Retrospective Studies; Survival Analysis; Venous Thrombosis | 2007 |
Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Enzyme-Linked Immunosorbent Assay; Epirubicin; Female; Fibroblast Growth Factor 2; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Neovascularization, Pathologic; Prognosis; Proportional Hazards Models; Statistics, Nonparametric; Survival Rate; Urokinase-Type Plasminogen Activator; Vascular Endothelial Growth Factor A | 2008 |
[Transhepatic arterial chemoembolization by epirubicin mixed with microspheres for hepatocellular carcinoma].
Topics: Adult; Aged; Alanine Transaminase; alpha-Fetoproteins; Antibiotics, Antineoplastic; Aspartate Aminotransferases; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Fever; Follow-Up Studies; Hemolysis; Humans; Leukocyte Count; Liver Neoplasms; Male; Microspheres; Middle Aged; Serum Albumin; Survival Rate | 2007 |
[A complete response to one-shot hepatic arterial infusion of epirubicin in a patient with highly advanced hepatocellular carcinoma].
Topics: alpha-Fetoproteins; Carcinoma, Hepatocellular; Epirubicin; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Tomography, X-Ray Computed | 2007 |
Pharmacokinetic studies of 4'-epi-doxorubicin in cancer patients with normal and impaired renal function and with hepatic metastases.
Topics: Chromatography, High Pressure Liquid; Doxorubicin; Epirubicin; Half-Life; Humans; Kidney; Kinetics; Liver Neoplasms; Neoplasms; Time Factors | 1982 |
Evaluation of the therapeutic effect of TAE on primary liver cancer.
Topics: Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Doxorubicin; Epirubicin; Female; Humans; Injections, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Necrosis; Prognosis; Survival Rate; Tomography, X-Ray Computed | 1994 |
Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases.
Topics: Adolescent; Adult; Aged; Antigens, Neoplasm; Carcinoma, Hepatocellular; Catheterization, Peripheral; Cell Division; Cell Survival; Chemoembolization, Therapeutic; Doxorubicin; Epirubicin; Female; Hepatic Artery; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin; Necrosis; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Staining and Labeling | 1994 |
[The chemoembolization of hepatocellular carcinoma: the computed tomographic findings and clinical results in prospective repetitive therapy].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Clinical Protocols; Contrast Media; Epirubicin; Female; Humans; Iodized Oil; Iohexol; Liver Neoplasms; Male; Middle Aged; Palliative Care; Prospective Studies; Remission Induction; Retrospective Studies; Tomography, X-Ray Computed | 1994 |
[Intra-arterial infusion chemotherapy for advanced liver metastases from lung cancer via implantable vascular access: report of six cases].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Mitomycin | 1995 |
[A case report of far advanced gastric cancer with multiple liver metastasis (H3) treated with transarterial intermittent chemotherapy and intradermal administration of low molecular lipopolysaccharide (LPSp) extracted from Pantoea agglomerans].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Enterobacteriaceae; Epirubicin; Fluorouracil; Humans; Immunologic Factors; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Injections, Subcutaneous; Lipopolysaccharides; Liver Neoplasms; Male; Mitomycin; Molecular Weight; Stomach Neoplasms | 1995 |
[Efficacy of treatment with frequent and low-dose epirubicin in two cases of pulmonary metastases after surgery of liver cancer].
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Drug Administration Schedule; Epirubicin; Fluorouracil; Hepatectomy; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged | 1995 |
[Hepatic artery chemotherapy-embolization and biological response modifiers for late hepatic carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Combined Modality Therapy; Epirubicin; Female; Fluorouracil; Humans; Immunologic Factors; Interferon-gamma; Liver Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate | 1995 |
[A case of liver metastasis of gastric cancer with portal vein tumor thrombosis responding to chemotherapy with 5-FU and epirubicin].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Fluorouracil; Humans; Liver Neoplasms; Male; Parenteral Nutrition, Total; Portal Vein; Stomach Neoplasms; Thrombosis | 1995 |
Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Disease-Free Survival; Epirubicin; Feasibility Studies; Female; Fluorouracil; Hepatectomy; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Prospective Studies; Survival Rate; Tegafur; Uracil | 1995 |
[Hepatic arterial infusion chemotherapy and embolization in the treatment of hepatic carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Gelatin Sponge, Absorbable; Hepatic Artery; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Survival Rate | 1994 |
Transcatheter arterial chemoembolization therapy with epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheterization, Peripheral; Emulsions; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Iodized Oil; Iohexol; Liver Neoplasms; Male; Middle Aged; Mitomycin; Retrospective Studies | 1995 |
[Home therapy approach in cancer patients-chemotherapy (case 2-3)--intra-arterial infusion cancer chemotherapy for hepatic metastasis of colorectal cancer--case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Cisplatin; Colorectal Neoplasms; Epirubicin; Female; Fluorouracil; Home Infusion Therapy; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Mitomycin | 1994 |
[The preoperative chemoembolization of hepatocarcinoma due to cirrhosis].
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Evaluation Studies as Topic; Humans; Iodized Oil; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Preoperative Care; Time Factors; Tomography, X-Ray Computed | 1994 |
[Transcatheter arterial chemoembolization technique in cirrhotic patients with hepatocarcinoma. Considerations on the procedure and evaluation of survival].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Proportional Hazards Models; Survival Rate; Time Factors | 1994 |
[A case of liver metastasis from bile duct cancer effectively treated with hepatic artery infusion chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Mitomycin | 1994 |
[A case of huge liver metastasis from jejunal leiomyosarcoma completely controlled by intra-arterial and intra-portal vein infusion chemotherapy following hepatectomy].
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Epirubicin; Female; Hepatectomy; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Infusions, Intravenous; Jejunal Neoplasms; Leiomyosarcoma; Liver Neoplasms; Portal Vein; Remission Induction; Tegafur; Uracil | 1994 |
[A case of metastatic breast cancer successfully treated with weekly low-dose epirubicin (EPI), cyclophosphamide (CPA), 5-fluorouracil (5-FU) and medroxyprogesterone (MPA)].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Medroxyprogesterone; Middle Aged; Tamoxifen | 1994 |
[A case of advanced gastric cancer successfully treated with resection after FEP (5-FU, epirubicin, CDDP) combined chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Epirubicin; Fluorouracil; Gastrectomy; Humans; Liver Neoplasms; Lymph Node Excision; Male; Middle Aged; Neoplasm Invasiveness; Stomach Neoplasms | 1994 |
[A case of liver metastasis of leiomyosarcoma of residual stomach successfully treated by TAE and intra-hepato-arterial chemotherapy with infusion-a-port with administration of epirubicin].
Topics: Embolization, Therapeutic; Epirubicin; Gastrectomy; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Leiomyosarcoma; Liver Neoplasms; Male; Middle Aged; Neoplasm, Residual; Stomach Neoplasms; Treatment Outcome | 1994 |
Undifferentiated (embryonal) sarcoma of the liver in an adult patient with metastasis of the heart and brain.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Epirubicin; Fatal Outcome; Female; Heart Neoplasms; Humans; Ifosfamide; Liver Neoplasms; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Pericardium; Ultrasonography | 1994 |
[Intra-arterial injection of pethidine for treatment of pain in chemoembolization of the liver].
Topics: Adult; Aged; Chemotherapy, Cancer, Regional Perfusion; Embolization, Therapeutic; Epirubicin; Female; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Meperidine; Middle Aged; Pain | 1994 |
[Hypervascular liver metastases of gastric cancer completely responding to transcatheter oily chemoembolization using epirubicin hydrochloride, mitomycin C and lipiodol].
Topics: Adenocarcinoma; Aged; Chemoembolization, Therapeutic; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Mitomycin; Stomach Neoplasms | 1994 |
Efficacy of CO2-DSA in embolization.
Topics: Adult; Aged; Angiography, Digital Subtraction; Carbon Dioxide; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Humans; Iodized Oil; Liver; Liver Neoplasms; Male; Middle Aged | 1994 |
Repeated arterial infusion chemotherapy for inoperable hepatocellular carcinoma using an implantable drug delivery system.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin | 1994 |
Therapeutic effect of a CDDP-epirubicin-Lipiodol emulsion on advanced hepatocellular carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Delayed-Action Preparations; Emulsions; Epirubicin; Female; Follow-Up Studies; Humans; Iodized Oil; Liver Neoplasms; Male; Microscopy, Electron, Scanning; Particle Size; Survival Rate | 1994 |
[Liver metastases from breast cancer: survival and an attempt at cauterization and thermocoagulation therapy combined with selective intra-arterial infusion chemotherapy].
Topics: Breast Neoplasms; Combined Modality Therapy; Electrocoagulation; Epirubicin; Female; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Microwaves | 1993 |
[Advanced breast cancer with onset of multi-organ metastases successfully treated with combined loco-regional therapies: a case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cholestasis; Combined Modality Therapy; Drainage; Epirubicin; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Mastectomy; Middle Aged; Mitomycin; Pleural Effusion, Malignant | 1993 |
[Effect of radio-immunochemotherapy-using antiferritin antibody combined with anthracycline drugs on hepatocellular carcinoma cell].
Topics: Antibodies; Carcinoma, Hepatocellular; Combined Modality Therapy; Doxorubicin; Epirubicin; Ferritins; Humans; Iodine Radioisotopes; Liver Neoplasms; Radioimmunotherapy; Tumor Cells, Cultured | 1993 |
[Long-term results of chemoembolization of primary liver cancer with epirubicin-lipiodol].
Topics: Adenoma, Bile Duct; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Follow-Up Studies; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects | 1993 |
[Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization (TAE)--significance of repetitive therapies and responses to them within 6 months after the first intervention].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Regression Analysis; Retrospective Studies; Survival Rate; Time Factors | 1993 |
[Transcatheter hepatic segmental chemo-Lipiodol-embolization against hepatocellular carcinoma accompanied by tumor thrombosis in the portal vein].
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin; Portal Vein; Thrombosis | 1993 |
[Significance of preoperative TAE as an adjuvant therapy for hepatocellular carcinoma].
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Epirubicin; Humans; Liver Neoplasms; Preoperative Care; Prognosis; Survival Rate | 1993 |
[Study of intra-arterial infusion chemotherapy for hepatocellular carcinoma using an implantable reservoir].
Topics: Aged; Carcinoma, Hepatocellular; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Survival Rate | 1993 |
[A case of gastric cancer with multiple liver metastases responding significantly to intra-arterial infusion of epirubicin/mitomycin C-lipiodol suspension].
Topics: Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cholecystectomy; Delayed-Action Preparations; Epirubicin; Gastrectomy; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Lymph Node Excision; Male; Middle Aged; Mitomycin; Stomach Neoplasms | 1993 |
[Combined mitoxantrone therapy for heavily pretreated metastatic breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Doxorubicin; Epirubicin; Female; Humans; Liver Neoplasms; Middle Aged; Mitoxantrone; Salvage Therapy; Skin Neoplasms | 1993 |
[A case of liver metastasis from retroperitoneal leiomyosarcoma successfully treated by intra-arterial infusion chemotherapy of adriamycin or epirubicin using an implantable reservoir].
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Leiomyosarcoma; Liver Neoplasms; Middle Aged; Prognosis; Retroperitoneal Neoplasms | 1993 |
Dynamic MR imaging and early-phase helical CT for detecting small intrahepatic metastases of hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Epirubicin; Evaluation Studies as Topic; Female; Humans; Image Processing, Computer-Assisted; Iodized Oil; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Sensitivity and Specificity; Tomography, X-Ray Computed | 1996 |
[Rupture of a liver cell carcinoma after chemoembolization].
Topics: Aged; Angiography; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Extravasation of Diagnostic and Therapeutic Materials; Humans; Iodized Oil; Liver; Liver Diseases; Liver Neoplasms; Male; Palliative Care; Rupture, Spontaneous; Tomography, X-Ray Computed | 1996 |
Squamous oesophageal cancer can be downstaged using protracted venous infusion of 5-fluorouracil with epirubicin and cisplatin (ECF).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Infusions, Intravenous; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Prospective Studies; Radiography; Remission Induction; Survival Analysis | 1995 |
[Long-term survival of patients with inoperable hepatocarcinoma, treated with interventional radiology].
Topics: Actuarial Analysis; Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Epirubicin; Female; Follow-Up Studies; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Palliative Care; Radiography, Interventional; Tomography, X-Ray Computed | 1995 |
[Therapy-related AML(M2) with t(8;21) that developed three years after chemotherapy for hepatocellular carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Doxorubicin; Epirubicin; Etoposide; Humans; Leukemia, Myeloid, Acute; Liver Neoplasms; Male; Middle Aged; Neoplasms, Second Primary; Translocation, Genetic | 1996 |
[A case of AFP (alpha-fetoprotein) producing gastric cancer successfully treated with FEP (5-FU, Epirubicin, cisplatin) therapy by continuous venous daily infusion of 5-FU and low-dose CDDP].
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Epirubicin; Fluorouracil; Humans; Infusions, Intravenous; Liver Neoplasms; Male; Middle Aged; Stomach Neoplasms | 1996 |
[Intra-arterial infusion chemotherapy for liver metastases from breast cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Epirubicin; Female; Floxuridine; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Medroxyprogesterone; Middle Aged | 1996 |
[A case of advanced hepatoma cured by repeated percutaneous isolated liver perfusion using hepatic venous isolation and charcoal hemoperfusion].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Charcoal; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Hemoperfusion; Hepatic Veins; Humans; Liver Neoplasms; Middle Aged; Perfusion | 1996 |
Fibrolamellar hepatocellular carcinoma responsive to platinum-based combination chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Hepatocellular; Cisplatin; Combined Modality Therapy; Epirubicin; Fluorouracil; Humans; Leucovorin; Liver; Liver Neoplasms; Male; Tomography, X-Ray Computed; Treatment Outcome | 1996 |
Human hepatoma cells rich in P-glycoprotein are sensitive to aclarubicin and resistant to three other anthracyclines.
Topics: Aclarubicin; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Cell Division; Cell Membrane; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Epirubicin; Humans; Liver Neoplasms; Microscopy, Confocal; Tumor Cells, Cultured | 1996 |
Arteritis following intra-arterial chemotherapy for liver tumors.
Topics: Aged; Antibiotics, Antineoplastic; Arteritis; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Gelatin Sponge, Absorbable; Hepatic Artery; Humans; Injections, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin; Radiography | 1997 |
Combination of transcatheter arterial embolization and percutaneous ethanol injection for hepatocellular carcinoma: comparison of efficacies of doxorubicin and epirubicin in transcatheter arterial embolization.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Doxorubicin; Epirubicin; Ethanol; Female; Humans; Injections, Intralesional; Liver Neoplasms; Male; Middle Aged; Survival Rate | 1997 |
Appraisal of combination treatment for hepatocellular carcinoma: long-term follow-up and lipiodol-percutaneous ethanol injection therapy.
Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Doxorubicin; Epirubicin; Ethanol; Female; Follow-Up Studies; Humans; Injections, Intralesional; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Survival Rate | 1997 |
Zinostatin stimalamer-transcatheter arterial embolization for hepatocellular carcinoma: a comparison with lipiodol-transcatheter arterial embolization.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Male; Maleic Anhydrides; Middle Aged; Polystyrenes; Radiography; Survival Rate; Zinostatin | 1997 |
Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Ethanol; Female; Gelatin Sponge, Absorbable; Humans; Injections, Intralesional; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Rate | 1997 |
Combined therapy with external beam irradiation and hepatic arterial epirubicin infusion through an implanted port for advanced hepatocellular carcinoma.
Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Catheters, Indwelling; Combined Modality Therapy; Epirubicin; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Survival Rate | 1997 |
Regional adjuvant chemotherapy after partial hepatectomy for metastatic colorectal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Catheters, Indwelling; Chemotherapy, Adjuvant; Colorectal Neoplasms; Doxorubicin; Epirubicin; Female; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Survival Rate | 1997 |
[Performance and complications of totally implantable port device in bolus hepatic intra-arterial chemotherapy].
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Cisplatin; Epirubicin; Female; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Time Factors | 1997 |
Chemoembolization for small hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Humans; Infusions, Intra-Arterial; Iodized Oil; Lidocaine; Liver Neoplasms; Portal Vein | 1997 |
[Long-term survival cases of hepatocellular carcinoma with portal tumor thrombus by repeated arterial infusion chemotherapy using implantable port system].
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Epirubicin; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Neoplastic Cells, Circulating; Portal System | 1997 |
[Combined intra-arterial locoregional and systemic treatment of nonresectable hepatic metastases of colorectal carcinoma].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Male; Middle Aged; Mitomycin; Time Factors | 1997 |
Spontaneous regression of hepatocellular carcinoma: a case report.
Topics: Aged; alpha-Fetoproteins; Antibiotics, Antineoplastic; Biomarkers, Tumor; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Epirubicin; Ethanol; Female; Hepatic Artery; Humans; Iodized Oil; Liver Neoplasms; Neoplasm Regression, Spontaneous; Remission Induction; Tomography, X-Ray Computed; Ultrasonography | 1997 |
[Percutaneous transcatheter thermotherapy (PTCT): use of hotwire for local tumor control].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheterization; Combined Modality Therapy; Epirubicin; Female; Humans; Hyperthermia, Induced; Liver Neoplasms; Male; Middle Aged; Mitomycin; Rectal Neoplasms; Stomach Neoplasms | 1997 |
[Hepatic arterial chemotherapy for liver cancer over a period of 8 years].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Stomach Neoplasms; Survival Rate | 1997 |
[Evaluation of hepatic resection and hepatic arterial infusion chemotherapy for multiple liver metastases from colon cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Epirubicin; Female; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate | 1997 |
[A case report of Vp3 hepatocellular carcinoma responding to multidisciplinary treatment].
Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Epirubicin; Hepatic Artery; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Neoplastic Cells, Circulating; Portal System | 1997 |
[A case of liver metastases from leiomyosarcoma in the chest wall which was made resectable by chemoembolization].
Topics: Adult; Antibiotics, Antineoplastic; Combined Modality Therapy; Embolization, Therapeutic; Epirubicin; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Iodized Oil; Leiomyosarcoma; Liver Neoplasms; Male; Thoracic Neoplasms | 1997 |
[A case of hepatic arterial infusion chemotherapy for multiple liver metastasis from breast cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Mastectomy; Middle Aged; Pleural Neoplasms | 1997 |
[Liver metastases from breast cancer 14 years after radical mastectomy; successful treatment with hepatic arterial infusion chemotherapy and systemic endocrine therapy--a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Epirubicin; Fadrozole; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Lymphatic Metastasis; Mastectomy, Radical; Medroxyprogesterone; Mitomycin; Time Factors | 1997 |
[Complication of reservoir hepatic artery infusion chemotherapy and additional treatments].
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Embolization, Therapeutic; Epirubicin; Equipment Contamination; Equipment Failure; Extravasation of Diagnostic and Therapeutic Materials; Female; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Prognosis | 1997 |
Comparison of resection, liver transplantation and transcatheter oily chemoembolisation in the treatment of hepatocellular carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Doxorubicin; Epirubicin; Humans; Liver Neoplasms; Liver Transplantation; Neoplasm Staging; Retrospective Studies; Survival Rate; Treatment Outcome | 1997 |
The long term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheterization, Peripheral; Chemoembolization, Therapeutic; Contrast Media; Doxorubicin; Epirubicin; Ethanol; Female; Gelatin Sponge, Absorbable; Hepatic Artery; Humans; Injections, Intralesional; Iodized Oil; Liver Cirrhosis; Liver Neoplasms; Longitudinal Studies; Male; Middle Aged; Proportional Hazards Models; Safety; Solvents; Survival Rate | 1998 |
Combined transcatheter arterial chemoembolization and percutaneous ethanol injection for the treatment of large hepatocellular carcinoma: local therapeutic effect and long-term survival rate.
Topics: Actuarial Analysis; Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Catheterization, Peripheral; Chemoembolization, Therapeutic; Disease Progression; Epirubicin; Ethanol; Female; Follow-Up Studies; Humans; Injections, Intralesional; Liver Cirrhosis; Liver Failure; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Remission Induction; Survival Rate; Tomography, X-Ray Computed | 1998 |
[Repeated arterial infusion of zinostatin stimalamer using port for advanced hepatocellular carcinoma].
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Drug Administration Schedule; Epirubicin; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Iodized Oil; Liver Cirrhosis; Liver Neoplasms; Male; Maleic Anhydrides; Middle Aged; Polystyrenes; Zinostatin | 1998 |
[Arterial infusion of SMANCS for multiple recurrent tumors after hepatic resection].
Topics: Adult; Aged; Aged, 80 and over; Anorexia; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Embolization, Therapeutic; Epirubicin; Female; Hepatectomy; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Maleic Anhydrides; Middle Aged; Nausea; Neoplasm Recurrence, Local; Polystyrenes; Zinostatin | 1998 |
[Transcatheter arterial embolization with SMANCS and epiADM for hepatocellular carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Administration Schedule; Embolization, Therapeutic; Epirubicin; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Maleic Anhydrides; Middle Aged; Polystyrenes; Zinostatin | 1998 |
Differential resistance to anthracyclines in P-glycoprotein-expressing human hepatoma cells.
Topics: Aclarubicin; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Cyclosporins; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Epirubicin; Humans; Liver Neoplasms; Tumor Cells, Cultured | 1998 |
Long-term chemotherapy of ovarian cancer: two case reports.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Chemotherapy, Adjuvant; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Fatal Outcome; Female; Follow-Up Studies; Humans; Liver Neoplasms; Long-Term Care; Medroxyprogesterone; Middle Aged; Ovarian Neoplasms; Ovariectomy; Pancreatic Neoplasms | 1998 |
[Percutaneous positioning of port catheter in the hepatic artery for chemotherapy of metastases using the Arai technique].
Topics: Adult; Aged; Angiography; Antibiotics, Antineoplastic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Catheters, Indwelling; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Male; Middle Aged; Mitomycins; Radiography, Interventional; Radiography, Thoracic; Time Factors | 1998 |
Effective TAE therapy using Lipiodol with epirubicin for liver metastases of nonfunctioning islet cell carcinoma of the pancreas.
Topics: Adult; Antibiotics, Antineoplastic; Carcinoma, Islet Cell; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Contrast Media; Epirubicin; Hepatic Artery; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Pancreatectomy; Pancreatic Neoplasms; Pancreaticoduodenectomy; Tomography, X-Ray Computed | 1998 |
Coupled-column liquid chromatographic analysis of epirubicin and metabolites in biological material and its application to optimization of liver cancer therapy.
Topics: Chromatography, Liquid; Drug Delivery Systems; Epirubicin; Humans; Indicators and Reagents; Iodized Oil; Liver Neoplasms; Spectrometry, Fluorescence | 1995 |
[Transcatheter oily chemoembolization and intermittent hepatic artery infusion chemotherapy in the management of advanced hepatocellular carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Drug Administration Schedule; Epirubicin; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Mitomycin | 1998 |
[Appearance of extrahepatic lesions in the superior lip and orbit of a patient with liver metastases of gastric cancer following partial response by hepatic arterial infusion chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Epirubicin; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Lip Neoplasms; Liver Neoplasms; Male; Mitomycin; Orbital Neoplasms; Stomach Neoplasms | 1998 |
[Preparation and in vitro activity of monoclonal antibody-pharmorubicin immunoconjugates].
Topics: Antibodies, Monoclonal; Epirubicin; Humans; Immunotoxins; Liver Neoplasms; Tumor Cells, Cultured | 1996 |
[A case of surgical resection for metachronous multiple liver metastases of chromophobe cell renal carcinoma].
Topics: Carcinoma, Renal Cell; Embolization, Therapeutic; Epirubicin; Female; Hepatectomy; Humans; Iodized Oil; Kidney Neoplasms; Liver Neoplasms; Middle Aged | 1998 |
Electrogastrographic study of the effect of transcatheter arterial chemoembolization on gastric myoelectric activity.
Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Case-Control Studies; Chemoembolization, Therapeutic; Electrodiagnosis; Epirubicin; Female; Hepatic Artery; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Myoelectric Complex, Migrating; Stomach; Time Factors | 1998 |
The watershed between right and left hepatic artery territories: findings on CT scans after transcatheter oily chemoembolization of hepatic tumors. A preliminary report.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Antibiotics, Antineoplastic; Catheterization, Peripheral; Chemoembolization, Therapeutic; Contrast Media; Epirubicin; Female; Hepatic Artery; Hepatic Veins; Humans; Iodized Oil; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Portal Vein; Portography; Tomography, X-Ray Computed | 1998 |
Nausea and vomiting induced by arterial chemo-embolization in patients with hepatocellular carcinoma and the antiemetic effect of ondansetron hydrochloride.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antiemetics; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Eating; Epirubicin; Female; Follow-Up Studies; Humans; Incidence; Infusions, Intra-Arterial; Injections, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Maleic Anhydrides; Middle Aged; Mitomycin; Nausea; Ondansetron; Polystyrenes; Quality of Life; Vomiting; Zinostatin | 1999 |
Epirubicin in a breast cancer patient with Gilbert's syndrome: apparent lack of major pharmacokinetic alterations.
Topics: Adult; Antibiotics, Antineoplastic; Area Under Curve; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Follow-Up Studies; Gilbert Disease; Humans; Liver Neoplasms; Treatment Outcome | 1999 |
Use of a combined CT-angiography system for demonstration of correlative anatomy during embolotherapy for hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Angiography; Angiography, Digital Subtraction; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Catheterization, Peripheral; Chemoembolization, Therapeutic; Contrast Media; Epirubicin; Female; Fluoroscopy; Gelatin Sponge, Absorbable; Hepatic Artery; Humans; Iodized Oil; Iopamidol; Liver; Liver Neoplasms; Male; Middle Aged; Tomography, X-Ray Computed | 1999 |
[A case of breast cancer with liver metastases responding remarkably to combination therapy of mitoxantrone (MIT), doxifluridine (5'-DFUR) and medroxyprogesterone acetate (MPA)].
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Resistance, Neoplasm; Epirubicin; Female; Floxuridine; Fluorouracil; Humans; Liver Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Mitoxantrone; Tamoxifen | 1999 |
Efficacy of an implanted drug delivery system for advanced hepatocellular carcinoma using 5-fluorouracil, epirubicin and mitomycin C.
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate | 1999 |
[A patient with hepatic metastasis of breast cancer successfully treated with combined chemoendocrine therapy using epirubicin, tegafur and tamoxifen].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Drug Administration Schedule; Epirubicin; Female; Humans; Liver Neoplasms; Middle Aged; Remission Induction; Tamoxifen; Tegafur | 1999 |
[A case of recurrent breast cancer successfully treated with docetaxel].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Middle Aged; Paclitaxel; Taxoids | 1999 |
[Percutaneous ethanol injection therapy with hepatic arterial infusion chemotherapy for liver metastases from gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Ethanol; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Injections, Intralesional; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin; Stomach Neoplasms; Survival Rate | 1999 |
[A case report: disappearance of cancer cells confirmed by surgical resection after transcatheter hepatic artery embolization (TAE) for ruptured hepatocellular carcinoma].
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Combined Modality Therapy; Embolization, Therapeutic; Epirubicin; Hepatectomy; Humans; Iodized Oil; Liver Neoplasms; Male; Rupture, Spontaneous | 1999 |
[A case of intra-arterial infusion chemotherapy for liver metastases of breast cancer].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Papillary; Drug Administration Schedule; Epirubicin; Female; Floxuridine; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Medroxyprogesterone; Middle Aged | 1999 |
Power Doppler sonography of hepatocellular carcinoma treated by transcatheter arterial chemoembolization. Assessment of the therapeutic effect.
Topics: Aged; Aged, 80 and over; Angiography; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Epirubicin; False Negative Reactions; False Positive Reactions; Female; Gelatin Sponge, Absorbable; Hepatectomy; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography, Doppler | 1999 |
Intraarterial chemoembolisation with lipiodol and epirubicin in hepatocellular cancer--improved survival in some patients?
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Survival Analysis | 1999 |
[Two cases of transcatheter therapy to hepatocellular carcinoma supplied by the right internal mammary artery].
Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Embolization, Therapeutic; Epirubicin; Gelatin; Humans; Iodized Oil; Liver Neoplasms; Male; Mammary Arteries; Middle Aged | 2000 |
[Transcatheter arterial embolization for advanced hepatocellular carcinoma--indications and limitations].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Doxorubicin; Embolization, Therapeutic; Epirubicin; Hepatic Artery; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms | 2000 |
[Hepatic arterial infusion chemotherapy using totally implantable port system].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin | 2000 |
Effect of segmental transcatheter arterial chemoembolization on branched chain amino acids and tyrosine ratio in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Amino Acids, Branched-Chain; Ammonia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality Therapy; Doxorubicin; Embolization, Therapeutic; Emulsions; Epirubicin; Female; Humans; Injections, Intra-Arterial; Iodized Oil; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Prothrombin Time; Tyrosine | 2000 |
[A study of liver metastasis from colorectal cancer in which hepatic resection was performed after hepatic arterial infusion chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Male; Middle Aged; Rectal Neoplasms | 2000 |
[Multimodality therapy for synchronous liver metastases of gastric cancer--significance of aggressive hepatic resection of liver lesions].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Electrocoagulation; Epirubicin; Ethanol; Female; Gastrectomy; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Microwaves; Middle Aged; Prognosis; Stomach Neoplasms | 2000 |
[Transcatheter arterial chemo-embolization using degradable starch microspheres (DSM) markedly effective for post-hepatectomy intra-hepatic recurrence in a patient with cholangioma].
Topics: Aged; Antibiotics, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cholangiocarcinoma; Epirubicin; Hepatectomy; Humans; Liver Neoplasms; Male; Microspheres; Mitomycin; Neoplasm Recurrence, Local; Postoperative Period; Starch | 2000 |
[Malignant islet cell tumor of the pancreas with multiple liver metastases effectively treated by transcatheter arterial embolization with degradable starch microspheres--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Islet Cell; Chemoembolization, Therapeutic; Cisplatin; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Microspheres; Middle Aged; Pancreatic Neoplasms; Starch | 2000 |
[A case report of successful transcatheter arterial embolization therapy for osseous metastasis of hepatocellular carcinoma].
Topics: Aged; Antibiotics, Antineoplastic; Bone Neoplasms; Carcinoma, Hepatocellular; Embolization, Therapeutic; Epirubicin; Humans; Iodized Oil; Liver Neoplasms; Male; Pelvic Bones | 2000 |
[Repetitive chemo-embolization with degradable starch microspheres (DSM) to each left and replaced right hepatic artery in a patient with multiple liver metastases of colon cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Colonic Neoplasms; Epirubicin; Fluorouracil; Hepatic Artery; Humans; Liver Neoplasms; Male; Mesenteric Artery, Superior; Microspheres; Middle Aged; Mitomycin; Starch | 2000 |
[A case of hepatocellular carcinoma fed by the cystic artery treated with chemolipiodolization therapy].
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Embolization, Therapeutic; Epirubicin; Gallbladder; Humans; Iodized Oil; Liver Neoplasms; Male | 2000 |
Contrast-enhanced subtraction harmonic sonography for evaluating treatment response in patients with hepatocellular carcinoma.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Epirubicin; Female; Humans; Liver Neoplasms; Male; Polysaccharides; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Ultrasonography | 2001 |
Comparison of double and triple high-dose chemotherapy with autologous blood stem cell transplantation in patients with metastatic breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Dose-Response Relationship, Drug; Epirubicin; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Liver Neoplasms; Middle Aged; Paclitaxel; Soft Tissue Neoplasms; Thiotepa; Treatment Outcome | 2001 |
[Long-term survival of a patient with postoperative liver metastasis of stage IVa gallbladder cancer responding to hepatic arterial infusion chemotherapy].
Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Duodenal Neoplasms; Epirubicin; Fluorouracil; Gallbladder Neoplasms; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin | 2001 |
Malignant fibrous histiocytoma of the trunk metastatic to the liver: treatment with transcatheter intrahepatic chemoembolization.
Topics: Carboplatin; Chemoembolization, Therapeutic; Epirubicin; Histiocytoma, Benign Fibrous; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin; Thoracic Neoplasms | 2001 |
Metastatic breast cancer with resistance to both anthracycline and docetaxel successfully treated with weekly paclitaxel.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Drug Resistance, Neoplasm; Epirubicin; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Liver Neoplasms; Paclitaxel; Salvage Therapy; Taxoids | 2001 |
[Clinical effectiveness of intra-arterial chemotherapy combined with degradable starch microspheres (DSM) for liver metastases and prediction of effectiveness by diagnostic imaging].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Colorectal Neoplasms; Epirubicin; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Starch; Stomach Neoplasms; Tomography, X-Ray Computed | 2001 |
[Transarterial chemoembolization (TAE) with degradable starch microspheres (DSM) in advanced hepatocellular carcinoma].
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Gelatin Sponge, Absorbable; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Starch | 2001 |
Testicular germ cell tumor with rhabdomyosarcoma successfully treated by disease-adapted chemotherapy including high-dose chemotherapy: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Cell Differentiation; Cisplatin; Combined Modality Therapy; Diphosphonates; Epirubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Liver Neoplasms; Lumbar Vertebrae; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Multiple Primary; Orchiectomy; Pamidronate; Remission Induction; Rhabdomyosarcoma; Seizures; Seminoma; Spinal Neoplasms; Teratoma; Testicular Neoplasms; Transplantation, Autologous | 2001 |
Clinical and pharmacokinetic data of a docetaxel-epirubicin combination in metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Progression; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Humans; Liver Neoplasms; Middle Aged; Paclitaxel; Taxoids | 2001 |
Successful management of breast cancer with liver metastases with medroxyprogesterone acetate treatment.
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Mastectomy, Radical; Medroxyprogesterone Acetate; Tomography, X-Ray Computed; Treatment Outcome | 2001 |
Resistance of multicellular aggregates to pharmorubicin observed in human hepatocarcinoma cells.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Aggregation; Cell Survival; Drug Resistance, Neoplasm; Epirubicin; Flow Cytometry; Humans; Liver Neoplasms; Male; Microscopy, Electron; Microscopy, Electron, Scanning; Middle Aged; Spheroids, Cellular; Tumor Cells, Cultured | 2002 |
Role of 2-[18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) in the early assessment of response to chemotherapy in metastatic breast cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Deoxycytidine; Drug Monitoring; Epirubicin; Female; Fluorodeoxyglucose F18; Gemcitabine; Glucose; Humans; Liver Neoplasms; Lung Neoplasms; Paclitaxel; Predictive Value of Tests; Radiopharmaceuticals; Remission Induction; Soft Tissue Neoplasms; Survival Analysis; Time Factors; Tomography, Emission-Computed; Treatment Outcome | 2000 |
[A case of gastric cancer with multiple liver metastasis treated with transarterial and transportal chemoembolization of tegafur/lipiodol and epirubicin].
Topics: Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Combined Modality Therapy; Epirubicin; Female; Gastrectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Middle Aged; Ovariectomy; Portal System; Stomach Neoplasms; Tegafur | 1992 |
[A case with hepatocellular carcinoma effectively treated by continuous hepatic arterial infusion of etoposide, epirubicin and CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Epirubicin; Etoposide; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged | 1992 |
Treatment of inoperable hepatocellular carcinoma by intra-arterial lipiodol and 4'-epidoxorubicin.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Remission Induction; Survival Analysis | 1992 |
[Chemoembolization of hepatocellular carcinoma in cases of isolated liver involvement].
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Germany, West; Humans; Liver Neoplasms; Male; Middle Aged; Retrospective Studies | 1992 |
[A case of hepatocellular carcinoma responding to intraarterial infusion of epirubicin and mitomycin C].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Epirubicin; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin | 1992 |
Hepatocellular carcinoma and transcatheter oily chemoembolization in Thailand.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Gelatin Sponge, Absorbable; Humans; Incidence; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate; Thailand | 1992 |
[Repeated arterial infusion chemotherapy for inoperable hepatocellular carcinoma using implantable drug delivery system].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate | 1992 |
[Dose finding of epirubicin in transcatheter hepatic chemoembolization].
Topics: Chemoembolization, Therapeutic; Epirubicin; Hepatic Artery; Humans; Iodized Oil; Liver; Liver Neoplasms | 1992 |
Transcatheter hepatic arterial chemoembolization using epirubicin-lipiodol: experimental and pharmacological evaluation.
Topics: Aged; Aged, 80 and over; Chemoembolization, Therapeutic; Drug Stability; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged | 1992 |
[Chemoembolization in the therapy of hepatocarcinoma. A 3-year experience].
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Epirubicin; Female; Humans; Iodized Oil; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Care; Preoperative Care | 1992 |
[The palliative treatment of primary hepatocellular carcinoma by chemoembolization].
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Palliative Care; Prospective Studies; Remission Induction | 1992 |
[The results of the chemoembolization of advanced hepatocellular carcinomas. The effect on the survival times, morphological findings and tumor markers].
Topics: Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Remission Induction; Survival Analysis | 1992 |
Clinical pharmacokinetics of epirubicin: the importance of liver biochemistry tests.
Topics: Adult; Aged; Aspartate Aminotransferases; Bilirubin; Breast Neoplasms; Epirubicin; Female; Humans; Liver; Liver Function Tests; Liver Neoplasms; Middle Aged | 1992 |
Primary liver cancer in Hong Kong.
Topics: Adult; Aged; Epirubicin; Etoposide; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged | 1992 |
[Intermittent intra-arterial infusion chemotherapy using implantable reservoir for the treatment of hepatic metastasis].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Infusion Pumps, Implantable; Liver Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate | 1992 |
[Therapeutic results of intra-arterial infusion chemotherapy using an implantable reservoir on metastatic liver tumors].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Prognosis; Stomach Neoplasms; Treatment Outcome | 1992 |
[Treatment of liver metastases from gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Gastrectomy; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Stomach Neoplasms | 1992 |
[A pharmacokinetic study of intra-arterial chemotherapy for prophylactic treatment of liver metastasis after hepatectomy for liver cancer].
Topics: Chemotherapy, Adjuvant; Doxorubicin; Epirubicin; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Liver; Liver Neoplasms; Mitomycin; Neoplasm Recurrence, Local; Postoperative Care | 1992 |
[Evaluation of repeated hepatic dearterialization combined with intra-arterial infusion chemotherapy of unresectable primary or secondary cancer of the liver].
Topics: Catheterization; Catheters, Indwelling; Combined Modality Therapy; Doxorubicin; Epirubicin; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Mitomycin; Prognosis; Stomach Neoplasms; Survival Rate | 1992 |
Selective regional chemotherapy of unresectable hepatic tumours using lipiodol.
Topics: Adenocarcinoma; Carcinoma, Hepatocellular; Emulsions; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Middle Aged | 1991 |
[Chemoembolization of primary liver cancer using epirubicin-lipiodol].
Topics: Adenoma, Bile Duct; Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Follow-Up Studies; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Survival Analysis | 1991 |
Phase II intravenous study of epirubicin with 5-fluorouracil in patients with advanced hepatocellular carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Dose-Response Relationship, Drug; Drug Evaluation; Epirubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Time Factors | 1991 |
Epirubicin in breast cancer patients with liver metastases and abnormal liver biochemistry: initial weekly treatment followed by rescheduling and intensification.
Topics: Adult; Aged; Analysis of Variance; Aspartate Aminotransferases; Bilirubin; Breast Neoplasms; Drug Administration Schedule; Epirubicin; Female; Humans; Liver; Liver Neoplasms; Middle Aged; Remission Induction | 1991 |
[Nutritional support for cancer bearing patients].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Fluorouracil; Home Nursing; Humans; Infusion Pumps, Implantable; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplasms; Parenteral Nutrition, Home; Quality of Life; Stomach Neoplasms | 1991 |
[Antitumor activities of oily suspended zinostatin stimalamer (YM 881) against VX2 carcinoma implanted in the liver of rabbits--comparison with another anticancer agent].
Topics: Animals; Antineoplastic Agents; Cell Division; Epirubicin; Female; Humans; Liver Neoplasms; Maleic Anhydrides; Neoplasm Transplantation; Polystyrenes; Rabbits; Zinostatin | 1991 |
[Hepatic arterial infusion of farmorubicin (FARM) and 5-fluorouracil (5-FU) in a patient with massive hepatic metastasis from gastric cancer].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Stomach Neoplasms | 1991 |
[Chemical embolization of carcinoid metastases in the liver].
Topics: Adult; Aged; Carcinoid Tumor; Embolization, Therapeutic; Epirubicin; Female; Gelatin Sponge, Absorbable; Hepatic Artery; Humans; Liver Neoplasms; Male; Middle Aged; Powders | 1990 |
[Chemoembolization of hepatocellular carcinoma with lipiodol, epirubicin and cisplatin].
Topics: Carcinoma, Hepatocellular; Cisplatin; Drug Combinations; Embolization, Therapeutic; Epirubicin; Hepatic Artery; Humans; Injections, Intra-Arterial; Iodized Oil; Liver Neoplasms; Middle Aged; Prognosis; Time Factors | 1989 |
[Chemoembolization of hepatocellular carcinoma--computed tomographic follow-up observation].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Combined Modality Therapy; Embolization, Therapeutic; Emulsions; Epirubicin; Female; Follow-Up Studies; Hepatic Artery; Humans; Iodized Oil; Liver; Liver Neoplasms; Male; Middle Aged; Time Factors; Tomography, X-Ray Computed | 1989 |
Weekly epirubicin for breast cancer with liver metastases and abnormal liver biochemistry.
Topics: Adult; Aged; Aspartate Aminotransferases; Bilirubin; Breast Neoplasms; Epirubicin; Female; Humans; Liver Neoplasms; Middle Aged; Time Factors | 1989 |
The efficacy of high-dose 4'epidoxorubicin in hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Doxorubicin; Epirubicin; Female; Humans; Liver Neoplasms; Male; Middle Aged | 1988 |
The role of pharmacokinetics in the clinical treatment of metastases.
Topics: Antineoplastic Agents; Doxorubicin; Epirubicin; Humans; Liver Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Neoplasms; Tamoxifen | 1988 |
4'Epidoxorubicin (epirubicin): activity in hepatocellular carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Doxorubicin; Drug Evaluation; Epirubicin; Female; Heart Diseases; Humans; Liver Neoplasms; Male; Middle Aged | 1985 |
Epirubicin pharmacokinetics after intrahepatic arterial and intraperitoneal administration.
Topics: Adult; Carcinoma, Hepatocellular; Colonic Neoplasms; Doxorubicin; Epirubicin; Female; Hepatic Artery; Humans; Injections, Intra-Arterial; Injections, Intraperitoneal; Kinetics; Liver Neoplasms; Male; Middle Aged; Rectal Neoplasms | 1985 |
[Intra-arterial administration of epirubicin in the treatment of non-resectable hepatocellular carcinoma. Epirubicin Study Group for Hepatocellular Carcinoma].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged | 1986 |
Intra-arterial administration of epirubicin in the treatment of nonresectable hepatocellular carcinoma. Epirubicin Study Group for Hepatocellular Carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Doxorubicin; Epirubicin; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Remission Induction; Tomography, X-Ray Computed | 1987 |
Interim results of intra-arterial 4'-epi-doxorubicin for liver metastases.
Topics: Adult; Aged; Colonic Neoplasms; Doxorubicin; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Rectal Neoplasms; Stereoisomerism | 1988 |
Epirubicin in rectal cancer.
Topics: Adult; Aged; Drug Evaluation; Epirubicin; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Rectal Neoplasms; Stereoisomerism | 1988 |
Comparative pharmacokinetics of doxorubicin and epirubicin in patients with gastrointestinal cancer.
Topics: Aged; Chromatography, High Pressure Liquid; Doxorubicin; Epirubicin; Female; Gastrointestinal Neoplasms; Humans; Intraoperative Period; Kinetics; Liver Neoplasms; Male; Middle Aged; Muscles | 1986 |
A pharmacokinetic study of adriamycin and 4'epi-adriamycin after simultaneous intra-arterial liver administration.
Topics: Adult; Aged; Doxorubicin; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Kinetics; Liver Neoplasms; Male; Middle Aged; Stereoisomerism | 1986 |
Anthracycline in colorectal carcinoma: an in vitro short-term assay to predict drug sensitivity. Preliminary results.
Topics: Colonic Neoplasms; DNA, Neoplasm; Doxorubicin; Drug Evaluation, Preclinical; Drug Resistance; Epirubicin; Humans; In Vitro Techniques; Liver Neoplasms; Rectal Neoplasms; RNA, Neoplasm | 1987 |
Intrahepatic arterial administration of 4'epidoxorubicin (epirubicin) in advanced cancer patients. A pharmacokinetic study.
Topics: Aged; Colonic Neoplasms; Doxorubicin; Epirubicin; Hepatic Artery; Humans; Infusions, Intra-Arterial; Kinetics; Liver Neoplasms; Middle Aged; Rectal Neoplasms | 1986 |
[Prevention of hepatic metastasis in patients operated on for colorectal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Doxorubicin; Epirubicin; Fluorouracil; Humans; Liver Neoplasms; Rectal Neoplasms | 1987 |
Effectiveness of scalp cooling in reducing alopecia caused by epirubicin treatment of advanced breast cancer.
Topics: Alopecia; Breast Neoplasms; Doxorubicin; Epirubicin; Female; Hypothermia, Induced; Liver Neoplasms | 1987 |
The rationale for intra-arterial chemotherapy.
Topics: Animals; Antineoplastic Agents; Doxorubicin; Epirubicin; Fluorouracil; Humans; Injections, Intra-Arterial; Injections, Intravenous; Liver Neoplasms; Rats | 1987 |
Epirubicin plasma and blood pharmacokinetics after single i.v. bolus in advanced cancer patients.
Topics: Bile; Doxorubicin; Epirubicin; Half-Life; Humans; Kidney Diseases; Kinetics; Liver Neoplasms; Mathematics; Neoplasms | 1985 |